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RÉSUMÉ:
Récemment, l’intérêt pour l’étude du métabolisme des cellules cancéreuses et
pour sa participation au développement tumoral s’est accru du fait de l’augmentation
des risques de cancers chez les personnes obèses. En effet, plusieurs études
épidémiologiques ont indiqué un lien entre obésité et cancers mais les mécanismes
moléculaires impliqués sont largement inconnus. Chez les personnes présentant une
résistance â l’insuline due à l’obésité, la métabolisation des acides gras libres (AGL)
par les adipocytes devient insuffisante, causant une augmentation du taux sanguin en
AGL. Peu de données permettent de comprendre comment les tissus et spécialement
les tumeurs gèrent ce surplus de nutriments.
Ces dernières années, notre laboratoire a étudié les effets des AG
alimentaires sur la prolifération et la mort de cellules issues de tumeurs mammaires
humaines en culture. Le but de cette étude était de rechercher la base biochimique de
l’action anti-apoptotique de l’oléate, un acide gras mono-insaturé à longue chaîne,
sur des cellules provenant de cancer du sein humain. Nous nous sommes
particulièrement concentrés sur le rôle de l’accumulation des triglycérides (TG)
induite par le traitement à l’oléate sur l’apoptose provoquée par l’absence de sérum
et de facteurs de croissance (FC) sur deux lignées cellulaires tes cellules MCF-IOA,
cellules immortalisées non-transformées épithéliales humaines et les cellules MDA
MB-231, lignée de cellules issues de cancer du sein humain. Les métabolismes des
AG, des 1G et du glucose, en parallèle avec la survie cellulaire à long terme en
absence de sérum et de FC ont été étudiés sur des cellules traitées avec de l’oléate.
L’effet de l’oÏéate a été étendu à plusieurs autres lignées cancéreuses mammaires
MDA-MB-468, T-47D, MCF-7.
Nous avons montré qu’un traitement de 3 à 24 h avec l’oléate empêche
l’apoptose induite par l’absence de sérum et de FC et favorise la survie cellulaire à
long terme suite au traitement de 3 des 4 lignées cellulaires mammaires humaines.
La survie de ces lignées cellulaires dans ces conditions a été associée à une
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augmentation du stockage des TG. Nos résultats suggèrent que les stocks en TG dans
les cellules tumorales telles que les MDA-MB-23 1 ne sont pas inertes et au contraire
subissent un cycle constant et rapide de lipolyse des TG en AGL et re-estérification
des AGL en TG (cycle TG/AGL). Ce cycle des TG/AGL qui a augmenté de manière
dépendante de la dose d’oléate, demeure élevé durant plusieurs jours (8-10 jours)
après le retrait de l’oléate et il est parallèle à la survie cellulaire en absence de sérum.
Le métabolisme du glucose reste élevé dans les cellules MDA-MB-23 I protégées de
Ï’apoptose due à l’absence de sérum, fournissant une grande quantité de glycérol-3-
phosphate nécessaire à l’estérification des AGL.
Ces résultats sont en accord avec l’interprétation que le cycle des TG/AGL
joue un rôle dans l’effet anti-apoptotique de l’oléate. Nous proposons 2 mécanismes
complémentaires pour expliquer comment un cycle élevé des TG/AGL pourrait
favoriser la survie des cellules tumorales. Le premier impliquerait le récepteur
membranaire aux acides gras couplé aux protéines G, GPR4O, et le second est basé
sur notre modèle de travail reliant l’augmentation du cycle des TG/AGL au maintien
de rapport NAD/NADH intracellulaire nécessaire à la survie des cellules
tumorales.
Mots clés cancer sur sein, survie cellulaire, acides gras, triglycérides, lipolyse,
cycle des TG/AGL, GPR4O
VABSTRACT:
Recently, there has been a renewed interest in metaboiism and its
participation in the deveiopment of cancers, due to a major increase in obesity.
Severai epidemiologicai studies iinking obesity with cancer have been published, but
the molecular mechanisrns invoived are largely unknown. In the obesity-induced
insulin resistant state, trapping of dietary free fatty acids (FFA) in adipocytes
becomes inefficient, causing elevated blood FFA levels in the fed state, when thcy
are not needed for energy production. Littie is known how various tissues, especially
tumors, deal with this surplus of fuels.
For the iast severai years, our laboratory has been studying the effects of
common nutrient fatty acids on proliferation and death of human breast tumor ceils
in culture. The aim of the present smdy was to investigate the biochemicai basis for
the antiapoptotic action of long chain monounsaturated fatty acid oleate in human
breast cancer cells. We focused specifically on the role of TG accumulation induced
by treatment with oleate in the protection from apoptosis induced by serum and
growth factor (GF) withdrawal in two ceil unes: the MCF- 1 OA non-transformed
hurnan breast epithelial cdl strain and the human breast tumor ccli line MDA-MB
231. The rnetabolism of FfA, TG and glucose, in parallel with long-term ccli
survival in the absence of serum and additional GF, was investigated in ceils treated
with exogenous oleate. The results were extended to a panel of human breast cancer
ccli unes: MDA-MB-46$, T-47D, MCF-7.
We have shown that short-term (3-24 h) treatrnent with oleate prevents
apoptosis and promotes long-term ceil survival in the absence of serum, GF and
exogenous oleate, in three out of four hurnan breast turnor cdl unes. The iong-term
serurn-free survival in these ccli unes was associated with a high capacity to store
TG. Our data suggest that TG stores in tumor cells like MDA-MB-23 1 are not inert
and instead undergo constant rapid turnover. This TG/FFA cycling which was found
to be markedly up reguiated in a dose dependent mamier in response to short-terrn
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oÏeate treatment remained stably elevated for many days and corresponded with
long-term serum-free celi survival (8-10 days). Glucose rnetabolisrn remained higli
in serum starved MDA-MB-23 1 celis rescued from apoptosis by short-terrn
treatment with oleate, providing glycerol-3-phosphate needed for FFA esterffication.
The resuits are consistent with the interpretation that TG/FFA cycling plays a
role in the antiapoptotic effect induced by treatment with oleate. We propose two
possible, but not mutually exclusive explanations, as to how the elevated TG/FFA
cycling could promote tumor celi survival. One may involve signaling via the ce!!
surface G protein coupled receptor GPR4O and the second one is based on our
working model, which links up regulated TG/FFA cycling with the maintenance of
intracelÏular NAD7NADH ratio needed for tumor ccli survival.
Key words: breast cancer, ce!! survival, fatty acids, triacy!glycero!, lipolysis,
TG/FFA cycle, GPR4O
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CHAPTER I
INTRODUCTION
21.1 foreword
The development of cancer lias been pcrceived as a microevolution during
which ceils acquire genetic changes and are subsequently selected for growth
advantage. Evolution is shaped by environmental pressures as much as by genetic
variations. Thus, the growing tumors and metastases are influenced by surrounding
tissues and stroma as well as by many soluble factors, like hormones and
metabolites. Whule the contribution of strorna to the dcvelopment of cancers lias
been recently explored and tlie importance of hormones and growth factors is well
established, the influence of metabolism on tumorigenesis in comparison has been
relatively neglected. Recently, however, due to the major increase in obesity, studies
focusing on the contribution of metabolism to the development of cancer have
increased in number. Severat epidemiologicaÏ studies linking obesity with cancers
have been published but the molecular rnechanisms involved are Iargely unknown.
31.2 Cancer researcli in the post-genomic era
The development of cancer involves a complex sequence of events that
usuaiiy occurs over many years. The Iast five decades of the 20th centuiy were
rnarked by the astonishing development of molecular bioiogy, initiated by the
discovery of the structure of DNA [1] and cuiminated with the sequencing of the
human genome [2, 3]. The prevailing paradigm in cancer research during this time
was the somatic mutation theory (SMT) of cancer. According to SMT,
carcinogenesis takes place at the cellular level and the multi-step process of cancer
development occurs through the graduai acquisition of genetic alterations in
individual epithelial ceil. The process of tumor development is thus perceived as
analogous to Darwinian evolution, in which a succession of genetic changes and
selection for growth advantage leads to clonai expansion of cancer celis [4, 5].
Studies of various mutations that occur during cancer deveiopment heiped to identify
a number of basic features of cancers, such as self-sufficiency in growth signais,
insensitivity to growth inhibitory signais, evasion of apoptosis, limitless replicative
potentiai, sustained angiogenesis, and tissue invasion and metastasis [reviewed in 6].
Although SMT stiil remains the most widely accepted, alternative concepts
are emerging. One of them is a the tissue organization field theory (TOFT)
[reviewed in 7, 8]. According to TOFT, the graduai deterioration of tissue
organization is the main cause of tumor progression. The concept of TOFT
originated from 19th century research on the ceilular pathoiogy of cancer [9].
Interestingly, the abnonriai appearance of cancer specimens observed with the light
microscope is stili the main criteria used in breast cancer diagnosis [reviewed in 10].
The tissue microenvironment or strorna which consists of fibroblasts, endotheliai
celis forming biood vessels, adipocytes and immune celis embedded in an
extracellular matrix, together with the basement membrane (BM), which separates
the epithelium from the stroma, have profound influence on epithelial tumor
indtiction. In support of the lOFT theory are the observations that non-transforrned,
genetically normal ceils can express a malignant phenotype when exposed to aitered
stroma. Thus, normal human breast epithelial organoids from reduction
4mammoplasty can form tumors when grown as xenografts in immunocompromised
mice, in the presence of altered hurnan mammaiy fibroblasts [11, reviewed in 121.
On the other hand, pre-malignant breast epithelial celis undergo growth arrest and
fonu polarized alveolar structures similar to normal epithelia in the presence of a
reconstructed basement membrane [13]. The most compelling evidence supporting
TOFT was provided by Maffini et al. [14]. They removed mammary epithelium from
fat pads (stroma) of experirnental rats and placed them in culture. One group of
experimental animais and some epithelia from primary cultures were treated with
carcinogen. Subsequently, the mammary tissue was reconstructed in treated and
untreated rats using either carcinogen-treated or untreated mammary epitheliai ceils
from primary culture. Ail animais which were treated with carcinogen and thus
contained carcinogen-treated stroma, developed epitheliai tumors, regardless of
whether or flot the mammary epithelium used to reconstruct their mamrnary tissue
was exposed to carcinogen [14, reviewed in 15].
Another thcory of cancer, which is becoming increasingly popular, is the
stem ceil theory of cancer. Originaily inspired by the 19th century embryoiogy, the
theory is based on the fact that there are similarities in signaling pathways between
embryonic and cancer celis. Jt suggests that cancers arise from stem celis, which are
present in ail tissues and are necded for tissue renewal [reviewed in 16, 17].
The molecuiar biology studies in the field of cancer over the past five
decades revealed a remarkable cornpiexity of the processes invoived in tumor
development. Recent reexarnination of concepts alternative to SMT reflects the
necessity to look at tumor progression from many angles and at many levels of celi
and tissue organization.
5Breast cancer
1.3.1 Statistics
Breast cancer is the most common cancer diagnosed among women (afler
non-melanoma skin cancer) and is the second icading cause of cancer death after
lung cancer according to the National Cancer Institute [1$]. An estimated number of
22,300 new cases wiIl be diagnosed and over 5,300 death from this disease will
occur in Canada in the year 2006 [19]. Based on current rates, 12.7 % of women
bom today (1 in 8) wilt be diagnosed with breast cancer and 30% ofthem will die of
the disease. it is important to emphasize, however, that the risk of breast cancer
increases sharply with age. Thus, a 35-year-old woman has a risk of Ï in 2,500, a 50-
year-old woman has a risk of 1 in 50 and only at age 85 will the risk actually be 1 in
8. Breast cancer is the leading cause of death in Arnerican women between ages 50
and 55 [20].
Breast cancer incidence in U.S as well as in Canada has been rising steadily.
Although better diagnosis and an aging of the population may be partially
responsible for that, the increase seems to reflect a real trend and suggests possible
involvement of environmental and life style factors in the developrnent ofthe disease
[20]. In spite of the increase in breast cancer incidence, in many countries rnortality
rates declined during the 1990s [19, 21] (Figure 1 and 2). This is encouraging and
likely reflects improvements in managing the disease, such as early screening and
broader use of appropriate treatments.
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Figure 1. Trends since 1977 in age-standardized rates for breast and lung
cancer among women in Canada.
Rates were standardized to the age distribution of the 1991 Canadian population.
Data from Surveillance Division, CCDPC, Public Health Agency of Canada.
Source: Canadian Cancer Statistics. Canadian Cancer Society/ National Cancer
Institute of Canada, www.cancer.ca
7Figure 2. Trends since 1950 in age-standardized (25-69 years) death rates*,
comparing breast and selecteil other types of cancer, among women in UK and
USA.
*The age-standardized rate is the mean of the seven separate rates in the 5-year age
ranges 35-39 up to 65-69. Data from WHO statistics on death and on population
estimates.
Source: Early Breast cancer Irialists’ Collaborative Group (2005) Lancet 365:1687-
1717
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$1.3.2 Breast cancer as û genetic disease
One of the main risk factors for breast cancer is a family histoiy, which
suggests an inherited component in the development of the disease. Around 5—10%
of ail cases and 25—40% of cases in younger patients (under the age of 35 years)
have a hereditary origin [22]. Two major susceptibility gdnes, which were identffied
about ten years ago, are BRCA1 and BRCA2 [23, 24]. Carriers of mutations in these
genes are also at increased risk for the development of ovarian cancer [25 reviewed
in 26]. Both mutations are highly penetrant. The chromosomal location of BRCAY
and BRCA2 genes and the structures of proteins coded by the genes are known, but
their functions are stili being investigated. They are both tumor suppressors involved
in the maintenance of genome stabiiity. BRCA1 is implicated in DNA repair,
transcriptionaÏ regulation, cell-cycie progression and meiotic sex chromosome
inactivation while BRCA2 is an essentiai component of the complex responsible for
homologous recombination [27]. Both mutations account for substantial proportions
(20 % each) of ail familiar cases [28]. Additional known familiar susceptibihties to
breast cancer include mutations in other tumor suppressors such as CHEK2, a gene
encoding the protein kinase required for DNA repair and replication, which accounts
for 5% of ail familiar cases, and TP53 gene encoding the p53 protein responsible for
celi cycle arrest during DNA damage and involved in the regulation of apoptosis.
Mutations in TP53 (Li-fraumeni syndrome) are responsible for about 1% of ail
familiar cases. A small fraction of other cases are related to mutations in PTEN
(Cowden’s syndrome), LKB1 (Peutz-Jeghers syndrome) or ATM (ataxia
telangiectasia-mutated gene) [28]. ATM encodes yet another protein kinase that acts
as a tumor suppressor. Activated via damage to DNA, ATM stimulates DNA repair
and btocks ce!! cycle progression. One mechanism through which this occurs is
ATM dependent phosphorylation of p53. Despite the evident progress in
understanding the genetic causes of breast cancer, the genetic bases of the rnajority
(54 %) of ail familiar predispositions are stili not known [29].
It shou!d be noted that while the majority of known mutations predisposing
to breast cancer are irnplicated in the maintenance of genome integrity, two of the
9predisposing factors for breast cancer (PTEN and LKB 1) are also linked to nutrient
uptake and the regulation of metabolism. Their place in the network of nutrient
sensing and signaling for survival is shown in Figure 3.
1.3.3 Non-geneticjàctors involved in breast cancer deveÏopment
- estrogens
Breast cancer is a heterogeneous disease in its clinical, genetic and
biochemical profile. It arises from the epithelium of the mammary gland (milk
producing lobules and ducts, whicb transport rnilk to the nipple). Malignant
transformation of the stromal components (fibroblasts, endothelial ceils forrning
blood vessels and adipocytes) is very rare and it is flot included in this category [20].
There is evidence that estrogens, the steroid hormones essential for development and
function of a normal mammary gland, play an important roTe in the development of
breast cancer. Thus, the risk ofthe malignancy is related to the cumulative exposure
to endogenous and exogenous estrogens and includes: early menarche, tate age of
menopause and honiional therapy after menopause.
Estrogens are steroid hormones produced primarily by ovaries, with some
contribution from the placenta, adipocytes and adrenal glands. They act mainly
through two nuclear receptors ERa and ER3, which are ligand-inducible
transcription factors and are both expressed in breast tissue [30]. Two thirds of ail
breast cancers express ERa, which is believed to be responsible for tumor celis
proliferation [31]. Curiously, however, the proliferating cells in a normal marnmary
gland rarely express steroid hormone receptors t31 ,32]. This apparent paradox is stili
the subject of debatc [33, 34]. Nevertheless, antiestrogen therapies are being
developed and have been found to be very effective for treatment of this mahgnancy
as well as successful in chemoprevntion for high-risk patients, such as those showing
abnormnal breast histology or carriers of a genetic predisposition [21, 35]. Cunent
antiestrogene strategies include: (a) antiestrogens, such as tamoxifen, that inhibit
estrogen binding to its main target, ERa, (b) aromatase inhibitors, that prevent
synthesis of endogenous estrogens, and (c) pure antiestrogens, such as flulvestrant,
that block the action ofestrogens [36].
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Although very successftil, endocrine therapies are still the subject of
intensive research for at least two reasons:
(1) They have to be designed in such a way so that they do flot interfere with other
aspects of women’s health. This is especially true for long-term chemopreventive
therapies. Estrogens influence physiology of reproductive and cardiovascular
systems, metabolism of bones and the integrity of the central nervous system. The
new category of therapeutic agents currently being devetoped for breast cancer
treatment, selective estrogen receptor modulators (SERMs), may be suitable for
endocrine therapy [36, 37]. These are nonsteroidal agonists/antagonists of estrogens
action. It is anticipated that the effects of these drugs may vary depending on the
target tissue. Indeed, tamoxifen, a widely used breast cancer therapeutic drug, is the
first of this type. It acts as an antagonist in the breast to prevent breast cancer
progression and as an agonist in the bone to preserve bone density.
(2) The second challenge facing endocrine therapies is the development of
resistance. Some ER-positive breast cancers do not respond to antiestrogen therapy
(intrinsic resistance), while others stop responding after long-terrn therapy (acquired
resistance). Interestingly, tumors that acquire resistance (30 to 50 % of treated ERa
positive tumors) retain the expression of the receptor. Resistance to endocrine
therapies is a complex phenomenon, which may involve many different mechanisms
[38]. For example, the direct interaction between signaling through ERa and several
other transduction pathways can convert the inhibitoiy effects of the tamoxifen-ERa
complex into a stimuÏatoiy effect. Cross-talk between signaling from ERa and
HER2/neu (EGFR type receptor and the common oncogene in breast cancer), rnight
be involved in dnig resistance of tumors overexpressing this ceil surface receptor
[36, 39] . In addition, ERa activity could be reguÏated by phosphorylation mediated
directÏy by Akt [40]. The signaling from HER2/neu involves the PI3K/Akt pathway
activation as wel[. As discussed later in this chapter, this pathway is implicated in the
upregulation of glucose uptake and the stimulation of lipogensis in many tumor ceils.
Interestingly, there are indications that interfering with lipogensis by inhibiting fatty
acid synthase (FAS), the final enzyme responsible for the synthesis of fafty acids
(FA), can alter upstream signaling form ERa. This suggests that lipid metabolisrn
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itself may be an important factor involved in the estrogen response of breast cancer
celi [41].
1.3.4. Breast cancer as a climnic disease — cancer dormancy
Ihe risk ofrecurrence for cancer patients is the highest within five years after
diagnosis and more then haif of the patients develop metastasis during this time.
Breast cancer belongs to the srnall group of cancers that have a relatively unusual
risk of late recurrence, even 20 years after diagnosis. The other cancers belonging to
this group are melanoma, non-Hodgkin’s lymphoma and renal carcinoma [42]. The
early relapse and late relapse seem to occur through different mechanisms. The
characteristic feature of a late relapse is that it occurs in two stages, an early stage,
when there is no expansion of tumor ceils and the late stage characterize by
exponential tumor growth. The earty phase of relative tumor quiescence followed by
late recurrence bas been called cancer or tumor dorrnancy[42]. Cancer dormancy is
flot well understood and it is extremely difficuit to study due to the veiy low
numbers of doniiant cancer ceils. By applying sensitive irnmunocytochemistry, one
can detect disseminated tumor ceils (DTC; one cell per bone marrow aspirate) in the
bone marrow of 20-40°/ of cancer patients that do flot show signs of metastasis [43].
Other very sensitive methods can identify circulating tumor ceils (CTC) from
the blood. They allow the detection of I celi per 20 ml of blood in about 36 % of
cancer patients that do not show clinical signs of disease [42]. The diagnostic value
of DTC and CTC detection is not yet clear. Considering that about 20 % of patients
will relapse after long-term remission, the phenomenon is worth serious
consideration. The late relapse has a stochastic characteristic and currently there are
no tests that can predict which patients are at risk for recurrence. Persistence of DTC
or dc in the body of cancer patients suggests that cancer may be considered as a
chronic disease.
We have already mentioned that environmental and life-style factors may be
involved in breast cancer development. Considering the possible chronic character of
the disease, prevention may be an important therapeutic option. Consistent with this
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view, the life-style factors, such as obesity. diet and exercise, were shown to
markedly affect breast cancer risk and survival after diagnosis.
1.3.5 Obesity and the risk ofdevetoping cancer
EpidemiotogicaÏ studies suggest that obesity is a metabolic disorder that
affects the development of many different types of tumors. including colon, breast
(postmenopausal), endometrium, kidney (renal ce!!), oesophagus (adeno-carcinoma),
gastric cancer, pancreati c, gallbladder, I iver, non-Hodgkin’ s iymphoma, leukemia,
multiple myeloma, rectum, ovary and prostate [reviewed in 44, 45]
Although the molecular mechanisms linking cancer promotion with obesity
are sti!! not understood, the association is strong. Thus, obese individuaÎs with a
body mass index above 30 kg/m2 (BMI, defined as weight in kiiograms divided by
height in meters squared) have an overali increased risk of developing many types of
cancer ofapproximately 1.5 to 2 fold and an over 3 fold increased risk ofdeveloping
cancers of the endometrium and oesophagus. Overweight postmenopausal women
have a 1.66 fold increased risk of developing breast cancer [45]. The parameters
indicating metabolic dysfunction, such as insulin resistance, visceral adiposity,
hypertriglyceridemia and hyperglycemia, were ail shown to correlate with an
increased risk of developing breast cancer [46-49]. Overweight women have not
only an elevated risk of developing breast cancer, but also an increased chance of
cancer recurrence (1.8-1.9 fold) and increased mortality (1.4-1.6 fold) [50 reviewed
in 51]. Obesity appears to be strongly related to mortality in women with estrogen
receptor-negative breast cancers, for which there exist fewer therapeutic options
[52].
1.3.6 Excessive adipositv and its contribution to cancer
Fat deposits in different anatomical sites of obese individuals are unequal.
Upper-body fat, including visceral and abdominal subcutaneous deposits, strongly
coiielates with increased risk for the development of insulin resistance, diabetes and
cancer [47]. The accumulation of fat in the upper body is controlled by various
factors, including heredity (about 50%) and sex (more common in males than in
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fernales), and is closely associated with glucose intolerance, hyperinsulinemia,
hypertriglyceridemia and other features of what is called metabolic syndrome or
syndrome X [53]. A causal Iink between visceral obesity and various disorders has
been difficult to determine. There is evidence that visceral adipose tissue is more
dynamic and has a higher lipolytic activity. The increased release of free fatty acids
(fFA) from visceral adipose tissue to the portal vein, which drains directly into the
liver, could cause liver dysfunction. However, it is also likely that visceral obesity is
not harrnful by itself but is a sign of an underlying metabolic phenotype, which
manifests itself in an altered adipose tissue distribution [reviewed in 53].
It bas been recognized that the storage and release of fat is not the only
function of adipocytes. These cells also participate in physiological horneostasis
through the production of hormones and cytokines, which can act in autocrine,
paracrine or endocrine fashion (for examples: leptin, resistin, adiponectin, tumor
necrosis factor a (TNFa), interleukin-6 (IL-6) and apolipoproteins [54]. The
endocrine function of adipocytes in obese individuals may well be one of the factors
contributing to the development of neoplasia [44]. This is particularly true for brcast
cancer in postrnenopausal women, since their adipose tissue is also the main source
of estrogen [55]. Adipocytes are major components of human breast tissue, making
up about 90 % of their volume. It bas been shown that in postmenopausal women,
local estrogen Levels in breast tumors could be as much as 10 times higher than in the
circulation [56]. Obesity-related breast cancers are also more often ER-positive [57].
It was proposed that various signaling pathways activated by adipocytes may
crosstalk with each other and with signaling from the ER and synergistically
promote tumorigenesis [55].
Obesity is also independently positively linked to elevated blood ffA levels,
which have been irnplicated in the development of pathologies such as insulin
resistance and tissue lipotoxicity [58 reviewed in 59, 60, 61].
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1.3.7 Metabolic inter’entions (diet and exercise) can ilnprove sttn’ival in breasi
cancer patients
Metabolism can affect the progression of cancer. The recent studies showed
that dietary interventions such as a decrease in dietary fat or the promotion of energy
expenditure by means of an increase in physical exercise can improve survival in
postrnenopausal women who have been treated for early-stage breast cancer.
Remarkably, only a few hours of exercise a week (3 to 5 hours of walking) can
reduce the risk of death from breast cancer by up to 50% [62] and decreased dietary
fat (to 20%, from about 40% of total calories from fat, which reflects the typical
Western diet), can reduce the risk of tumor recurrence for ail breast cancer patients
by 24%, and for patients with estrogen receptor-negative breast cancer by 42% [63].
The efficacy of these interventions is comparable to that of established adjuvant
therapies. Thus, the risk reduction of recurrence after hormone therapy is estirnated
at about 50% for estrogen receptor-positive cancers [64] and treatrnent with
Trastuzumab, the monoclonal antibody inhibiting the activity of HER2/neu tyrosine
kinase receptor (often amplified in breast cancers) reduces mortality by 33% [65].
1.4 Metabolism and the contro] of celi survival
1.4. 1 Growth factors regulate cell survival be inhihiting apoptosis and by directly
controlling cell access to nutrients
The nutritional environment of most celis in the body of heatthy individuais
is highiy regulated. The individual celis within the body are usuaiiy not limited for
growth by the extracellular concentration of glucose, fatty acids (FA) and other
nutrient substrates. ihus, cell survivai, growth and proliferation are mainly
controiied by the signals from exogenous growth factors (GF) rather than nutrient
substrates [66]. CelIs within multicellular organisms are constantly exposed to
numerous signais from their surroundings, including soluble factors, signals from the
extracellular matrix or the signais from neighboring cells. GF signaling is
responsible for the balance between ccli accumulation and cell death within tissues.
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Individual ceils require GF signaling to maintain their surviva! and in the absence of
those permissive signais they undergo apoptosis. They also require GF to initiate ce!!
division. During tumorigenesis, individual celis acquire mutations in the signaling
pathways that a!!ow them to avoid apoptosis and proliferate in the absence of GF [6].
Recently, Thompson et al. showed that Gf also contro! the access to extrace!!uiar
nutrients in individuai ceils. They showed that when ceiÏs are withdrawn from GF,
the rates of uptake of glucose and amino acids decrease and the transporters for iron
(transferrin receptor), as wel! as cholesterol (LDL receptor), are also down regu!ated
[67, 68]. Finally, they dernonstrated that when Rab7 (which regulates endocytic
membrane traffic and mediates the intemalization and degradation of nutrient
transporters) was inhibited, GF-deprived celis displayed protonged, growth factor
independent ce!1 surviva!. Therefore, GF reguiate celi survivai by inhibiting
apoptosis as we!1 as by direct!y control!ing ce!! access to nutrients [69].
1.4.2 Signating via Akt serine/threonine kinases regutates celi survivat by severaÏ
mechctnisnis
Thompson et al. hypothesized that cancer ceils have to acquire autonomy for
uptake of nutrients in order to become ful!y transforrned. They showed that
activation of the Akt farniÏy of serine/threonine kinases, often triggered by oncogenic
alterations in GF signaiing, promotes increased nutrient uptake [70, 71 reviewed in
72]. Thus, they were the flrst to reveai that Akt can contro! celi survival by
contro!!ing ce!!ular metabo!ism.
Akt serine/threonine kinases are activated in many types of cancers and this
activation leads to enhanced resistance to apoptosis [73]. Signaling via Akt can
induce ce!! growth and division in addition to survival. Sorne of the survival
signaling pathways overlaps with the mitogenic pathways, but some are distinct. A
recent review on ceil cycle reguiation by Akt was published by Brazi! et al [74] and
reviews on regu!ation of ce!l survival by Akt signaling can be found in Harnrnenrian
et al. and in Mc Corniick [75, 76]. Figtire 3 briefly summarize the cuiTent know!edge
regarding Akt induced regulation of ce!! surviva!, and can be described as fo!lows.
Akt can be activated by signais from various tyrosine kinase receptors in breast
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cancers, sucli as the HER2 oncogene. Activated Akt increases ce!! survival by
inhibiting various proapoptotic targets, such as TSC1/2, IKKa, FOXO and Bad [761.
In addition, Akt activation promotes ce!! survival by stimulating ce!!ular g!ucose and
fatty acid metabolism. Akt activates g!ycolysis, presumably by stabilizing HIF-1
transcription factor [77], which in turn is responsib!e for the upregulation of a!1 the
glycolytic enzymes (for detailed discussion see section 1.5.2). In addition to this, Akt
may directly activate the expression of several enzymes invotved in metabolism of
glucose, including glucose transporters, hexokinase [7$] and phosphofructokinase 1
and 2 [79]. The intracellular metabolism of glucose and FA are tightly
intercomiected (for detai!ed discussion sec section 1.6.3). Akt activition of glycolysis
will resuit in the production of more substrate for FA synthesis. Thus, Akt was
shown to activate enzymes involved in FA synthesis via SREBP-! [$0] and it can
direct!y phosphoiylate ACL, the enzyme cata!yzing the first step in conversion of
glycolytically-derived citrate to cytosolic acetyl CoA ta precursor of FA, cholesterol
and isoprenoid synthesis) [8!]. There is evidence that upregulation of FA synthesis
itself could be important for cancer ce!! surviva! but the mechanisms are not yet
understood [$2].
.4.3 CeÏls can sense changes in the ÏeveÏs ofinani’ nutrients and cciii adapt their
metaboÏism
As discussed above, the ce!!ular metabo!ism of g!ucose and fatty acids may
be directly up regulated by growth factors to promote the survival of pro!iferating
ceils. However, it lias long been recognized that individual ce!ls are a!so able to
sense their metabolic status independent of GF. Such homeostatic responses are
evolutionarily conserved [$3]. For example, a deciine in the ce!lu!ar ATP/ADP ratio
resuits in activation of AMPK, which tums on ATP-generating catabolic pathways
while turning off ATP-consuming processes (ccl! growth) (Figure 3).
Activated AMPK can adjust the activities of various metabo!ic enzymes by
phosphorylation and may also modulate intrace!!u!ar signa!ing for ccli growtb and
division [84]. A recent discovery is that celis may also sense their NAD7NADH
ratio. It was demonstrated that the yeast !ongevity protein Sir2 (sirtuin) is a NAD
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dependent histone deacetylase [$5]. Rernarkably, sirtuins are highly conserved in
evolution, and are implicated in the controt of metabolism and lifespan in yeast,
wornis and flues, particularty in the effects of calorie restriction (CR) on longevity
[86]. Mammalian sirtuin (SIRIY) inhibits apoptosis by direct deacetylation of
FOXO, p53 or Bax-binding partner Ku-70 [87,8$]. The exact mechanism of
regutation of sirtuins in humans is not wetl understood and its coimection to
NAD/NADH ratio stiil needs to be clarffied.
Another protein involved in sensing and communicating the metabolic status
of celis is mTOR (Figure 3), the mammalian kinase which is a target of rapamacin.
mIOR is located downstream ofAkt. h is known to respond to arnino acid starvation
and regulates protein translation. However, mTOR also integrates signais regarding
celiular metabolism and energy status by communication with AMPK and by
directiy responding to ATP leveis. In addition, mTOR controls aspects of glucose
homeostasis and recent studies suggest that it may aÏso control fat metabotism
[reviewed in 89]. The physiological function of mTOR is the control of cellular
growth (increase in celi mass). mTOR is also involved in the response to starvation
by controlling degradation of cellular content, including organelles, to ensure
survival under nutrient-depleted conditions, a process known as macroauthophagy.
The yeast TOR protein can forrn two types of complexes, TOR complex 1 (TORd)
and TOR complex 2 (TORC2). TORCI is sensitive to rapamycin and it regulates the
timing of ccli growth. TORC2 is insensitive to rapamycin and regulates spatial
growth (where ceil wilÏ grow). One interesting aspect of mTOR signaling is the
recently discovered existence of a negative feedback loop from nutrient sensing to
the insulin-responsive Akt signaling pathways. Thus, mTOR is emerging as a very
important factor in the control of flot only ceil growth but also ceil survival and
metabolism [89].
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Figure 3. Akt signaling for celi survival
Akt inactivates by phosphorylating proteins, which are directly or indirectty involved
in the induction of apoptosis (Bad, IKKa, FOXO). Akt signais through the
mammalian target of rapamycin (mTOR) by inactivating its repressor, tuberous
scierosis complex (TSC1/2). TSC1/2 is a tumor suppressor mutated or deleted in
several cancers [90]. Interestingly AMPK can activate the complex having an
antagonistic effect on mTOR function. Akt activates directly or indirectly glycolysis
and lipogenesis. This resuits in changes in the leveis of important metabolites (AMP,
NAD+), wbich can signal back via proteins sensitive to their levels (AMPK and
SIRT1 respectively) to modulate metaboiism and/or celi survival. Hexokinase (HK)
directly prevents apoptosis by binding to the mitochondriai outer membrane. Black
unes indicate inhibition and red airows indicate stimulation. Transcription factors are
encircled, metabolites are green and tumor suppressors are in blue.
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1 .4.4 Some inetabolic enz’ines direct!y participate in signaling for ce!! sun’ival
The interesting aspect of upregulation of glycolysis in the context of the
control of ccli survivai is that glycolytic enzymes themselves can directiy participate
in antiapoptotic effects. The best-known exampie of this is hexokinase (HK) (Figure
3), which binds with high affinity to the outer mitochondriai membrane and interacts
with other mernbrane-associated proteins, including VDAC to inhibit apoptosis [91,
92]. In fact, rnany enzymes involved in glycolysis have additional, nonglycolytic
functions, which include transcriptionai reguÏation, stimulation of ccii motiiity,
apoptosis [reviewed in 93], and even DNA repair [94]. Glycolysis is one ofthe rnost
ancient metabolic pathways, and these recently discovered nonglycolytic functions
of glycolytic enzymes may reflect an evoiutionaiy strategy, designed to coordinate
rnetabolism with other ceilular functions.
1.5 New concepts regarding the role of glucose metabolism in tumorigenesis
1.5.1 Glucose metabolisin is ttp regttlated in tuinor celÏs: the Warbttrg effect
Cancer ceiis show major changes in the rnetabolisrn of glucose. While the
majority ofnon-transforrned ceiis use oxidative phosphorylation in mitochondria for
energy production and switch to glycolysis oniy upon oxygen deprivation (hypoxia),
tumor ceils show high glycoiytic rates and rely on glycolysis for energy production
even in the presence of oxygen. Up-reguiation of both glucose uptake and giycoiysis
are common features of many cancers and have application in noninvasive cancer
imaging used for diagnosis and staging of turnors by positron emission tomography
(PET) [95]. This test uses radioiabeled glucose analogs to detect differentiai glucose
uptake by fast-growing tumors and metastases.
The reason for the metaboiic switch to giycolysis in the presence of oxygen
in tumors, the so-caiied “Warburg effect”, is stili not ciear. Over 70 years ago
Warburg proposed that the effect is a resuit of mitochondriai dysfunction [96] and
developed a cancer theory based on altered metabolism [97]. However, according to
the generally accepted views, aiterations in turnor ccii metaboiisrn are symptoms of
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transformation or response to the turnor’s microenvironment rather than a cause of
cancer. Thus, the Warburg’s theory was neyer accepted.
1.5.2 The transcrttion factor HIf-1 coordinateÏy reguÏates an integrated response
to Ïow oxygen and a switch to high glvcolysis
Growing tumors are often hypoxic due to insufficient blood supply. Thus, up
regulation of glycolysis could occur in response to hypoxia and could be an
adaptation to hostile tumor environment. The ceilular response to oxygen deprivation
is controlled by the transcription factor: hypoxia-inducible factor 1 (HIF-1), which
regulates a rnuitiplicity of genes, including those coding for ail of the giycoiytic
enzymes, and others encoding paracrine growth factors such as vascular endotheiial
growth factor (VEGF). Activation of these genes assures an integrated response to
Iow oxygen, including a switch to high giycolysis and recruitment of new biood
vessels [9$].
1.5.3 Tumor suppressor genes and oncogenes are invoÏved in the upregiclation of
glvcoÏys’is: the Warhttrg effect re-examined
HIF-1 is degraded in the presence ofoxygen. Disruption ofHIF-l’s oxygen
dependent degradation leads to its constitutive activation. Interestingly, recent data
shows that HIFI could be activated by factors other then tumor environment and
that it may possibly play a crucial role in the process of transformation [99]. First of
ail, it was demonstrated that genes involved in the control of HIF- 1 degradation
function as ciassicai tumor suppressors ta germiine mutation in one aiiele
predisposes carriers to develop tumors in specific organs). Three genes of this type
were identified: the von-Hippel-Lindau (VHL) gene, which predisposes carriers of
gerniline mutations to kidney, blood vessel and adrenal tumors, and two genes
encoding enzymes of the tricarboxylic acid cycle: succinate dehydrogenase (SCD)
and fumarate hydratase (Fil), which predispose calTiers of germtine mutations to
hereditary paraganglioma and Ieiomyomato sis/renal ccli cancer syndromes,
respectively [reviewed in 100, 101]. Moreover, HIF-l could be detected in non
hypoxic areas of tumors [102] being stabilized in response to stimulation by a
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growth factor, such as insulin-like growth factor (IGF), or in ceils transformed by
oncogenes including v-Src, c-Src, ras or HER 2 [reviewed in 103].
Stabilization of HIF-1 is flot the only way in which ceils can acquire higli
glycolytic rates. Some oncogenes can directly activate glycolytic enzymes. So far
two examples are known: MYC and Akt oncogenes. In the case of MYC, it was
shown that several key glycolytic genes have highÏy conserved Myc binding sites.
Myc directly binds to their promoters and transactivates them in non-hypoxic
conditions [104]. The exact mechanisrn involved in activation of glycolysis by Akt is
flot known, but it appears to be independent of HIf-1 [70, 105]. Akt is involved in
redirecting cellular metabolism in response to growth factors stimulation or
oncogenic alterations to support ce!! growth and proliferation [reviewed in 72].
The present views on up-regulation of glycolysis in cancer ceils are
surnmarized in Figure 4 [103]. Thus, it seems clear that the up-regulation of
glycolysis that is so often observed in cancer celis may flot be just an adaptive
phenomenon, since it could be autonomously acquired during tumor progression. Its
contribution to tumorigenesis, however, is stiil controversial and flot widely accepted
[106].
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Figure 4. CeIl autonomous oncogenic alterations and adaptation to hypoxia
contribute to tumor aerobic gIyco1ysi
The figure denotes a tumor mass that could have sustained genetic alterations that
activate either AKT or MYC, resulting in ceil autonomous activation of aerobic
glycolysis. In the case of MYC, which encodes a transcription factor, glycolytic
genes are directly activated. As the tumor mass continues to enlarge, diffusion
limitation causes local hypoxia that induces the HIF- 1. HIF- 1, in turn, activates the
glycolytic genes as well as factors such as VEGF, which induces angiogenesis. The
glycolytic pathway is shown on the right. Genes affected by either HIF-l or MYC
are indicated by unes. For MYC, the thickness represents the level of direct binding
ofMyc to glycolytic genes.
Source: Kim, J.W., Gardner, L.B. and Dang, C.V. (2005) Dnig Discovery Today:
Disease Mechanisms 2 (2): 233-238.
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1.6 Overview of FFA metabolism and ïts regulation
1.6. 1 Control offfA Ïevels in the bÏood
The level of FFA (those which are flot components of circulating
triacylglycerols, Figure 5) in the blood is highly controÏÏed between 0.1
- 0.2 mM
[107]. After a meal, FFA released from dietary fat are absorbed by enterocytes that
une the smali intestine [102]. Inside the enterocytes, they are esterified to form
triacylglycerols (TG) and then are exported into the circulation as chylomicrons.
They are released from chylomicrons after hydrolysis mediated by lipoprotein
lipases (LPL), which are produced by adipose tissue and muscles, and then secreted
to the surface of capillary endotheliat celis nearby. In fed state, the majority of FfA
released from chylomicrons will be taken up by adipocytes and immediately re
esterified to form storage TG inside the ceil. Thus, the multistep process of trapping
dietary FFA inside adipocytes consists of sequential cycles of esterification and
lipolysis. In normal individuals, this complex process is almost 100% efficient 1 h
afier a meal and the efficiency then decreases to 10-30% by 6 h [109]. This allows
for a graduai release of FFA into the blood at longer times after the mea!. Thus, the
FfA levels in the blood are highest in a fasted state (over-night fast) when they are
needed as a fuel in various tissues. Lipolysis in adipocytes is calTied out by the
highly regulated enzyme hormone sensitive lipase (HSL) and other associated
lipases [110, 111].
Obesity is often linked to insulin resistance, which is flot well understood,
and manifests itself in an inability of various tissues to respond to insulin signaling
[reviewed in 112]. In the obesity-induced insulin resistant state, trapping of dietary
FFA in adipocytes becomes inefficient, causing elevated blood FFA levels even in
the fed state. In this situation, higher than normal amounts of FfA are available to
rnany tissues and organs, even though they do flot need them for energy production
[54]. Little is known how these tissues deal with the surplus ofFFA fuel. For human
tissues other than adipocytes, liver, skeletal muscles, heart and pancreatic 3-ceHs.
there is littie or no data describing the metabolism of FFA, their rate of oxidation,
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esterification, formation of lipid stores or lipolysis in the healthy or obese states.
Considering the profound influence of obesity, diet and life-style on the developrnent
of breast and other types of cancer, as welI as development of metabolic syndrome
and diabetes, more knowledge is needed regarding FfA metabolism in different
normal and tumor tissues.
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Figure 5. Structure of selected fatty acids and common complex lipids
A, Model molecules and chemical structure of common FA: palmitate (C 16:0) and
oeate (C18:1) B, Structure of most common polyunsamrated fatty acids: linoleic
acid (C1$:2) and linolenic acid (C1$:3) C, Structure of triacylgtycerol (TG) D,
Structure of phosphatidylcholine, a common membrane glycerophopholipid.
Source: Lodish H, Berk A, Zipursky L, Matsudaira P, Baltimore D, Darneil J:
Molecular Celi Biology. Fourth edition. W.H. Freeman and Company (2000)
•_\ ,—,—,—
:E*1*
,
sc c C ç c -c c C- C—C C C -c C -C C C
COMMON EATTY &CIDS TRI AClGLY CEROL (TG)
B D
f .ifly acv I çt. ail,12 9/%.\/\\/==\/==\\/\\J/\//\/COOH
CI)
Linoleic AciLi (onieçja-6)
Aipha-Linolenic Acid tomeua-])
POLYUNSATUW-fTED FAIIY ACIOS IPUF.’.]
25
1 .6.2 Intracellular metaboÏism ojexogenous fFA: introduction
FA are the simplest lipids, consisting of long aikyl chains with a terminal
carboxyl group. Most FA in human body exist in complex form, as storage TG as
wetl as structural phospholipids (PL) (figure 5). Circulating FFA (those which are
flot components of complex lipids) are bound to serum albumin and their level in the
blood is tightly controlled [107]. The transport ofFfA into celis is believed to occur
via passive diffusion as well as by protein mediated transmembrane transport [113,
114]. Once inside the ce!!, FFA are activated to the corresponding fatty acyl-CoA
(FA-CoA) by acyl-CoA synthetase (ACS). The fate of FA-CoA subsequently varies
between tissues and depends on the overait metabolic state of the body as wel[ as on
the individual needs of different specialized ceils [115]. When esterified with
glycerol-3-phosphate (G3P), FA-CoA are preserved in the form of storage TG or can
be chaimeled to form phospholipids. Enzymes, which initiate the esterification
process, are called G3P acyl transferases (GPAT) [116]. Alternatively, FA-CoA can
be transported to mitochondria by carnitine palmitoyl transferase 1 (CPT 1) and
oxidized, generating ATP and CC2 [117]. Thus, FA, like glucose, are fuel substrates.
1.6.3 Coordinate regutation of glucose and FFA metaboflsm in the bodv and
within an individual ce!!
The metabolic pathways of the fuel substrates: FFA and glucose are
interdependent and reciprocally regulated. Utilization of glucose and FfA by
different tissues within the body is largely coordinated by insulin but the fine-tuning
is brought about by various intracellular mechanisms. Hence, elevated glucose
concentration stimulates pancreatic f3-celts to secrete insulin, which suppresses
lipolysis in adipocytes, preventing release of FFA. Ibis eliminates competition for
fuel substrates in peripheral tissues (muscles). Thus, in healthy individuals, FFA
becorne the major fuel substrate only when glucose and insulin concentrations are
low [107, 11$, 119]. Fine-tuning mechanisms, which allow individual cells to sense
the availability of fuels and adjust their metabolic pathways accordingly, include the
inhibitory effect of etevated FFA concentrations on glucose metabotism described in
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skeletal muscles by Randie et al [120], and the inhibitory effect of high glucose
concentration on fatty acid oxidation discovered by McGarry and Foster [121]. The
McGarry’s effect described in hepatocytes is briefly illustrated in Figure 6. When
glucose is abundant, ceils in various tissues, in particular liver celis, have an elevated
glycolytic rate and produce large amounts ofpyruvate, which enters the tricarboxylic
acid (TCA) cycle in mitochondria. TCA cycle intermediates are replenished and the
surplus is transported from the mitochondrial matrix back to the cytoplasm in the
form of citrate. Citrate is then metabolized by a sequence of cytoplasmic enzymes:
ATP citrate lyase (ACL), acetyl CoA carboxylase (ACC) and finally fatty acid
synthase (FAS) to produce endogenous fatty acids. MalonyÏ-CoA, which is an
intennediate in this process, acts as an allosteric inhibitor of CPT I. Therefore, the
presence of malonyl-CoA signals the abundance of glucose in liver cells that begin
to produce endogenous FA from glucose and shuts off oxidation of the newly forrned
FFA, prornoting their esterification and storage. Inhibition of CPI I by malonyl-CoA
will also prevent oxidation of exogenous FFA if they are available.
An additional level of complexity to this intracellular metabolic regulation is
added by signaling from AMP-activated protein kinase (AMPK). AMPK is an
evolutionarily conserved sensor and regulator of energy balance in celis. It becomes
activated by phosphorylation when levels of AMP increase, indicating a reduced
ATP/ADP ratio. Actïvated AMPK turns on ATP-generating catabolic pathways
while tuming off ATP-consuming processes (in particular celi growth) in response to
an energy crisis. Thus, it will induce oxidation ofFFA when glucose is not providing
enough energy or in the situation of high energy consumption (muscle contraction)
[122, 123]. lnterestingly, the upstream kinase responsible for AMPK activation is a
turnor suppressor LKB1, responsible for the developmcnt ofbenign intestinal tumors
(Peutz-Jeghers syndrome) and predisposing carriers to malignant cancers in other
tissues (including a breast) [124]. The deregulation of the AMPKImalonyl-CoA fuel
sensing and signaling network bas been proposed to be involved in the developrnent
of the metabolic syndrome, which predisposes to several chronic disorders, including
obesity, diabetes, hypertension and premature atherosclerosis t 125].
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Exogenous FFA become activated inside the celi by ACS to form FA-CoA, which
can be further metabolized in mitochondria to produce ATP. CPT-1 catalyzes the
first rate-limiting step of its transport to mitochondria. Atternatively, fA-CoA can be
esterified to glycerol-3 phosphate to fonri storage TG or PL. When glucose is
available, it is metabolized via glycolysis and the TCA cycle to produce ATP. At
high glycolytic rates, the TCA cycle will be replenished and the surplus will be
transported from the mitochondrial matrix back to the cytoplasrn in the form of
citrate. Citrate is a precursor for de novo FFA synthesis. MaÏony-CoA, an
intermediary metabolite between citrate and FFA, is an allosteric inhibitor of FFA
oxidation. Its levels can also be controlled by AMPK, which inactivates ACC by
phosphorylation.
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Figure 6. Intracellular metabolism of glucose and FA are interdependent
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1 .6.4 Storage oJffA and TG, lipoïvsis and TG/FFA eveling
Although most ceils in the body are able to esterify FFA to produce TG,
surplus dietary FFA are stored almost exclusively in lipid droplets of adipocytes in
the form of TG. Liver ceils and adipocytes are speciatized in the synthesis of TG,
which can be hydrolyzed when FFA are needed as fuel (between meals). In healthy
individuals, some storage of TG occurs in skeletal and cardiac muscles in addition to
adipocytes and liver. However, this ïs only for local needs [126].
TG stored in lipid droplets can be hydrolyzed to produce fFA and glycerol.
This process (lipolysis) lias been mostly studied in adipocytes, whcre it is canied out
by the highly regulated enzyme, hormone sensitive lipase (HSL) in addition to other
less smdied lipolytic enzymes in particular, adipose TG lipase (ATGL) [reviewed in
111]. FFA that are released from TG by lipolysis can be immediately re-esterified
within the ceH to form TG again. Lipolysis and re-esterification arc two opposite
processes involved in what is refeiied to as intracellular TG/fFA cycling [127, 12$].
TG in lipid droplets of adipocytes are constantly turning over with an average half
life of a few days [126]. Celtular TG/FFA cycling can occur in all tissues containing
TG stores. It is a multi-step, complex cycle involving many enzymes. As shown in
Figure 7, at least one enzyme activates FFA to form FA-CoA [129], then at least five
others are involved in the sequential esterification of FA-CoA onto the glycerol
backbone [116], and subsequently at least three different lipases are involved in the
sequential hydrolysis of the esterification products: triacylglycerols (TG),
diacylglycerols (DAG) and monoacylglycerols (MG) [111]. TG/FFA cycling is
considered to be a “futile cycle”, since it’s main outcome is the consumption of
energy (production of 1 molecule of TG consumes 6 molecules of ATP). However,
this process allows preservation of intracettular FA pools when they are flot oxidized
for energy production, and has been Ïinked to thermogenesis in brown adipose tissue
[130].
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figure 7. Schematic illustration of the intracellular TG/fFA cycle
TG/FFA cycling consists of sequential reactions of esterification (left) and
hydrolysis (lipolysis shown to the right). The cycle is supplied by free fatty acids
(FFA) from exogenous and/or endogenous sources and by glycerol-3-phosphate
(G3P) (green arrows). Ihe cycle can be depleted at several steps (red arrows). Thiis,
fatty acyl-CoA (FA-C0A) can be channeled to oxidation in mitochondria and
intermediates in triacylglycerol (TG) synthesis may be channeled to the production
of phospholipids (PL). FfA released by tipolysis can be secreted outside the ceit or
irnrnediately re-csterified.
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A comprehensive literature searcb revealed that there are no publications
describing data on lipolysis or on TG/FFA cycling in cancer celis. 1G are stored
within cytoplasmic lipid droplets (LD). LD are macromolecular lipid assemblies
consisting of hydrophobic core of neutral lipids (TG, DAG, and sterol esters)
surrounded by a monolayer ofphospholipids. Their presence in mammalian ceils has
been associated with the storage and transport of energy (FA). Ihus, they are present
in adipocytes, liver and muscle celis. However, most, if flot ail mammalian ceils can
form LD in some circumstances, such as exposure to exogenous oleate [131].
Recently, it became apparent that some proteins are tightly associated with LD in
various ce!! types. These proteins include those involved in LD biogenesis,
trafficking and mobilization (such as lipases) as welI as caveolin and others, which
are not directly involved in metabolism [132]. Formation of LD resuits in
redistribution of caveolin from the plasma membrane to the surface of LD. Thus, it
appears that LD are flot just drops of fat, but instead are dynamic organelle-like
structures that might be involved in modulating signal transduction from ce!! surface
receptors [reviewed in 132, 133, 134].
1.7 Alteration of Iipid metabolism in cancer ceils
1.7.1 Overexpression offattv acid synthase (FA S) and upreguÏation of tipogenesis
Many cancers are able to synthesize FA endogenously and express high FAS
activity. A!though the complex interrelations between glucose and FFA metabolism
are well known (described above), the research on FAS in cancers has largely been
perfoniied independently from investigations in glucose metabolism. It was shown in
1953 that neoplastic tissues have high !evels of fat synthesis in vitro [135]. However,
interest in this phenomenon was only generated in 1994, when it was discovered that
the oncogenic antigen-5 19 (OA-5 19) that is Ïinked to poor prognosis in breast cancer
patients is actually the FAS enzyme [136]. Subsequently, FAS was found to be
overexpressed in other types of turnors, including prostate, colon, ovarian,
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endometrial and thyroid, and to be a marker of a more advanced disease [reviewed in
$2].
The mechanism involved in overexpression of FAS in cancers is not well
understood. There is evidence that the whole pathway of fatty acid synthesis is up
regulated and that ail its key enzymes, including ACL and ACC (see Figure 6), are
also overexpressed [137]. Severai studies demonstrated that the sterol regulatory
element binding protein Ïc (SREBP ic) might participate in upregulation of this
pathway [80,138-140]. SREBP le is a member of a family of transcription factors,
which play an important role in normal celi physiology as they co-ordinate lipogenic
gene expression and celtular iipid homeostasis [reviewed. in 141, 142].
Overexpression of FAS correlates with elevation in levels of SREBP ic in various
ceils in culture that are stimulated with androgen, EGF or transformed with H-ras,
suggesting that the activation of signaling pathways leading to proliferation induces
lipogenesis via SREBP ic [80, 137, 13$].
Interestingly, high FAS activity is linked to proliferation flot only in turnors.
FAS is essential in ernbryonic development [143] and it is highly expressed in
rapidty proliferating tissues tikc the endometrium [144]. The signaling upstrearn of
SREBP le in tumor ceils may involve the PI3K/Akt pathway, which was shown to
be implicated in the upregulation of FAS in different celis and tumors [145-147].
The central role of Akt in the coordinated stimulation of glucose and fatty acid
rnetabolism is illustrated in Figure 8, which shows an integrated vicw of the cancer
ceil metabolism [72].
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Figure 8. Akt signaling coordinately stimulates glucose and fatty acid
metabolism
Akt activation downstream of growth receptor tyrosine kinease (RTK) signaling
upregulates glycolysis to fuel FA synthesis and inhibits FA oxidation. Increased
glucose uptake through the Glut 1 transporter and increased glucose catabolism
through activation ofthe glycolytic enzymes hexokinase (HK), phosphofructokinase
I (PFK-1) and PFK-2. lead to a high flux of glucose carbons into the mitochondria
as pyruvate (pyr). This Ieads to the formation of citrate, which is then transported to
the cytosol and cleaved by ACL to generate cytosolic acetyl CoA, the precursor of
FA, cholesterol and isoprenoid syntheses. ACL is an Akt phosphorylation target and
its levels are increased downstream of Akt activation coordinately with those of
lipogenic enzymes, including acetyl ACC and FAS. This increase can be attributed
to increases in the activity of SREBP-1. The NADPK essential for fatty acid and
cholesterol synthesis can be produced from the pentose phosphate pathway (PPP)
downstream of glucose-6-phosphate generation by HK. fligh activities of ACL and
ACC, coupled with high levels of citrate, lead to high amounts of malonyl CoA,
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which is an allosteric inhibitor of CPT-1, the enzyme responsible for the
transiocation of FA into the mitochondria for FA oxidation (FAO). In addition, Akt
phosphorylates and inactivates the transcription factor F-box protein subclass A
FoxA2, which normally activates CPT-1 to stimulate FAO. Overa!!, Akt favors
anabolic processes (glycolysis and fatty acid synthesis) and inhibits catabolic
processes (fatty acid oxidation). ECM: extracellular matrix; OOA, oxaloacetate.
Source: Hatzivassiliou G et al. (2005) Drug Discovery Today: Disease Mechanism
2(2): 255-262.
1.7.2 Positive feedback regttÏation between Ïtogenesis and signctÏingfrom varions
receptors
As discussed above, stimulation of ce!! proliferation by signaling initiated
from celi surface receptors and honiiones causes up regulation of FAS activity. A
common oncogene in breast cancer ceils involved in the stimulation of ccli
proliferation is HER2 (erbB2/neu), an EGFR type receptor. Transcription ofthc FAS
gene is directly downstream of HER2/neu signa!ing, as it was shown in an
immorta!ized hurnan mammary epithelial ce!! une H16N2 overexpressing HER2
gene [14$]. Interestingly, inhibition of FAS activity marked!y reduces expression of
this oncogene in breast and ovarian cancer ce!! unes (SK-Br3, BT-474, MDA-MB
453 and SK-0v3) [149]. At least two other reports described a similar response to
the inhibition of FAS. Thus, dep!etion of FAS protein by RNAi resuits in loss of
ERa in the human endometriat adenocarcinoma celi line (Ishikawa cells) [1501 and
chemica! inhibition of FAS down-regu!ates phospho-Akt in ovarian carcinorna ceils
(SK-0v3) [!46]. These may suggest the existence of a positive feedback regulation
between FAS activity and the expression of ce!! surface receptors. The rnechanisrn
responsib!e for this feedback regu!ation is presently unknown.
1.7.3 Imaging ofÏtids and their inetaboiltes in cancer ceÏÏs
Lipids and other metabotites within the body and in cultured ceils are
detectable with noninvasive techniques like magnetic resonance spectroscopy
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(MRS). This technique, particularly clinical ‘H MRS imaging, repeatedly shows
important differences in choline phospholipid metabolites of malignant versus
benign breast tissues [151]. Recent evidence suggests that increased activity of
choline kinase and phospholipase C in breast cancer ceils could contribute to the
effect [152]. Although, the molecular basis for the effect is stiil flot well understood,
choline metabolism is already considered as a potential target for anticancer therapy
[153, 154].
1.7.4 DietaiyJatty acids and cancer
Human ceils are able to synthesize most of their FA de novo from glucose,
but to a large extent dietary supply determines the composition of FA in body lipids.
Many animal studies have been conducted to determine how different types of
dietary fat affect the risk of developing cancer. They clearly demonstrated that flot
only quantity but also the type of fat is an important modulator of mammary
tumorigenesis. A particularly important role in this process was assigned to the
essential FA, those that cannot be synthesized by humans. These are ornega w-3 and
w-6 polyunsaturated fatty acids (PUFA), which contain a double bond near the
methyl end of the molecule (Figure 5). The animal studies indicated that PUFA
inhibit carcinogenesis, especially u-3 fatty acids present in fish. However, the
epidemiological studies in humans on the relationship between fish in the diet and
cancer risk arc flot very consistent, so the effect of PUFA on cancer prevention in
humans remains unclear [reviewed in 155]. AIl FA can be oxidized in mitochondria
or peroxisomes to produce energy, but PUFA can also be metabolized by other
specialized enzymes, such as cyclooxygenases (COX), lipooxygenases and
cytochrome P450 monoxygenases, to produce eicosanoids, which are short-tived,
hormone-like lipids (eg. prostaglandins, leukotrienes, thromboxanes and
docosanoids). They have a wide array of biological activities, from modulation of
inflarnmatory and immunological responses to effects on cell growth and
differentiation. Dietary PUFA and their metabolites are also natural ligands of the
peroxisome proliferator-activated receptors (PPARs), which act in a similar manner
to other nuclear hormone receptors and transcription factors [reviewed in 156, 157].
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The PPARs influence the expression of genes invoÏved in the control of ceil growth
and differentiation. Thus PUFA could affect tumorigenesis in many different ways
[reviewed in 158, 159]. However, more epidemiological studies are needed to clarify
their effects on tumorigenesis.
Epidemiological studies on the effect of individuat FA on breast
carcinogenesis are extremely difficuit to do in humans. The assessment of FA intake
from reported dietary intake is very complex since converting food items into their
FA content may be cornplicated by the fact that same foods may vary in their FA
composition over the years due to different methods of food production and
processing. One way to overcorne this type of probtems is to use biomarkers of
dietary FA intake such as FA composition of adipose tissue, erythrocyte membranes,
serum and plasma. Meta-analysis of published resuits correlating the composition of
FA in biological samples with breast cancer risk suggest that w-3 PUFA protect
while monounsaturated FA (MUFA) and saturated FA (SFA) increase the risk of
developing breast cancer [160].
1.7.5 Effects ofcommon ,iutrient/ztti; acids on breast cancer ceÏÏs in culture
For the last several years our laboratory has studied the effects of exogenous
FFA on hurnan breast tumor ceils in culture. We have studied the effects ofthe long
chain saturated FA palmitate (C 16:0) and the monounsaturated FA oleate (C18:1) on
ceil proliferation and ceil death. These are the most common dieta;y FA and are also
the main FA in ail tissues (for example mouse adipose tissue consists of 48% oleate
and 18% palmitate). It is important to emphasize that these two FA are not the direct
substrates for the above-mentioned oxidative enzymes which metabolize PUFA,
neither are they good ligands for PPARs, although oleate was shown to activate
PPARa [161].
The focus of our research has been on the effects of these FA as fuel
substrates on breast cancer celi survival and proliferation. We have shown that they
have profound effects on human breast cancer ceiis in culture. Palmitate induces
apoptosis in a number ofbreast cancer celi lines and oleate has the opposite effect; it
promotes ceil proiiferation and prevents apoptosis induced by palmitate [162].
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Studies on the toxicity of palmitate in various celi systems have suggested
that the most likely reason for its proapoptotic action is the stimulation of ceramide
synthesis. Examples include hematopoietic cells [163], f3-cells [164],
cardiomyocytes [165] and astrocytes [166]. The resuits published from our
laboratory have shown that ceramides may flot be responsible for the apoptotic effect
ofpalmitate on breast cancer celis. The effect is most likely related to a deficiency in
mitochondrial cardiolipin (CL) brought about by an inadequate supply ofunsaturated
FFA and increased CL turnover during exposure to exogenous palmitate. We have
found that palmitate and oleate are channeled to different metabolic pathways, and
oleate protects against lipotoxicity induced by palmitate by channeling this saturated
FA into intracellular lipid storage pools and by sustaining the synthesis of CL for
mitochondrial membrane integrity [167].
1 .7.6 fattv acids inav exert their effects bv binding to G-pmtein-coupÏed receptors
It was recently demonstrated that FFA could act as signaling molecules by
activating G-protein-coupled receptors (GPCR). Medium and long chain FFA are
ligands for GPR40 and short chain fatty acids are ligands for GPR41 and GPR43
[reviewed in 168]. Another receptor (GPRI2O), for long chain unsaturated fatty
acids, was recently discovered in the intestine [169]. GPR4O is exprcssed mainly in
the human pancreas and possibly also in the brain. The GPCRs responding to other
lipids [reviewed in 170] and various metabolites, including nicotinic acid and TCA
cycle intermediates, such as succinate (GPR91) and a-ketoglutarate (GPR99), form a
growing family of tissue specific receptors which might be involved in the
coordination of the metabolism between different parts of the body [171, 172].
We have dernonstrated expression of GPR4O in human breast cancer ceils.
Our data suggest that the effects of oleate on human breast cancer cells may involve
signaling via this celi-surface G protein coupled receptor and activation of the P13 K
AKT survival pathway [173].
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1 .7.7 Accunitilation of TG induced bv oÏeate inay have more generat significance
in celi deatÏi/survivaÏ pathwavs
We already mentioned that palmitate and oleate are chaimeled to different
metabolic pathways, and that oleate is a particularly good precursor for 1G
formation. It is flot clear why the metabolism ofthese two common FA would be so
different, but it appears that this is a general phenomenon. Thus, the observations
regarding the accumulation of lipids induced by oleate, the toxicity of paimitate, and
the protective role of oleate versus palmitate were previously reported in other ccli
types: cardiornyocytes [174], human skin fibroblasts [175] and lymphocytes [176].
However, these studies did flot deal with the mechanism and biological significance
of this protection.
Evidence that TG rather then exogcnous oleate, protect against ccli death
induced by saturated FA, comes from studies on overexpression of stearoyl-CoA
desaturase, the enzyme responsible for synthesis ofunsaturated FA from endogenous
saturated precursors. The studies showed that elevated endogenous levels of
monounsaturated FA resuit in the resistance to palmitate-induced lipotoxicity. In the
same study it was also demonstrated that impaired of 1G synthetic activity sensitize
to lipotoxicity induced by both saturated and rnonounsaturated FA [177]. Therefore,
the accumulation of 1G promoted by exogenous and/or endogenous oleate may have
an adaptive function and protect tissues against lipotoxicity.
We as well as other investigators have observed that monounsaturated fatty
acids may also be protective against apoptosis induced by factors other than
paimitate. For exampie, oleate prevents apoptosis induced by serum withdrawal in
MDA-MB-231 human breast cancer cells [162] and palmitoteate (C16:i) protects
against apoptosis induced by serum withdrawal and cytokines in rat 13-ceÏls [178].
This may suggest that accumulation ofTG induced by oleate may have more general
significance in ccli death/survival pathways.
The link between TG accumulation and ccli death/survival pathways is
circumstantial at the moment. In the above mentioned studies (including our own)
1G were produced by addition of oleate, but oleate was always present in the
medium. Thus, one can argue that the antiapoptotic effect observed was exerted by
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exogenous oleate itsetf, for example by signaling via the ceil-surface G protein
coupled receptor and activation ofthe PI3K-AKT survival pathway.
1.8 The aïm ofthe present study
In the last decade, there has been a renewed interest in the metabolism of
cancer celis. The exciting new findings obtained recenfly can be sumrnarized as
follows: 1) signaling pathways induced by GF affect metabolism, and just as
importantly, metabolic pathways such as lipogenesis can modulate the
expressionlfunction of GF; 2) changes in metabolism observed in tumor celis are flot
just passive homeostatic adjustments to transformation or adaptation to the tumor
microenvironrnent, they are induced by oncogenic mutations and can actively
contribute to tumor progression; 3) some of the regulators of metabolism are tumor
suppressors, which can promote the development of tumors and 4) metabolism of
glucose and fatty acids contributes in various ways to the antiapoptotic effects of
oncogenes. Clearly, celi metabolism is becoming an exciting area of research and the
elucidation of the Iinks between basic metabolic pathways and survivat pathways
may offer new therapies for cancer.
Breast cancer is one of those cancers for which life-style factors, such as
obesity, diet and exercise, were shown to influence the risk of cancer development
and have an impact on survival after diagnosis, but the molecular mechanisms
involved are largely unknown. The endocrine function of adipocytes may well be
one of the factors contributing to the development of breast cancer in obese
postrnenopausal wornen, since their adipose tissue is the main source of estrogen and
can directly affect breast cancer progression. However, obesity is also independently
positively Ïinked to eÏevated bïood FFA tevels, which have been implicated in the
development ofvarious pathologies. The most common dietary FA and the main FA
in our tissues are oleate and palmitate. We have evidence that oleate is a particularly
good precursor for TG formation and it protects breast tumor ceils against apoptosis
induced by palmitate or by serum withdrawal.
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The aim of the present study was to address the foliowing hypothesis: FA
(especially oleate) present in excess in the blood of breast cancer patients
suffering from metabolïc conditions such as obesity or metabolic syndrome,
contribute to the progression of breast cancer by promoting accumulation of
TG in cancer celis, whïch help them to survive in unfavorable conditions, such
as in the absence of appropriate GF.
As it was mentioned above, some of the effects of oleate and palmitate that
we observed in breast turnor ceil unes were already described in different ccli types,
including cells flot derived from tumors (neonatal cardiomyocytes, human fetal skin
fibroblasts and mouse lymphocytes). We needed to determine if the effects that we
investigated were specific to cancer ceils or were more generai and common to both
cancer and non-cancer ccli types. Thus, it was of interest to include as a control in
our smdy, the MCF-IOA ccli strain, which is derived from normai human breast
epitheliai tissue. Therefore, our model system consisted of two ceil unes: the MCF
1OA non-transformed human breast epithelial ccli strain, and the human breast tumor
ce!! !ine MDA-MB-23 1. Thc studies wcre further extended to a pane! of wel!
characterized human breast tumor ccli unes: MDA-M3-468, T-47D and MCF-7. The
survival and proliferation of MCF-1OA ceils in culture is controlted by several GF,
including epidermal growth factor (EGF), hydrocortisone. insulin, in addition to
other serum factors present in 5% fetal bovine serum (FBS). In contrast, MDA-MB
231 cells (and other breast turnor cells) can grow without the presence of the growth
factors (EGF, hydrocortisone and insulin), but stili require the unknown serum
factors present in 5 ¾ FBS to survive and proliferate in vitro. Thus, MDA-MB-23 1
celis arc more autonomous, consistent with their origin from advanced, highly
metastatic breast tumor.
Using these mode) celis we addressed direct)y the question of 1G being
involved in ccii survivai pathways. TG were produced inside the ceils by exposure to
exogenous oleate and then oleate was removed from the medium. This simple
manipulation aliowed comparison between cells containing eievated TG ieveis,
easily detectabie under microscope as lipid droplets, and the control, untreated ceiis.
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Since ccli survival is governed mainly by GF it seems reasonable to address the
protective role of TG against death induced by withdrawal of serum and exogenous
GF. Our model system was used to address the following specific questions:
#1: Could treatment with oleate and elevated TG content protect non
transformed, less autonornous MCF-1OA celis against celi death induced by serum
and GF withdrawal?
#2: Is elevated intracellular TG content in human breast cancer celis
responsible for protection against serum withdrawai induced apoptosis and which
mechanisrn(s) might be invotved in this protection?
Here, we present evidence from this modet system, which suggests that ccli survivai
in GF-dependent norrnaI” celis cannot be altered by oleate, wbile survival of more
autonomous turnor celis may be modulatcd by this ftiel/nutrient. Our data in vitro is
consistent with the proposed hypothesis about possible contribution of rnetabolism to
the progression ofbreast cancer.
CHAPTER II
METHODOLOGY
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Materials
Fatty acid sodium saits were purchased from Nu-Check, Prep (Elysian, MN).
F etal bovine serum (FBS) was from Invitrogen (Carlsbad, CA) and was heat
inactivated at 56°C for 30 min. Fatty acid-free BSA (Fraction V, 96% essential FFA
free), was obtained from Sigma (St-Louis, MO). [1-’4C] palmitic acid (55
mCi/mmol) was purchased from Perkin-Elmer Life Sciences (Boston, MA). [1-’4C]
oleic acid (60 mCi/mmol), D-[U-14C] glucose (317 mCi/mmol), and D-[5-3H]
glucose (17 Ci/mmol) were obtained from Amersham Biosciences (Baie d’Urfé,
Quebec, Canada). [l,2’4C] acetic acid, sodium salt (ll3mCi/mrnol) was obtained
from ICN (Costa Mesa, Califomia) and (+)-Etornoxir, Na-sait was obtained from
HHAC Labor Dr. Heusler GmbH (Stutensee, Germany).
Special Solutions
5% BSA sterile solution was prepared by dissolving BSA (fatty acid-free) in
Krebs-Ringer bicarbonate buffer containing 10 mM HEPES/pH 7.4 (KRBH). The
pH was adjusted as necessary and the solution was flltered through a 0.22-tm filter.
The solution was stored at 4°C for a week or at -20°C for 2-3 months.
Unlabeled alburnin-bound fatty acids (oleate and palmitate) were prepared as
foilows: fatty acids sodium saits (?99% purity) were stirred with 5% BSA (fatty
acid-free) at 37°C for 16 h, then the suspension was filtered through a 0.22-jim filter,
and the fatty acid concentration was rneasured using a NEFA C kit (Wako Chemicals
USA, Inc. Richmond, VA). Concentration of stock solutions was adjusted to 4 mM,
using 5% BSA. FFA stocks were stored frozen in aliquots and thawed only once.
Celi Lines and Culture Conditions
Tumorigenic human breast cancer ceIl unes MDA-MB-23 1, MDA-MB-468,
T-47D and MCF-7, and the non-tumorigenic ceil strain derived from normal human
epithelial cells MCF-1OA, were obtained from the American Type Culture
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Collection (Manassas, VA). Celis were routinely cultured at 37°C in a humidified
atmosphere with 5% C02 in a 50/50 mixture of DuÏbecco’s modified Eagte’s Medium
and Rams F-12 (DMEM/F12; Wisent; St-Bruno, Quebec) containing 2 mM
glutamine and 5% heat-inactivated fBS. For MCF-1OA ceils, DMEM/F12 was
supplemented with insulin 10 tg/mi, hydrocortisone 0.5 ig/m1 (both from Sigma,
St-Louis, MO) and recombinant human epidermal growth factor (EGF) 20 ng/rni
(Invitrogen).
Ail experiments were perfonued in minimai essential media (MEM) (phenol red
free; Sigma-Aldrich, Oakville. ON, Canada) as described beiow. Thus, MDA-MB
23 1 cells were cultured in MEM medium containing 5% fetal bovine serum (FBS),
which will be referred to in this thesis as “turnor celI Growth Medium” (tGM) and
MCF-1OA ceils were cultured in MEM medium containing 5% fetal bovine serum
(FBS) and aiso the above-mentioned defined growth factors (insuiin, hydrocortisone
and EGF). This medium wiii be referrcd to in this thesis as “normal ceti Growth
Medium” (nGM). Apoptosis was induced in both ccli types by piacing them in
“Experimental Medium” (EM), which was a MEM medium without serum or added
growth factors
Treatment Protocols
Treatment protocols used are indicated in figure tegends. When iwo ccli
types were compared, they were treated with the saine pro tocol.
The rnajority of experirnents with MDA-MB-231 cetis were performed as foiiows:
celis were plated in triplicate in 25 cm2 flasks at a low density of I x i0 cells per
flask in a growth medium (tGM). MCF-YOA celis, when used for comparison, were
piated at 2.5 x i05 cells/flask in nGM. After two days of growth, celis were washed
with PBS and the medium was replaced with 1M for 18 h. After this period of GF
starvation, the medium was replaced with fresh 1M containing albumin-bound oieate
at concentrations ranging from O to 400 tM completed with 0.5% BSA. The final
concentration of fatty acid free BSA was adjusted to 0.5%. For long-tenu survival
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experiments, MDA-MB-23 Ï celis were cultured in EM, after exposure to oleate for
24 h, and media were changed daily.
The majority of experiments with MCF-YOA celis (sections 4.1.2 and 4.1.3) were
performed as follows: celis were plated in triplicate, in 25 cm2 flasks at a density of
2.5 x i05 cells/flask in a growth medium (nGM). MDA-MB-231 ceils when used for
comparison were plated at 1 x i05 cells/flask in tGM. After 24 h growth, the media
was replaced with the fresh growth media containing albumin-bound oleate at
concentrations ranging from O to 400 tM completed with 0.5% BSA. The final
concentration of fatty acid free BSA was adjusted to 0.5%. Then cells were washed
with PBS and subjected to GF starvation in fresh EM.
Celi Counting
b determine the number of adherent celis, culture dishes were washed with
PBS and treated with trypsin for 2 min. lml of 0.05% solution of trypsin containing
0.53 mM EDTA (Wisent; St. Bnrno, Quebec) was used per 25 cm2 flask. The ceils
were collected with additional 2 ml of MEM containing 0.1 % BSA and immediately
counted using a hemocytometer. Ceil number was calcutated from a mean value
obtained after counting celis in five individual squares. The number of celis in each
square was usually between 50-100.
Ce!! Protein Assay
Celis were grown in individual 25 cm2 flasks, washed once with PBS at
room temperature (RT) and scraped using a plastic cell scraper in 3 ml PBS at RT.
The celis were collected by centrifugation at 1,500 rpm (400 x g) for 5 min at RI
and the celi pellet was lysed with 100 pi of lysis buffer containing 6.25 mM Tris pH
6.8 and 2% SDS and 6 M urea. The solution was sonicated on ice, 2 x 10 sec, using a
sonicator at maximum setting (Vibra Cell; Sonics & Materials Inc., Danbmy, CI).
Protein concentration was deterrnined using a BCA Protein Assay kit from Pierce
(Rockford, IL) with albumin as a standard.
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Caspase 3 Assay
Caspase 3 activity as an index of apoptosis was determined in celi lysates
prepared from individual cultures using the protocol described in CaspACE’TM
Fluoremetric assay system (Promega, Madison, WI) with Ac-DEVD-AFC as the
caspase-3 substrate (BIOMOL; Plyrnouth Meeting, PA). Briefly, after treatment both
adherent and unattached celis were harvested and combined. After sedimentation at
500 x g for 10 mm, the cells were washed twice with ice-cold PBS, lysed for 10 min
on ice with a ceil lysis buffer containing: 10 mM Tris-HC1/pH 7.5; 10 mM
NaH2PO4/NaHPO4; 130 mM NaCI; 1% Triton x-100; 10 mM sodium pyrophosphate
and centrifuged (10 mm, 15,000 x g, 40 C) to remove nuc[ei and debris. Fifty tg of
proteins were incubated with 50 tM Ac-DEVD-AFC at 30° C. Fluorescence was
analyzed using a FluoStar-Optima microplate reader (BMG Lab Technologies,
Offenbtirg, Germany) in fluorescence mode using an excitation wavelength of 380
nm and an ernission wavelength of 505 nm. The reaction was allowed to proceed for
30 min with a reading every minute. Caspase-3 activities were determined by
calculating the siope of the reaction over 30 min.
Fatty Acid and Glucose Oxidation
Fatty acid oxidation was determined by measuring the amount of ‘4C02
liberated fiom samples incubated with [1-’4C] palmitic acid or [1-14C] oleic acid
using a modified procedure described in reference [179]. Briefly, cells were grown
according to experimental procedure in duplicate 25 cm2 flasks. Then, media were
discarded and replaced with 0.9 ml of fresh MEM containing 0.1% BSA and
incubated at 37°C for 30 min in a C02 incubator. Subsequently, 100 tl ofthe IOX
reaction mix (prepared freshly 2 h in advance and containing 10 mM camitine, 1
mM patmitate, 4% BSA and 0.5 iCi per culture flask of labeled fatty acid) was
added to each flask. The flasks were immediately sealed with rubber senim viat
stoppers. The stoppers were fitted with plastic tubes containing folded glass fibre
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lifter paper (Whatman GF/B) saturated with 0.15 ml of 5% KOH. The sealed flasks
were incubated for 1 h at 37°C. Control blank flasks contained ail reagents without
celis. The reaction was stopped by injecting 0.3 ml of 40% perchloric acid through
the serum stopper into each flask with a syringe and the flasks were then shaken
gently for 24 h at RT. filters were then rernoved and placed into scintillation vials
containing scintillation liquid. Radioactivity was counted 24 h later, using a liquid
scintillation counter (Tri-Carb 2100TR). Resuits were expressed as nanomoles of
FFA released/h/mg of celi protein.
Glucose oxidation was rneasured by determining the release of 4CO2 from
[U-’4C] glucose. The experimental setup to capture 4CO2 was as described above for
FFA oxidation. Ceils wete preincubated in 0.9 ml MEM medium (with or without
serum or with 0.1% BSA) for 30 min at 37°C in a COE incubator (5% C02 and 95%
air) aller which 100 tl aliquot of D-[U-14C] glucose diluted in MEM was added to
each flask (0.5 tCi/flask). The flasks were then sealed and incubated for 1 h at 37°C.
The reaction was stopped and the radioactivity captured by the filters was measured
as described above. The results were expressed as nmol of glucose oxidized/h/rng of
protein.
Glucose Utilization
Glucose utilization was measured as described in [180]. Briefly, cells were
grown in duplicate 25 cm2 flasks according to experimental procedures. The media
were discarded and ce ils were preincubated with 0.9 ml of MEM media for 30 min at
37°C under C02, then 100 il ofD-[5-3H] glucose in MEM media (1 mCi/flask) was
added per flask and the cells incubated for 1 hr at 37°C. Adding 0.3 ml of 40%
perchioric acid (PCA) to each ftask stopped the reaction. 300 fl of ceil culture
supernatants were then spotted onto glass liber filters (Whatman GF/B) and placed
inside the caps of scintillation vials. The vials containing 600 tl of water were
closed and left at RT for 3 days. Radioactive watcr evaporated from the filter
samples and equilibrated with the water in the vials. Radioactivity was determined as
described above after addition of 5 ml of scintillation fluid to each flask and ciosing
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the flask with new caps. The resuits were expressed as cpm/h/mg of protein. Protein
concentration was measured in ce!! extracts obtained from separate flasks treated in
parallet but without addition of radioactive glucose or PCA (see celi protein assay).
Lïpogenesïs
CeÏÏs were grown according to experirnentaÏ procedure in duplicate 25 cm2
flasks. Then media were discarded and replaced with 1 ml of fresh MEM containing
0.1% BSA and incubated at 37°C for 1 h in a C02 ïncubator. Subsequently, 5 d of
the 5 times diluted [1 ,2 ‘4C] acetic acid (1 rnCi/flask) was added to each flask and the
ceils were incubated for 4 1w at 37°C in a C02 incubator. Cetis were then harvested
on ice by scraping, washed twice with cold PBS and lipids were extracted as
described below. The exfracted lipids were dried under N2, dissolved in a small
volume of chloroform and analyzed by TLC as described below.
Lipid Extraction
Lipids were extracted from cells as described in reference [181]. Briefly,
celis were harvested on ice by scraping, transferred to glass tubes and washed twice
with 3 ml of cold PBS. After centrifugation at 500 x g for 5 min at 4°C, celi pellets
were resuspended in 3 ml ofrnethanol/chloroforrn mixture (2:1), vortexed and left at
4°C for 16 h. After this penod of extraction, 0.8 ml ofPBS, imi of 1 M NaCI and 1
ml of chlorofonn were added to each tube. Tubes were vortexed again and
centrifuged at 500 x g for 5 min at 4°C to separate water the phase from the organic
phase. The organic phase (at the bottom of the tube) was aspirated using glass
Pasteur pipette and transferred to clean glass tube. The organic phase was then
washed once with a mixture of I M NaC1/methanol (9: 1) and collected as described
above. The organic phase containing total lipids was stored at -20°C in closed tubes,
under N2.
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Thïn Layer Chromatographv (TLC) of Neutral Lipids
The extracted lipids were dried under N2, dissolved in 30 t1 of chloroforrn
and 15 d was spotted on silica gel TLC plate (Whatman). The plate was then
developed in a closed chamber containing mixture of petroleum ether: diethyl ether:
glacial acetic acid (70:30:1). Lipids were visualized by staining with iodine vapors
and classes of lipids were identified by comparison with standards (Sigma-Aldnch
Corp., St. Louis, MO). Radioactively Iabelcd lipids were visualized by
autoradiography.
Triacylglycerol Assay
Cellular TG content was determined using the GPO-Trinder kit (Sigma
Diagnostics, St-Louis, MO) and samples were prepared as described in reference
[182]. MDA-MB-231 celis were pi ated in 75 cm2 flasks at 3x105 cells/flask. Three to
four flasks were prepared to obtain cell numbers needed for an assay (two million
celis were required for each sample). Cells were harvested on ice by scraping,
washcd twice with cold PBS and lipids were extracted as described above. The
extracted Ïipids were dried under N2, dissolved in 100 jil of 2% v/v Thesit detergent
(Sigma, St-Louis, MO) in chÏoroforrn, dried again under N2, and resuspended in 50
tl of water. The samples were then vortexed and sonicated in a water bath sonicator
(Crest Tru-Sweep (50/60 Hz), Trenton, NJ) for 15 min at RT. Two hundred jil of
GPO-Trinder kit reagent vas added directly to each sample tube, mixed gently and
incubated for 5 min at 37°C. The reaction mixture was transferred to a 1.5 ml
microfuge tube and centrifuged at 10,000 rpm at 4°C for 5 min. The supematants
were transferred to a 96 welI plate and the OD measured at 540 nm using a
microplate reader (Bio-Rad 3550). Triolein (glyceryl trioleate; Sigma-Aldrich) was
used as a standard.
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Lipid Droplets Staining
Lipid droplets were visualized by staining with Ou Red O. The stock solution
was prepared by dissolving 300 mg Ou Red O (Allied Chemical) in 100 ml of 99%
2-propanol. The working solution was prepared freshly by diluting the stock solution
with water (3:2), kept at RT for 10 min and filtered through a 0.22 trn filter (Corning
PIES filter). Cells grown in Petri dishes (60 mm) were washed twice with 5 ml PBS
and incubated with 3 ml of Oil Red O working solution for 15 min at RT with gentle
shaking. The staining solution was removed and the cells were then washed once
with PBS, and fixed with 10% fornialin (Anachemia) for 25 min. The ceils were then
washed again with PBS and stained for 5 min with Harris Hematoxilin (Sigma
Aldrich). 3 ml of 10% glycerol in PBS was added to each dish to prevent drying.
Photomicrographs were taken from a representative field using an inverted
microscope (Nikon Eclipse TE300) at 400X magnification and a digital camera
(Nikon CoolPix 990).
Lipolysïs
MDA-MB-23 1 cells were plated in 75 cm2 flasks at 3 x 1 ceÏls/flask. Three
to four flasks were prepared to obtain ceil numbers needed for an assay (two million
celis were required for each sample). Cells were trypsinized, pooled, resuspended in
senim-free MEM medium containing 0.1% BSA and counted. The ceils were then
resuspended in fresh MEM medium containing 0.5% BSA at a density 2 x 106
cells/100 pi and incubated in 48 well plates (100 pJ/well) for 3 h at 37°C in a C02
incubator. S amples were then transferred to Eppendorf tubes and centrifuged at
1,500 rpm for 5 min at 4°C. The supernatants were collected and frozen at -80°C.
The rate of lipolysis was rneasured using two complementary assays. Glycerol
released from the cells to culture media was measured in triplicate using the
Triglyceride GPO-Trinder kit (Sigma Diagnostics, St-Louis, MO) and the amount of
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FFA released was measured in duplicate using the Wako NEFA test kit (Wako
Cliemicals USA, Inc. Richmond, VA). ResuÏts were expressed as nmol glycerol or
FFA released/h/106 celis.
FACS Analysis
DNA staining for FACS analysis was perfonried as described in reference
[183]. Briefty, cells were harvested by trypsinization, washed with PBS containing
0.1% BSA at 4°C and fixed with 70% ethanol for 10 min at -20°C. They were then
collected by centrifugation (1,000 rprn per 5 mm) and resuspended in staining buffer
prepared by adding NP4O (0.6% v/v) and 36 tg/mÏ RNase to a I x dilution of a 20 x
stock (1.17 g of sodium chloride, 2.13 g of sodium citrate, and 0.10 g ofpropidium
iodide in 100 ml of water, pH 7.6 adjustcd with acetic acid). Stained cefls (10,000)
were analyzed with a flow cytorneter (FACS SCAN, Beckton Dickinson) and ceil
cycle analysis was perforrned using Celi Quest Pro software.
Statistical Analv sis
Statistical significance was calculated with the Student’s t-test. A P-value of
<0.0 1 was considered significant.
CHAPTER III
RESULTS
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3.1 Elevated intracellular TG content is associated with resistance to
apoptosis in MDA-MB-231 breast cancer celis but flot in MCf-1OA non
transformed celis
3.1.1 Seruin-,free survivaÏ ofMDA-MB-231 breast cancer ceÏÏs afler treatment with
oleate correÏates with the formation of intraceÏtuÏar Ïipid dropÏets
Senim withdrawal is known to induce apoptosis in ceils that require GF for
survival. We have shown that exogenous oleate added to culture media promotes the
accumulation of triacylglycerols (TG) [167] and protects MDA-M3-231 ceils from
apoptosis induced by serum withdrawal [162]. To determine if treatment with oteate
and e!evated TG content could protect non-transforrned, !ess autonornous ceils
against ce!! death induced by serum and GF withdrawal, we perforrned experiments
with human non-transformed breast epithelial celis MCF-1OA. These cel!s require
both uncharacterized growth factors present in 5% FBS, as we!! as defined growth
factor supplements, including EGF, hydrocortisone, and insulin, to promote ce!!
growth. They are therefore cultured in MEM medium containing 5% FBS and also
the above-rnentioned growth factors. This medium wilI be referred to in this thesis as
normal ce!! Growth Medium tnGM) as opposed to tumor ce!1 Growth Medium
(tGM) used for culturing MDA-MB-231 celis and containing 5% FBS as the only
supplement.
Figure 9A shows that treatment of MDA-MB-23 1 cells with oleate for 24 h,
foltowing 24 h of senim starvation, prevents apoptosis (caspase-3 activation) that
occur after placing these ceils in senirn-free conditions. In contrast, the presence of
oleate has no effect on survivat ofMCF-1OA ce!!s. They enter apoptosis after being
transfelTed to serum and GF-free medium regardless of the presence of oleate
(Figure 9B). We therefore perforrned rnetabo!ic studies to try to understand how
oleate protected MDA-MB-23 1 celis and not MCF- 1 OA ce!!s from apoptosis induced
by withdrawal of GF and serum. For the sake of sirnplicity, MEM medium without
any additives (no serum and no defined GF) wilI be cal!ed Experimental medium
(EM).
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figure 9. Effect of treatment with 100 jiM oleate on apoptosis induced
by serum and Gf withdrawal in MDA-MB-231 and MCF-1OA ceifs
MDA-MB-231 human breast tumor celis (A) and MCF-IOA human breast
epithelial ceils (B) were grown in con-esponding growth media (GM);
tumor celi Growth Medium (tGM) and normal celi Growth Medium (nGM),
respectively, as described in Methods. Ceils were placed in Experimental
Media (EM) for 24 h to starve for senmi and GF, and then were treated with
100 tM oleate (bound to 0.5% BSA) for 24 h in fresh EM (light grey bars).
Controls included O tM oleate (0.5% BSA only) (white bars) and
coiiesponding growth media (dark grey bars). Caspase-3 activity was
assessed in celi lysates prepared from individual cultures at the end of
experiment. The data represent the mean and SE for two independent
experiments performed in duplicate (n=4).
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In various tissues, exogenous oleate, once taken up by the ceil, can be
chaimeled to oxidation or esterification, depending on the overali metabolic state of
the body and the needs of an individual celi. Figure I OA shows that MDA-MB-23 Ï
celis have an aÏmost 30-fold lower rate of oleate oxidation compared to MCF-IOA
celis. On the other hand, exposure to 100 iiM oleate causes the formation of lipid
droplets in MDA-MB-231 (f igure lOB) but flot in MCf-YOA ceils (Figure IOC).
Since the main components of lipid droplets are storage TG, the appearance of lipid
droplets is a marker of oleate esterification and formation of TG. Thus, our results
show that MDA-MB-23 1 breast turnor celis, which have a reÏatively tow rate of fatty
acid oxidation and a relatively high capacity for esterification and for storage of TG
in lipid droplets, are protected by oleate from apoptosis induced by withdrawal of
serum. In contrast, MCF-1OA non-transfomed breast epithelial celis, which have a
relatively high rate of fatty acid oxidation and a retatively low capacity for
esterifciation and storage of 1G, are not protected by oleate from apoptosis induced
by withdrawal of serum and Gf.
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Figure 10. Differential oleate metabolism in two ceil types: MDA-MB-231
and MCF-1OA
Celis were grown and treated as in Figure 7 legend. A, Oleate oxidation was
deterrnined by measuring the release of radioactive C02 from [1-14C] labeled
oleate at the end of 24 h serum and GF starvation period. The data represent the
mean and SE for two independent experirnents performed in duplicate (n4). B,
C, Representative photomicrographs (400X) of MDA-MB-23 1 (B) and MCF- 1 OA
(Ç celis stained with Ou Red O to visualize neutral lipids after 24 h treatrnent
with 100 iM oleate.
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3.1.2 Lipid dropiez’ Jàrination does flot protect non-transformed MCF-1 OA
ceÏÏsJoin apoptosis indttced bv serum cmd GF withdrawaÏ
We tested whether MCF- 1 OA celis would produce lipid droplets when treated
with elevated concentrations of oleate. The celis were grown in nGM and then
treated with a range of physiological oteate concentrations (100 jiM and 400 rM) for
24 h in nGM. Figure 9 shows that 400 iM oleate induced formation of lipid droplets
in MCF-1OA celis, suggesting that these ceils are abÏc to esterify fatty acids and store
TG in Iipid droplets when treated with sufficiently high oleate concentrations. For
comparison, MDA-MB-23 1 ceils fornied lipid droplets when treated with both 100
tM and 400 .tM oleate (figure 11). Furthermore, the size of the lipid droplets
increased with increasing oleate concentrations. After the treatrnent with oleate, ceits
were washed with PBS and shifted to Experimental Medium (EM), which contains
no serum or added growth factors for 4$ h. MDA-M3-23 Ï ceils containing droplets
were completely protected from apoptosis induced by 48 h incubation in EM (Figure
12A). It is important to point out that this protection occurred in the absence of
exogenous oleate (48 h after treatrnent with oleate). In contrast, MCf-1OA cetis,
even though they initially contained lipid droplets (after treatment with 400 uM
oteate) were not protected against apoptosis when placed in EM for 48 h (Figure
12B).
Thus, MDA-MB-23 1 ceils when treated with oleate forrned lipid droplets and
become resistant to apoptosis. The formation of tipid droplets however was flot
associated with the resistance to apoptosis in non-transfornied MCF-YOA hurnan
breast epithelial celis.
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Figure 11. Effect of treatment with 100 cM and 400 iM oleate on Iipid
droplet formation in two celi types: IVIDA-MB-231 and MCF-1OA
Celis were grown in colTesponding growth media as described in Methods.
The ceils were treated with the indicated concentration of oleate in growth
media for 24 h and representative photomicrographs (400X) of MDA-MB
23 1 and MET- 1 OA celis stained with Cil Red O were taken.
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Figure 12. Effect of treatment with 100 iM and 400 iM oleate on
apoptosis in two ce!! types: MUA-MB-231 and MCF-1OA
Celis were grown and treated as in Figure 9 legend. Then, MDA-MB-231
(A) and MCF-1OA ceils (B) were washed in PBS and incubated for 4$ h in
EM (lacking serum and GF) to induce apoptosis. After this incubation
period, caspase-3 activity was assayed in celi lysates. The data represent the
mean and SE for two independent experirnents performed in duplicate
(n=4).
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3.1.3 Inhibition offat oxidation in Mcf-]OA ceils does not impmve their sttn’ivctt
in Gf-free conditions
The resistance to apoptosis in celis treated with oleate appeared to be
inversely corretated with the rate of fatty acid oxidation in our mode! ccli unes (see
Figure 10). Therefore, we asked whether the inhibition of fatty acid oxidation couid
affect the survival of MCF- 1 OA cells after they formed lipid droplets with elevated
oleate concentration. Figure 13A shows that 200 nM etomoxir, an iireversible
inhibitor of CPT I, the enzyme that catalyzes the rate limiting step in fatty acid
oxidation, does flot prevent apoptosis induced by GF withdrawal in MCF- 1 OA ceils
treated with 400 tM oleate. Etomoxir reduced fatty acid oxidation by more than 90
% in these ceils (Figure 13B). Thus, although the rate of fatty acid oxidation in
etornoxir treated MCF-1OA cet!s was similar to that of MDA-MB-231 celis, this did
flot render them resistant to apoptosis induced by serum and GF withdrawal.
3.1 .4 Glttcose ,netabolism is Gf dependent in MCF- 10 A celis and Gf independent
in MDA-MB-231 cetts
fatty acids and glucose are both flic! substrates and their metabolic pathways
are interdependent. The rate of glucose uptake, and in consequence glucose
rnetabolism is down regulated in many ce]I types when GF are withdrawn [67,68].
We decided to verify this in both ccli lines by detenriining the effect of the
Experimental Medium on the rate of glycolysis (glucose utilization) and the rate of
glucose oxidation. Figure 14A and 3 shows that in MCF-IOA celis gLucose
metabolisrn (both utilization and oxidation) is down reguiated by about 65%, 24 h
after serum and GF withdrawal. In contrast, glucose metabolism in MDA-MB-231
celis is not altered in EM (Figure 14C and D). MDA-MB-231 ce!!s have a high rate
of glucose rnetabolism, which is typical for cancer celis. At basal conditions (in
corTesponding growth media) glucose utilization and glucose oxidation were
respectively 1.8 fold and 2.7 fold higher in MDA-MB-231 celis compared to MCF
1OA celis.
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figure 13. Effect of etomoxir, an inhibitor of fat oxidation, on apoptosis
induced by serum and GF withdrawal in MCf-1OA ceils
A, Ceils were grown in a growth medium (nGM) for 24 h and incubated
without or with 400 iiM oleate in fresh growth media for another 24. Then
ceils were washed with PBS, and exposed to EM, which did flot contain
oleate, with or without 200 nM etomoxir for 48 h. After this incubation
period, caspase-3 activity was measured in ceil lysates prepared from
individual cultures. B, Fatty acid oxidation was deterrnined in control
conditions (no oleate) by measuring the release of radioactive C02 from [1-
14C] labeled palmitate 2 h after the addition of etomoxir. The data represent
the mean and SE for two independent experiments perforrned in duplicate
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Figure 14. Effect of growth media vs. experîmental media on glucose
metabolism in MCF-1OA and MDA-MB-213 ceils
MCF-IOA ceils (A, B) aiid MDA-MB-213 ceils (C, D) were grown in a
colTesponding growth medium (nGM or tGM respectively) for 24 h, washed with
PBS, and incubated in EM for another 24 h. Glucose utilization (release oftritiated
water from D-[5-3H]-glucose (A, C) and glucose oxidation (release of labeled C02
from D-[U-14C] glucose (B, D) were deterrnined as described in Methods.
Measurements were performed in GM before transferring celis to EM and then in
EM, 24 h later. The data represent the mean and SE for two independent experirnents
perfomied in duplicate (n=4).
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3.2 Upreguation of TG[FFA cycling by oleate is assocîated with Jong-term
growth factor independent survival of MDA-1’1E-231 ceils.
3.2.1 MDA-MB-231 ceÏts show Ïzigh rates of TG/FFA vcÏing in serttm-free
conditions
The ability of MDA-MB-23 1 celis to efficiently esterify oleate for storage as
TG is illustrated in Figure 15A. Total intracellular TG content ofthe ceils was found
to increase in a dose dependent maimer in response to 24 h treatment with increasing
concentrations of oleate. TG stored in lipid droplets can be hydrolyzed to produce
FFA and glycerol. This process (tipolysis) has been rnostly studied in adipocytes,
where it is carried out by the highly regulated enzyme, hornione sensitive lipase
(HSL) in addition to other less smdied tipolytic enzymes such as ATGL [111]. ffA
that are reteased from TG by tipotysis can be imrnediately re-esterifled within the
ceil to form 1G again. Lipolysis and re-esterification are two opposite processes
invoÏved in what is refelTed to as intracellular TG/FFA cycling [127,128].
Lipolysis in MDA-MB-23 1 cetts was studied using two complementary
assays, in which the amounts of gtycerol and fFA released into the celi media from
the breakdown of 1G were compared (Figure 15B and Table I). Figure 15B shows
that MDA-MB-231 ceils have a high rate of lipolysis as measured by glycerol
released relative to their total 1G content. Moreover, their rate of lipolysis increased
drarnaticaîly with exposure to increasing concentrations of exogenous oleate.
Following a 24 h incubation with the highest concentration of exogenous oleate
tested (400 1iM), cellular 1G content was determined to be 52 nmol/106 cells and
glycerol released during 1 hr was 35 nmol/106 ceÏÏs. The resutts presented in Table I
and Figure 153 suggest that MDA-MB-231 cells mtist re-esterify FFA very
efficiently and have very active TG/FFA cycling.
63
60
j,
50
40
— ‘0
-
.f 10
o
0 100 200 300
Okate (pM)
B MDA-MB-231 celis — Lipolysis
C
d
ç,
ç,
A MDA-MB-231 celis — TG Content
400
O J 00 200 3t)O 300
Oteate ItMI
concentration on cellular TG content and rate of
30
30
20
10
o
Figure 15. Effect of oleate
Lipolysis in N’IDA-MB-231 celis
Ceils were grown in a growth medium (tGM), washed with PBS and placed in
Experirnental Medium (EM) for 24 h to starve for growth factors as described in
Methods. Then the celis were treated with the indicated range of oleate
concentrations (bound to 0.5% BSA) for 24 h in fresh 1M. At the end of the
treatment period, TG content (A) and lipolysis rate (B) were measured as described
in Methods. The data represent the mean and SE for two independent experiments
perforrned in duplicate (n=4).
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Table I: Comparison between the cellular 1G content after treatment with
different oleate concentrations and the rate of lipolysis of MDA-MB-231 celis
measured by two complementary methods (glycerol release and FFA release)
MDA MB 231 ceils were grown in a growth medium (tGM), washed with PBS and
placed in Experirnental Medium (EM) as described in Methods for 24 h to starve for
growth factors. Then celis were treated with the indicated range of oleate
concentrations (bound to 0.5% BSA) for 24 h in fresh EM. At the end of the
treatment period, 1G content and lipolysis rate (sec Methods) were measured by two
compïementary rnethods. The resuits show that glycerol released from lipolysis
greatly exceeds the amount of FfA released (instead of being 1/3 the amount),
suggesting that FFA are retained inside the celis and most tikely irnrnediately re
esterified to TG. The data represent the means and SE for two independent
experiments perforrned in duplicate (n=4).
TG content
(nmols/106 ceils)
Rate of Lipolysis
[OleateJ (pM) Glycerol released FfA released
(nmolslh/106 celis) (nmols/h/106 ceils)
o
33
100
400
2.78 ± 0.25
4.76 ± 0.37
18.25 ± 1.38
52.28 ± 3.62
3.91± 1.51
12.72 ± 1.38
21.48 ± 1.45
35.8 ± 1.32
<0.5
0.56 ± 0.22
0.84 ± 0.39
3.13 ±0.18
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The data presented in Table I show the rate of lipolysis rneasured by the two
complernentary rnethods and reveals that the values are flot stoichiometrically related
as might be expected. For the celis treated with 400 iM oleate, we found only 3.13
nmol/h/106 cells of fFA released, instead of 3 x 35.8=107.4 nmol/h1106 ceils
calculated from the results obtained usÏng glycerol release (1 molecule of TG is
cornposed of 1 glycerol and 3 FFA motecules). The rate of FFA oxidation in MDA
MB-231 ceils (approximately 0.05 nmol/hul 06 cells) cannot explain the discrepancy
between the arnount of glycerol and FFA released. The resuits therefore indicate that
>95% of FFA are indeed recycled back to TG in these ceils rather than being
oxidized. The net effect is that these hurnan breast cancer celis when exposed to
exogenous oleate, both synthesize and maintain TG in lipid droplets very efficiently
(Figure iSA), in spite of a very high rate of lipolysis (Figure 15B). These resuits
suggest that both anus of the TG/FFA cycling pathway, esterification and lipolysis
are very active and that the entire pathway is rnarkedly upregulated by oleate in
MDA-MB-23 1 tumor ceits.
3.2.2 Short—terni oleate treatinent promotes long—terni serum—free ceÏl survival in
MDA -MB-231 hiunan breast tumor ceÏÏs
To test the hypothesis that the presence of elevated levels of intraceltular TG
induced by exposure to exogenous oleate might be involved in the protection against
apoptosis induced by serum withdrawal, we studied the long-terni survival of MDA
MB-231 cells exposed briefly to oleate. After a 24 h treatment with various
concentrations of exogenous oleate in EM, the cells were maintained in EM for an
additional eight days (with daily changes of media) and the live adherent ceils were
counted daily. Figure I 6A shows that senirn-starved cells without oleate treatment
died, however oleate-treated ceils survived for many days. Short-term (24 h)
treatment with 400 M oleate afforded complete protection against apoptosis
induced by serum withdrawal for at Ieast 10 days, while lower concentrations of
oleate provided partial protection in a dose dependent maimer.
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Figure 16. Effect of short-term oleate treatment on long-term serum
free survival and celi cycle dïstribution of MDA-MB-231 celis
A, Celis were grown in growth medium (tGM), washed with PBS (Day 0),
and pÏaced in experimental medium (EM) for 24 h (Day 1). CelIs were
treated with a range of oleate concentrations (0-400 .tM) in EM for 24 h
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(Day 2) transferred to fresh EM, and cultured for up to $ days in EM.
Viable celis were counted daily (see Methods) and the results were
expressed as the mean number of live adherent cefls/flask. The data
represent the mean and SD from 3 separate flasks in a representative
experiment, which was repeated two tirnes. B, FACS analysis for DNA
content was performed on the indicated days using propidium iodide.
Resuits for cells treated with 100 jiM oleate are shown with untreated
control cultures for comparison. The percentages of cells in the different
phases ofthe ccli cycle are shown inside the panels.
The percentage of live adherent MDA-MB-231 ceils on Day 10 after the 24 h
treatment with 400 1iM oleate was 10$ ¾ relative to the cell number on Day Ï
(Figure 16A). This suggests that celis protected from apoptosis by treatrnent with
oleate were proliferating at a very low rate, if at alt. Using FACS analysis, we
deterrnined the ccii cycle distribution of serum starved and oleate treated MDA-MB
23 1 cells from Day I until Day 4 post serum withdrawal and compared these with
the ccli cycle distribution of cells grown in tGM (Figure 16B). A graduai decrease in
the percentage of cells in Gi phase of the ceit cycle was observed with a
concomitant increase in the percentage of cells in S and G2/M phases. Together,
these resuits (Figure 16A and Figure 16B) suggest that the celis rescued from
apoptosis by oleate did not proliferate due to difficulty completing ccli division.
Figure 17 shows that treatrnents as short as 3 h with 100 tM oleate protected
human breast cancer celis from apoptosis induced by withdrawal of serum. This
short pulse of oleate prevented activation of caspase-3 for up to 24 h. Remarkably,
even a one-hour pulse was partially protective against apoptosis.
The resuits indicate that a short pulse of a physiologicai concentration of
exogenous oleate protects MDA-MB-23 I human breast cancer ceils from apoptosis
induced by serum withdrawal. The survival effect is oleate dose dependent and long
lasting. Surviving ceils slow down their proiiferation and tend to accumulate in the S
and/or G2/M phases of the cdl cycle.
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Figure 17. Effect of a short pulse of 100 iM oleate on apoptosîs induced
by serum withdrawal in MDA-MB-231 ceils
Celis were grown in growth medium (tGM), placed in EM for 24 h, and
washed with PBS. Ceils were treated with 100 tM oleate for a range of
time periods (1, 3, 6 and 24 h). They were then washed with PBS and
incubated with fresh EM until the 24 h tirne point. Caspase-3 activity was
assessed on total cells at the 24 h time point for all cultures. The data
represent the mean and SE for two independent experirnents performed in
duplicate (n=4).
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3.2.3 Short-terni oteate treatment cotises a long—Ïasting change in cettular Ïipid
metabotism in MDA-MB-23] cetis
Figure 18 shows that short-term (24 h) treatment of serum-starved MDA
MB-23 1 ceils with 100 jtM oleate leads to long-terrn stable (at least 7 days) elevated
intracellular TG content (Panel A) and elevated lipolysis rate (Panel B). Thus,
lipolysis remained high, between 20 and 17 nmol/h/106 celis, from Day 2 until Day
7, whereas within the same time period, cellular TG content was tnoderately
lowered, from 20 to 12 nmol/106 ceils. This suggests that during the 7 days post
oleate treatrnent, the cellular TG pool continued to turnover at a high rate because of
very active TG/FFA cycling.
3.2.4 MDA-MB-23] ceÏÏs rescuedfrom apoptosis bi’ oleate and cultured in serum
free conditions maintain a high rate of glttcose oxidation
Continuous TG/FFA cycling requires a constant supply of glycerol-3-
phosphate, which can be produced by gtycolysis. It was therefore important to assess
the metabolism of glucose in MDA-MB-231 ceils rescued from apoptosis by oleate.
MDA-MB-23 1 cells have a high rate of glucose metabolism compared to MCF- 1 OA
and, contrary to these non-transforrned celts, they maintain a high glucose oxidation
rate after serum and GF withdrawal (Figure 14 and 19A). The measurements of
glucose oxidation at Day 2, 48 h after serum withdrawal were performed on live
adherent ceils only (not on total cells), because at this time, the cells were begiming
to enter apoptosis. At Day 3 post serum withdrawal, MDA-MB-23 1 celis rescued by
short-terni treatment with oleate still maintained a high glucose oxidation rate, while
the maj ority of non-treated celis t> 90%) had detached from the dishes and were
dead as deterrnined by Trypan Blue staining. Thus, elevated glucose metabolism in
MDA-MB-23 I celis most likely provides glycerol-3-phosphate needed for fatty
acids esterification and remains the main energy source in MDA-M3-23 1 celis
rescued from apoptosis by short-terrn treatrnent with oleate. It is therefore unlikely
that FFA released from droplets by lipolysis are needed as an alternative energy
source (via fatty acid oxidation in mitochondria) to promote survival of these cells in
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the absence of serum. Consistent with this hypothesis, MDA-MB-23 1 cells were
found to have a veiy low rate ofFFA oxidation (Figure 1OA).
3.2.5 MDA-MB-231 ceÏÏs rescuedfronz apoptosis by oÏeate and cuttured in serum
free conditio,is svnthesize de izovofattv acids
We have shown that the cellular 1G content of MDA-MB-23 1 celis increased
and the rate of lipolysis was upregulated by oleate in a dose dependent manner and
both effects persisted for days after oleate rernoval. This implies that during this tirne
TG/FFA cycling was actively going on. We have also shown data suggesting that
fatty acids are being recycled to maintain continuous synthesis of TG. However, the
recycling of fatty acids is not comptetely efficient. Sorne of FFA released during
lipolysis can be secreted outside the celi (1-2% as shown in Table I). Some fatty
acids can be cbanneled to phospholipid synthesis. It was shown that MDA-MB-231
celis incorporate equal amounts of [4C]-labeled oleate into TG and phospholipids
during 1 h incubation [167]. Finally, sorne fatty acids are oxidized in mitochondria
and peroxisornes. In spite of the above pathways that served to reduce available FFA
for recycling, and the absence of oleate in EM to supply the 1G pool in these celis,
oleate treatment promoted the survival of MDA-MB-23 1 ceils for many days. Thus
we hypothesize that MDA-MB-23 1 celis synthesize FFA de novo from glucose. We
have shown that MDA-MB-231 celis rescued from death by treatment with oleate
metabolize glucose at a high rate; therefore it is likely that they producc sufficient
arnounts of pyruvate required for anaplerosis and de novo fatty acid synthesis. We
suggest that newly synthesized fatty acids could supply the pool of endogenous FfA
contributing to maintenance ofthe stable 1G levels in these cells. Figure 19 B shows
that indeed MDA-MB-23 1 ceïls rescued from death by short—term treatment with
oleate, synthesize fatty acids de novo from acetate, and produce TG containing these
newly synthesized FFA.
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Figure 18. Long-term effect of 24 h treatment wïth 100 iM oleate on
TG content and lipolysis rate in MUA-MB-231 celis
A, B, Ceils were grown in growth medium (tGM), placed in EM for 24 h,
washed with PBS, and treated with 100 jtM oleate for 24 h in EM.
Subsequently celis were cultured for up to 7 additional days in EM. Total
cellular TG content (A) and lipolysis rate (B) in adherent celis was
determined at the indicated tirne points. The data represent the mean and SE
for two independent experiments perfonned in duplicate (n=4).
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Figure 19. Long-term effect of 24 h treatment with 100 tM oleate on
glucose oxidation rate and lipogenesis (fat synthesis) in MUA-MB-231
ceils
A, B, Ceils were grown in growth media, placed in EM for 24 h, washed
with PBS, and treated with 100 tM oleate and O tM oleate (0.5% BSA) for
another 24 h. Subsequently, cells were cuttured for up to 7 additional days
in EM. A, Glucose oxidation was measured on the indicated days (see
Methods) in MDA-MB-23Ï celis. Oxidation rate in MCF-10A cells is also
shown for comparison. The data represent the mean and SE for two
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independent experiments perforrned in duplïcate (n=4). B, Lipogenesis was
measured in MDA-MB-213 celis on Day 7 as described in Methods. The
autoradiogram shown represents a TLC plate on which total lipid extracts
were separated. The markers used to identify the different class of lipids
were non-radioactive; they were visualized by staining with iodine vapors.
Abbreviations: CE, cho!esterol ester; DAG, diacylglycero!; FA, fatty acids;
PL, phospholipids; 1G, triacyÏglycerol.
3.2.6 HigÏz capacitv b store TG is corretated with enÏzanced serum-free surviva! in
various human brecist cancer ce?? hies
The effect of oleate treatrnent on ce!! survival was tested in three other
hurnan breast cancer ce!! !ines; together with the non-transformed human breast
epithelia! ce!! strain MCF- 1 OA (Figure 20). The design of the experirnent was similar
to that shown in Figure 16A and ce!ls were counted on Day 6. Ihe resu!ts are
expressed as a percentage of the ce! J number at Day 1 (before the addition of o!eate).
It should be noted that each of the different celi unes had different growth
characteristics. MCF-1OA was the only cel!s une in our panel that needed
supplementaiy GF for surviva! and proliferation in vitro. As shown in Figure 9 and
12, MCF-1OA celis were veiy sensitive to serum withdrawal and were not protected
by oleate treatment when maintained in EM. T-47D and MDA-MB-468 human
breast tumor celis responded similarly to oleate treatrnent as did MDA-MB-23 Y
ceits, although the three ce!! !ines differed in their sensitivity to serum withdrawa!,
with MDA-MB-23 1 being the rnost sensitive. Oleate treatment had no effect on ccli
survival in the absence of GF of the fourth ce!l une tested, MCF-7. The three ce!!
unes that responded to oleate treatrnent accurnuÏated high leve!s of ce!lular 1G when
exposed to 100 iM oleate (Figure 2 lA), whereas the ce!! une that did not respond to
oleate (MCF-7) had low tota! TG content, as did MCF-1OA ce!!s. These resu!ts
further confirm that a high capacity to store TG is associated with enhanced serum
free ce!! survival after treatrnent with oleate in three of four human breast cancer ce!!
unes tested.
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FFA esterification to forrn complex lipids, in particular TG, represents one of
two main metabo!ic pathways for fatty acids within the celi, the other being fatty
acid oxidation. It was of interest to examine the relative rate of fatty acid oxidation
in our panel of celi unes. We expected to see an inverse correlation between
oxidation and esterification. Figure 21B shows that MDA-MB-231 and T-47D ceil
unes, which have high capacity to store TG, had a low intrinsic fatty acid oxidation
rate, whi!e MDA-MB-468, MCF-7 and MCF-ÏOA ce!! !ines showed high fatty acid
oxidation rates. $urprisingly however, MDA-ME-468 celis (but not MCF-7) a!so
had a high capacity to produce TG when exposed to exogenous o!eate. Thus, the rate
of fatty acid oxidation of the different human breast cancer ce!! !ines tested was
variable (high and low) and did flot correlate with the ability to store cel!u!ar TG or
the !ong-term serurn-free surviva! after short-term treatrnent with o!eate.
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Figure 20. Effect of short-term oleate treatment on long-term serum
free survival of a panel of human breast ceil unes and control MCF
1OA ceils
Celis were grown in growth medium (tGM), washed with PBS, and then
placed in EM for 24 h (Day 1). The celis were treated with a 100 jiM oleate
for another 24 h in EM (Day 2), and then cultured for 6 days in EM. Viable
cetis were deterrnined on Day 6 as described in Methods and the long-terni
sentm-free ccli survival was catculated as the mean percentage of the ceti
number at Day 1 (grey bars). Untreated controls received 0.5% BSA (white
bars) and were also calculated the sarne way. The data shown are the means
and SE for 2-4 independent experiments performed with triplicate flasks per
experiment per cdl type (n=6 for T-47D, n=9 for MDA-MB-231. n=12 for
MDA-M3-46$, n=8 for MCF-7 and n=6 for MCF-IOA). , p <0.01 versus
respective control.
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Figure 21. Effect of short-term oleate treatment on cellular TG content
and FFA oxidation of a panel of human breast ceil unes and control
MCF-IOA celis
A, Ceils were grown in growth media (tGM), washed with PBS, placed in
EM for 24 h (Day 1), treated with a 100 tM oleate in EM for another 24 h
(Day 2), and immediately assessed for TG content. B, Fatty acid oxidation
rate was determined on Day Ï as described in Methods. The data in Panel A
and B represent the mean and SE for two independent experiments
performed in duplicate (n=4).
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DISCUSSION AND CONCLUSIONS
78
4.1 Upregulation of TG/FfA cycling by oleate may be involved in the
maintenance of Iong-term serum-free survival of human breast cancer celis
We have shown that the common nutrient fatty acid oleate prevents apoptosis
and promotes tong-terni celi survival in the absence of growth factors in three out of
four human breast turnor ccli unes (MDA-MB-231, MDA-MB-468, and T47D). The
ceils were protected for many days from apoptosis and death induced by serum
withdrawal, by short-term (3-24 h) treatment with physiological concentration of
oleate (100 1iM). This long-terni survival effect occurred in the absence of
exogenous oteate and was associated with the accumulation of TG. The period of
survival was oleate dose dependent as shown in MDA-MB-23 1 ceils, even though
oleate was no longer present in the media. The cells proliferated very slowly if at ail
in serurn-free conditions, suggesting that treatment with oleate influences mainly ccli
survival with little effect on cdl proliferation. After short-term treatrnent with oleate,
the cellular TG pool enlarged and the rate of lipolysis (measured as glycerot released
into the culture medium) increased in a dose dependent mairner. Subsequentiy, both
TG levels and the rate of lipolysis rernained high for a tong period of time (8-10
days).
MDA-MB-23 1 cells have very efficient TG/fFA cycling. Thus, they recycle
fFA to maintain elevated 1G content in spite of very active ongoing lipolysis. This
suggests that they atso have a very high rate of FFA esterification. Despite the
absence of serum, glucose rnetabolism remains high in MDA-MB-23 1 cells rescued
from apoptosis by short-term treatment with oleate. Thus, glucose serves as the main
energy source and provides the glycerol-3-phosphate needed for FFA esterification.
It is attractive to propose that the abihty to efficiently esterify oleate and to maintain
elevated TG content, due to upregulated TG/FFA cycling, plays a role in the
antiapoptotic effect induced by treatment with oleate. Moreover, it may also be
involved in the maintenance of long-term survival of hurnan breast cancer cells in
the absence ofserum.
Cettular IG/FfA cycling occurs in rnany tissues. It is a multi-step, complex
cycle involving many enzymes. h lias been considered a “futile cycle” since its main
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outcome is the consumption of energy (the production of I molecule of TG
consumes 6 molecules of ATP). However, it al!ows the preservation of intracellular
pool of fatty acid, when they are flot oxidized for energy production and bas been
linked to thermogenesis in brown adipose tissue [130]. The present study suggests a
novel role for TG/fFA cycting, which is enhancernent of human breast cancer celi
survival.
4.2 Oleate cannot modify survival of GF-dependent non-transformed ceils
The relationship between the regulation of cellular metabotic pathways and
the signaling pathways for ce!! survival and proliferation is not well understood and
is on!y beginning to be discovered. Surviva! of non-transforrned MCF-1OA celis
depends on the presence of EGF, hydrocortisone and insuÏin in the culture medium.
We have shown that glucose metabo!ism decreases considerab!y in these celis in
senim and GF-free conditions. Dowmegulation of the rnetabo!isrn of glucose in
MCF-IOA ceils upon withdrawa! of GF is consistent with the notion that GF
regu!ates celi survival by controlling celi access to nutrients in addition to inhibiting
apoptosis [75,184]. Thus, MCF-1OA ceils cou!d suffer from atrophy when they are
withdrawn from GF, even in conditions of nutrient abundance. MDA-MB-23 1 breast
cancer celis, on the other hand, maintain a high rate of glucose oxidation even in
serum-free conditions. Thus, we wou!d like to propose that o!eate can promote
survival of certain cancer ceils like MDA-MB-23 1 that acquire upregu!ated and GF
independent rnetabolisrn of glucose. In contrast, it cannot modify surviva! of GF
dependent ceils like MCF-1OA. This is consistent with the hypothesis described
above, wbich suggests that oleate induced protection against ceil death involves
upregulation of TG/FFA cyc!ing. TG/FFA cycling requires a source of gÏycerol-3-
phosphate for continuous FFA esterification. This requirement can be met in ce!!s
like MDA-MB-23! at sentm-free conditions, but not in MCF-IOA celis, which
downregulate the rnetabolism of glucose upon withdrawal ofserum and GF.
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4.3 Model of Alternative NAD+ regeneration system linking TG/FFA cycling
to the metabolism of glucose
We have shown that the 1G pool in MDA-MB-23 1 ceils is relatively
constant for a long period of time after short-term treatrnent with oleate. Our data
shows that TG/FFA cycling is upregutated and de novo fatty acid synthesis could
supply the FFA pooL that is required for cycling. We have shown that the rate of
lipolysis is also constant, and depends on celÏular 1G content. Figure 22 presents a
schernatic model, which describes how we think the metabolic pathways for FFA,
1G, glucose, and NAD are linked into a larger metabolic circuit that can be
upregulated by the initial supply of exogenous oleate. FFA are esterifled to forrn 1G.
The increase in the 1G content is proportional to exogenous oleate dose. The 1G
pool is not inert but is constantly turning over due to high rates of both lipolysis and
esterification involved in TG/FFA cycling. The rate of cycÏing increases as a
function of the original exogenous oleate concentration. Cycling needs G3P for
esterifcation to produce 1G. the production of which is coupled to NAD
regeneration. Therefore, the high rate of TG/FFA cycling sets the high rate of NAD
regeneration, which in tum maintains the high rate of glycolysis. This allows the
production of sufficient amounts of pyrnvate required for anaplerosis and de novo
fatty acids synthesis. De novo synthesized FFA support 1G production and
completes the circuit.
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Figure 22. Model of the Alternative NAD Regeneration System, which
sets a stable rate for cytoplasmic NAD regeneration
Exogenous FFA (oleate) enter the celi and are activated to forrn FA-CoA,
which is esterified to glycerol-3-phosphate (G3P) to forrn TG. Cellular TG
content increases proportionally to the exogenous oleate dose. The 1G pool
is not inert but is constantly turning over due to high rates of both lipolysis
and esterification involved in TG/FFA cycling. The rate ofTG/FfA cycling
increases as a function of the original exogenous FFA (oleate)
concentration. TG/FfA cycling needs G3P, the production of which is
coupled to NAD regeneration. Therefore, the high rate of TG/ffA cycling
sets the stable rate of cellular NAD regeneration, which in turn allows the
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maintenance of a high rate of glycolysis. This aflows the production of the
sufficient amounts of pyruvate required for anaplerosis and de novo FFA
synthesis, which can supply the pool of FFA and contribute to continuing
TG/FFA cycling. FFA released from the ceil can bind to GPR4O, the fFA
receptor, to initiate intracellular signaling cascade.
Abbreviations: FBP, fructose 1,6-bi phosphate; GAP, glyceraldehydes-3-
phosphate; DHAP, dihydroxyacetone phosphate; G3, glycerol-3 -phosphate;
TCA, tricarboxylic acid cycle; MAL-CoA, malonyl CoA; FFA, fatty acids;
FA-CoA, Fatty acyl CoA; TG, triglycerides.
4.4. TG/FFA cycling might preserve the pool of FFA to ensure long-term
signaling via GPR4O
As it was mentioned above, MDA-MB-23 1 breast cancer celis appear to have
acqtiired autonomy in controlling their access to glucose, but their apoptotic
machinery can stili respond to a lack of serum growth factors. The best-studied
system responsible for cell survival and extracellular nutrient uptake is the
PI3K/AKT pathway [reviwed in 73]. Our previous work [173], as well as that of
others [185], demonstrated that this pathway could be stimulated via the G protein
coupled FFA receptors GPR4O and GPR12O. It is possibte that the antiapoptotic
effect described here, which involves upregulation of TG/FFA cycling, is also in part
GPR4O mediated. Thus, TG/FFA cycling which preserves the pool of fFA inside the
ceils foi- long periods of tirne would ensure the continuous availability of srnall
arnounts of FFA released into the medium upon lipolysis, for binding to the GPR4O
receptor and activation of the survival signaling cascade.
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4.5. Relevance of the oleate-induced long-term survival effect to cancer
The human breast cancer ce!! unes used in this study are derived from
metastases, so they represent aggressive, advanced breast turnors [186]. The ability
of oleate to modify their survival in vitro appears to be independent of their ER
status. However, it seems to be positively con-eiated with their invasiveness. Thus,
two ce!! unes, which responded to oleate, were estrogen receptor tER) negative
(MDA-MB-231, MDA-MB-468), whuie another one was ER positive (T-47D).
Furthermore, MCF-7 celis that did flot respond to oleate at ail are the ieast invasive
of the cancer ccli unes used in this study, while MDA-MB-23 1 ceils, which were the
rnost responsive to oleate, are known to be the rnost invasive [187]. Additional
experirnents are required to determine whether the response to oleate might provide
a good prognostic marker of breast cancer ceil invasiveness.
MDA-M3-23 1 celis rescued from death by treatrnent with oleate were viable
for long periods of time but blocked in ceti division. In this respect, they resemble
disseminated turnor celis (DTC), which have been detected in the bone marrow of
patients with breast tumors [188]. Most DTC are not activcly proliferating and
rernain in a state of “domiancy” for many years [reviwed in 43]. The Persistence of
DIC is associated with a poor clinicai outcome [189]. It wouÏd be tempting to
speculate that oleate couid contribute to the survival of DTC via upregulating
TG/FFA cyciing. Furtherrnore, we suggest that upreguiation of TG/FfA cycling,
which may confer resistance to apoptosis, may aiso contribute to the drug resistance
common in DTC [190]. More evidence, especially studies in vivo with prirnary
tumors and metastasis, are needed to verify if the TG/FFA cycle couid be indeed a
marker of tumor invasiveness or could contribute to DIC survival and/or drug
resistance.
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4.6. Search for markers which could identify cancer phenotype sensitive to
treatment with oleate
Celis with a higli capacity for FFA esterification can be identified
phenotypicalty under the light microscope following exposure to 100 tM exogenous
oleate for 24 h and staining with Ou Red O to visualize lipid droplets (lipid bodies)
in the cytop!asm. Alt three ce!! unes protected from apoptosis induced by GF
withdrawal by short-term (24 h) treatment with 100 !.tM oleate contained many lipid
droplets in the cytoplasm (data shown oniy for MDA-MB-23 1 cells) and showed
elevated TG content. Thus, it is tempting to speculate that the presence of lipid
dropiets may be a marker for resistance to apoptosis in tumor celis. However, MCF
7 breast cancer ceils, as we!l as MCf-1OA non-transformed ceils, which were flot
protected from apoptosis by the treatrnent with oleate, produced large droplets when
the fFA concentration in the medium was increascd to 400 jiM oleate (data shown
for MCF- I OA celis only). When extrapolating this to the in vivo situation, we predict
that obese, insulin resistant cancer patients, who have constantly elevated levels of
FFA in the b!ood, may contain Iipid droplets in many ce!! types in the body,
including tumor ce!ls, but this may not indicate that these ceÏ!s are capable to
upregutate their TG/FFA cycle and becorne resistance to apoptosis. Thus, the
presence of !ipid droplets per se may not be a good marker for resistance to
apoptosis in breast tumor ce!!s. A low rate of FFA oxidation, which is often
corretated with the high capacity for esterification may flot be a good marker either.
Three out of four breast cancer cet! unes tested showed an inverse colTelation
between their capacity for oleate esterification and their rate of Ff A oxidation
(MDA-MB-231, T47-D and MCF-7). However, the two main metabolic pathways
for FFA metabolism, oxidation and esterification, may flot be rnutual!y exctusive in
ai! hurnan breast tumor celis since MDA-MB-468 had both a relatively high abllity
for oleate esterification and a high FFA oxidation rate. According to our data
possible markers for the antiapoptotic phenotype described in this thesis cou!d be a
combination of a high giyco!ytic rate and a high rate of lipo!ysis. This however,
needs further investigation using more defined ce!! modeis such as non-transfonned
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breast epithelial ceils that stably express myristoylated Akt, to test if upregulation of
aerobic glycolysis brought about by Akt activation could lead to stable long-term
upregulation of lipolysis and long-term Gf-free survival after short-terrn treatment
with oleate [70, reviewed in 191].
4.7 Conclusions
The data described here suggest that the metabolism of fatty acids plays an
active role in the control of breast cancer ce!! survivat. We have found that the
common nutrient fatty acid oleate prevents apoptosis and promotes Iong-term celi
survival in the absence of serum in three out of four human breast tumor ce!! unes
tested. The long-terrn senim-free survival of these cell unes is associated with a high
capacity to store TG and is oleate dose dependent. We propose that the ability to
efficiently esterify oleate and to maintain elevated TG content due to upregulated
TG/FFA cycling may play a role in the antiapoptotic effect induced by treatment
with exogenous oleate and may be involved in the maintenance of long-term GF-free
survival of human breast tumor celis. This is the first report proposing a role of the
TG/FFA cycle in cancer ce!! survival. We also propose that treatment with oleate
may protect tumors, which have acquired GF independent and upregulated
metabolism of glucose from apoptosis. The in vitro resuits presented here provide
support for epidemiological studies which show a positive correlation between
elevatcd oleate content in breast tissue and increased breast cancer risk [192,193].
They are also consistent with recent reports showing that dietary fat reduction
signiflcantly reduces (up to 42%) the risk of tumor recurrence in postmenopausal
women [63]. Further studies are required to elucidate how the complex TG/FFA
cycle is regulated in breast tumor ceils, particularly how the TG/FfA cycle is linked
to GF signaling and how it may enhance ceil survival in GF independent cancer
cells. As well, further studies are needed to elucidate whether upregulated TG/FFA
cycling promotes tumor ce!! survival by NAD+ regeneration and/or FFA signaling,
possibly via GPR4O or another FFA receptor. It would also be important to
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determine whethcr our in vitro resuits are relevant to human breast cancer ceil
metabolism in vivo, for both primary tumors and their metastases.
Ihe important points to retain from this work can be summarized as follows:
1) Metabolic and signaling pathways for ce!! survival and proliferation are
intertwined and the GF status of the ceils may deeply influence their response to
nutrients. 2) The metabolisrn of fuel substrates, glucose and FFA, is coordinately
regulated in individual ce!!s, thus suggesting that FFA metabolism should be studied
in the context of the metabolisrn of glucose. 3) Cancer cells, which become GF
independent may be vuinerable to the nutritional environrnent, may flot be able to
deal with the lack of some basic nutrients like glucose (they are glucose dependent)
or they may be susceptible to overabundance of nutrients. In other words, they may
be incapable to adjust their rate of rnetabolism to their energetic requirements,
particularly under conditions like celi cycle arrest, when these requirements
markedly decline. 4) The rnetabolism of FFA is different in cancer cells versus
normal, non-transfomied celis, and it may vary between individual cancers.
However, it may also vary between different stages of cancer development, and thus
may have a prognostic potentiat. Further research in the area of glucose and FFA
rnetabolisrn may help to design novel strategies for cancer staging and classification
independent forni existing ones and may help to design cancer prevention strategies
based on diet and therapies that directly or indirectly rnodify tumor cdl rnetabolism
to reduce tumor ceil survival.
REFERENCES
$8
1. Watson JD, Crick FH: Molecular structure of nucleic acids; a structure for
deoxyribose nucleic acid. Natttre 1953, 171:737-73$.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K,
Dewar K, Doyle M, FitzHugh W, et al.: Initial sequencing and analysis of the
human genome. Nature 2001, 409:860-921.
3. Stem LD: Human genorne: end of the beginning. Nature 2004, 431:915-916.
4. Noweil PC: The clonai evolution of tumor celi populations. Science 1976, 194:23-
2$.
5. NowelI PC: Tumor progression: a brief historical perspective. Semin Ccmcer BioÏ
2002, 12:261-266.
6. Hanahan D, Weinberg RA: The hallrnarks of cancer. Ccli 2000, 100:57-70.
7. Sonnenschein C, Soto AM: Somatic mutation theory of carcinogenesis: why it
should be dropped and replaced. Moi Carcinog 2000, 29:205-211.
8. Soto AM, Sonnenschein C: The somatic mutation theory of cancer: growing
problems with the paradigm? Bioessavs 2004, 26:1097-1107.
9. Triolo VA: Nineteenth Century Foundations 0f Cancer Research Advances In
Tumor Pathology, Nomenclature, And Theories 0f Oncogenesis. cancer Res
1965, 25:75-106.
10. Gilbert SF: Opening Darwin’s black box: teaching evolution through
developmental genetics. Nat Ree Genet 2003, 4:735-741.
11. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson
A, Weinberg RA: Reconstruction of functionally normal and malignant human
breast tissues in mice. Froc NatÏAcadSci USA 2004, 101:4966-4971.
12. Bhowmick NA, Moses HL: Turnor-stroma interactions. Curr Opin Genet Dcv
2005, 15:97-101.
13. Roskelley CD, Bissell MJ: The dominance of the microenvironment in breast
and ovarian cancer. Semin Cancer Biol 2002, 12:97-104.
14. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C: The stroma as a
crucial target in rat marnrnary gland carcinogenesis. J Ccii Sci 2004, 117:1495-
1502.
89
15. Weaver VM, Gilbert P: Watch thy neighbor: cancer is a communal affair. J Ceil
Sci 2004, 117:1287-1290.
16. Seli S: Stem ce!! origin of cancer and differentiation therapy. Crit Rev Oncol
Hematol 2004, 51:1-2$.
17. Al-Hajj M, Clarke MF: Seif-renewal and solid tumor stem ceils. Oncogene 2004,
23:7274-7282.
18. Genetics of breast and ovarian cancer. National Cancer Institute, US NITL
wwwcancer.gov 2006.
19. Canadian Cancer Statistics 2006. C’anadian Cancer Society, NC’IÇ
www.cancer.ca 2006.
20. Couch Jf, Weber BL: Breast Cancer in The genetic basis of human cancer.
Edited by Vogelstei B, Kinzler KW: McGraw-Hill Companies, inc.; 1998.
21. Effects of chemotherapy and hormonal therapy for early breast cancer on
recunence and 15-year survival: an overview of the randomised trials. Lancet
2005, 365:1687-1717.
22. Lux MP, Fasching PA, Beckmaim MW: Hereditary breast and ovarian cancer:
review and future perspectives. JMoÏ lied 2006, 84:16-28.
23. Hall JM, Lee MK, Newman B, Morrow JE. Anderson LA, Huey B, King MC:
Linkage of early-onset familial breast cancer to chromosome 17q21. Science
1990, 250:1684-1689.
24. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K,
Seal S, Tran T, Avenu D, et al.: Localization of a breast cancer susceptibility
gene, BRCA2, to chromosome 13q12-13. Science 1994, 265:2088-2090.
25. Tonin P, Serova 0, Simard J, Lenoir G, Feunteun J, Morgan K, Lynch H, Narod
S: The gene for hereditary breast-ovarian cancer, BRCA1, maps distal to
EDHY7B2 in chromosome region 17q12-q21. Hum Mot Genet 1994, 3:1679-
1682.
26. Sinilnikova 0M, Mazoyer S, Bonnardel C, Lynch HT, Narod SA, Lenoir GM:
BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection
on the Creighton University histonical series of high risk famities. fam Cancer
2006, 5:15-20.
90
27. Boulton SJ: Cellular functions of the BRCA tumour-suppressor proteins.
Biochem Soc Trans 2006. 34:633-645.
28. Wooster R, Weber BL: Breast and ovarian cancer. N Engi J lied 2003,
348:2339-2347.
29. de Jong MM, Noïte 1M, te Meernan GJ, van der Graaf WT, Oosterwijk JC,
Kleibeuker 1H, Schaapveld M, de Vries EG: Genes other than BRCAÏ and
BRCA2 involved in breast cancer susceptibility. JMed Genet 2002, 3 9:225-242.
30. Kuiper GG, Carlsson B, Grandien K, Enrnark E, Haggblad J, Niisson S,
Gustafsson JA: Comparison ofthe ligand binding specificity and transcript tissue
distribution of estrogen receptors alpha and beta. EndocrinoÏogi’ 1997, 138:863-
$70.
31. Clarke R3, Howeli A, Potten CS, Anderson E: Dissociation between steroid
receptor expression and ceil proliferation in the hurnan breast. Cancer Res 1997,
57:4987-4991.
32. Clarke RB: Human breast ceil proliferation and its relationship to steroid
receptor expression. Climacteric 2004, 7:129-137.
33. Cheng G, Weihua Z, Warner M, Gustafsson JA: Estrogen receptors ER alpha and
ER beta in proliferation in the rodent mammary gland. Proc NatÏ Acad Sci US A
2004, 101:3739-3746.
34. Mallepeil S, Krust A, Chambon P, Brisken C: Paracrine signaling through the
epithelial estrogen receptor alpha is required for proliferation and morphogenesis
in the mammary gland. Froc NatÏ A cad Sci USA 2006, 103:2196-2201.
35. Ketloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ,
Szabo E, Jordan VC, Spitz MR, MilIs GB. et al.: Progress in chemoprevention
drug developrnent: the promise of molecular biomarkers for prevention of
intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res
2006, 12:3661-3697.
36. Lewis JS, Jordan VC: Selective estrogen receptor modulators (SERMs):
rnechanisrns ofanticarcinogenesis and drug resistance. MutatRes 2005, 591:247-
263.
91
37. Jordan VC: Chernoprevention in the 2lst century: is a balance best or should
women have no estrogen at ail? J Clin Oncol 2005, 23:1598-1600.
38. Girault I, Bieche I, Lidereau R: Role of estrogen receptor alpha transcriptional
coregulators in tamoxifen resistance in breast cancer. Maturitas 2006, 54:342-
351.
39. Shou J, Massarweh S, Osborne CK, Wakeling AE, Ah S, Weiss H, Schiff R:
Mechanisms of tarnoxifen resistance: increased estrogen receptor-HER2/neu
cross-talk in ERJHER2-positive breast cancer. J NatÏ Cancer Inst 2004, 96:926-
935.
40. Osborne CK, Schiff R: Growth factor receptor cross-talk with estrogen receptor
as a mechanism for tamoxifen resistance in breast cancer. Breast 2003, 12:362-
367.
41. Lupu R, Menendez JA: Targeting fatty acid synthase in breast and endometrial
cancer: An alternative to selective estrogen receptor modulators? Endocrinology
2006, 147:4056-4066.
42. Marches R, Scheuerrnaim R, Uhr J: Cancer dormancy: from mice to man. Ccli
Cycle 2006, 5:1772-1778.
43. Pantel K, Woelfle U: Detection and molecular characterisation of disseminated
Wmour celis: implications for anti-cancer therapy. Biochim Biophys Acta 2005,
1756:53-64.
44. Calie EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence
and proposed mechanisms. NatRev Cancer 2004, 4:579-591.
45. Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y: Association of obesity and
cancer risk in Canada. Am JEpidemioÏ 2004, 159:259-268.
46. Boyd DB: Insulin and cancer. Integr Ccmcer Tuer 2003, 2:3 15-329.
47. Harvie M, Hooper L, Howeli AH: Central obesity and breast cancer risk: a
systematic review. Obes Rev 2003, 4:157-173.
48. Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A,
Redwood S, Hood N, DelGiudice ME, Sidlofsky S, et al.: Elevated levels of
plasma triglycerides are associated with histoiogically defined premenopausal
breast cancer risk. Nutr C’ancer 1997, 27:284-292.
92
49. Muti P, Quattrin T, Grant Bi. Krogh V, Micheli A, Schunemann HJ. Ram M,
Freudenheim JL, Sien S, Trevisan M, et al.: Fasting glucose is a risk factor for
breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002,
11:1361-1368.
50. Goodwin PJ, Boyd NF: Body size and breast cancer prognosis: a critical review
ofthe evidence. Breast Cancer Res Treat 1990, 16:205-2 14.
5 1. Chlebowski RT: Obesity and early-stage breast cancer. J Clin Oncol 2005,
23:1345-1347.
52. Enger SM, GreifJM, Polikoff J, Press M: Body weight conelates with mortality
in early-stage breast cancer. Arch Surg 2004, 139:954-958; discLtssion 958-960.
53. Montague CT, O’Rahilly S: The perils ofportliness: causes and consequences of
visceral adiposity. Diabetes 2000, 49:883-888.
54. Yu YH, Ginsberg FIN: Adipocyte signaling and Iipid homeostasis: sequelae of
insulin-resistant adipose tissue. Circ Res 2005, 96:1042-1052.
55. Lorincz AM, Sukurnar S: Molecular links between obesity and breast cancer.
Endocr Relat Cancer 2006, 13:279-292.
56. van Landeghem AA, Poortrnan J, Nabuurs M, Thijssen JH: Endogenous
concentration and subcellular distribution of estrogens in normal and malignant
human breast tissue. &zncer Res 1985, 45:2900-2906.
57. Rose DP, Komninou D, Stephenson GD: Obesity, adipocytokines, and insulin
resistance in breast cancer. Obes Rev 2004, 5:153-165.
58. E1-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R, Hardy S, JoIy E, Dbaibo
G, Rosenberg L, Prentki M: Saturated fatty acids synergize with eîevated glucose
to cause pancreatic beta-celi death. EndocrinoÏogv 2003, 144:4154-4163.
59. McGarry JD: What if Minkowski had been ageusic? An alternative angle on
diabetes. Science 1992, 258:766-770.
60. Unger RH: Longevity, lipotoxicity and leptin: the adipocyte defense against
feasting and famine. Biochimie 2005, 87:57-64.
61. Prentki M, JoIy E, El-Assaad W, Roduit R: Malonyl-CoA signaling, tipid
partitioning, and glucolipotoxicity: role in beta-ceil adaptation and failure in the
etiology ofdiabetes. Diabetes 2002,51 Suppl 3:S405-413.
93
62. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA: Physical
activity and survival after breast cancer diagnosis. Jania 2005, 293:2479-2486.
63. Chlebowski R, Blackburn G, Elashoff R, Thompson C, Goodman M, Shapiro A,
Giuliano A, Karanja N, Hoy M, Nixon D: Diatery fat reduction in
posmonopausal women with primary breast cancer: Phase III Women’s
Intervention Nutrition Study. 2005.
64. Jonat W, Hilpert F, Maass N: The use ofaromatase inhibitors in adjuvant therapy
for early breast cancer. C’ancer Cliemother FharmacoÏ 2005, 56 Suppi 1:32-38.
65. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE, Jr., Davidson NE, Tan
Chiu E, Martino S, Paik S, Kaufman PA, et al.: Trastuzumab plus adjuvant
chernotherapy for operable HER2-positive breast cancer. N Engi J lied 2005,
353:1673-1684.
66. Conlon I, Raff M: Size control in animal development. Ccii 1999, 96:235-244.
67. Vander Heiden MG, Plas DR, Rathrnell JC, fox CJ, Haiiis MH, Thompson CB:
Growth factors can influence celi growth and survival through effects on glucose
rnetabolism. Mol Ccli Bio! 2001, 21:5899-5912.
68. Edinger AL, Thornpson CB: Akt maintains cdl size and survival by increasing
mTOR-dependent nutrient uptake. Mol Biol Ccli 2002, 13:2276-2288.
69. Edinger AL, Cinalti RM, Thompson CB: Rab? prevents growth factor
independent survival by inhibiting cell-autonomous nutrient transporter
expression. Dcv Ccli 2003, 5:57 1-582.
70. Elstrom RL, Bauer DE, Buzzai M, Kamauskas R, Harris MH, Plas DR, Zhuang
H, Cinalli RM, Atavi A, Rudin CM, et al.: Akt stimulates aerobic glycolysis in
cancer ceils. Cancer Res 2004, 64:3892-3899.
71. Buzzai M. Bauer DE, Jones RG, Deberardinis RJ, Hatzivassiliou G, Elstrom RL,
Thompson C3: The glucose dependence of Akt-transformed cells can be
reversed by pharmacologie activation of fatty acid beta-oxidation. Oncogene
2005, 24:4165-41 73.
72. Hatzivassiliou G, Andreadis C, Thompson C: Akt-directed metabolic alterations
in cancer. Drttg Discoveiy Today: Disease Mechanisms 2005, 2:255-262.
94
73. Thompson JE, Thompson CB: Putting the rap on Akt. J Clin Oncol 2004,
22:4217-4226.
74. Brazil DP, Yang ZZ, Hemmings BA: Advances in protein kinase B signalling:
AKTion on multiple fronts. Trends Biochem Sci 2004, 29:233-242.
75. Hammerman PS. Fox CJ, Thornpson CB: Beginnings of a signal-transduction
pathway for bioenergetic control of celi survival. Trends Biochein Sci 2004,
29:586-592.
76. McCorrnick F: Cancer: survival pathways meet their end. Nature 2004, 428:267-
269.
77. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev cancer 2003, 3:72 1-
732.
78. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N: Inhibition of
earty apoptotic events by Akt/PKB is dependent on the first comrnitted step of
glycolysis and mitochondrial hexokinase. Genes Dey 2001, 15:1406-1418.
79. Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH: Phosphorylation and
activation of heart 6-phosphofructo-2-kinase by protein kinase B and other
protein kinases ofthe insulin signating cascades. J Bio! Chem 1997, 272:17269-
17275.
80. Yang YA, Morin PJ, Han WF, Chen T, Bornman DM, Gabrielson EW, Pizer ES:
Regulation of fatty acid synthase expression in breast cancer by sterol regulatory
element binding protein-ic. Exp C’eÏÏRes 2003, 282:132-137.
81. Berwick DC, Hers I, Heesom KJ, Moule SK, Tavare 1M: The identification of
ATP-citrate lyase as a protein kinase B (Akt) substrate in prirnary adipocytes. J
Bio! Cheni 2002, 277:33895-33900.
82. Kuhajda FP: Fatty-acid synthase and hurnan cancer: new perspectives on its role
in tumor biology. iVutrition 2000, 16:202-208.
83. Lindsley JE, Rutter J: Nutrient sensing and metabolic decisions. C’onzp Biocheni
PhvsioÏ B Biochen; Mol Bio! 2004, 139:543-559.
84. Hardie DG: The AMP-activated protein kinase pathway--new players upstrearn
and downstream. J Ce!! Sci 2004, 117:5479-5487.
95
$5. 1mai S, Armstrong CM, Kaeberlein M, Guarente L: Transcriptional silencing and
longevity protein Sir2 is an NAD-dependent histone deacetylase. Natttre 2000,
403:795-$00.
86. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D: Sirtuin
activators mimic calorie restriction and delay ageing in metazoans. Nature 2004,
430:686-689.
$7. Vaziri H, Dessain SK, Ng Eaton E, 1mai SI, frye RA, Pandita TK, Guarente L,
Weinberg RA: hSIR2(SIRT1) functions as an NAD-dependent p53 deaeetylase.
Ce!! 2001, 107:149-159.
88. Cohen HY, Miller C, Bitterrnan KJ, Wall NR, Hekking B, Kessier B, Howitz
KT, Gorospe M, de Cabo R, Sinclair DA: Calorie restriction prornotes
mammalian ceil survival by indueing the SIRTÏ deacetylase. Science 2004,
305:390-392.
$9. WullschÏeger S, Loewith R, Hall MN: TOR signaling in growth and metabolism.
Ce!! 2006, 124:471-484.
90. Inoki K, Li Y, Zhu T, Wu J, Guan KL: TSC2 is phosphorylated and inhibited by
Akt and suppresses mTOR signalling. Nat Ce!! Bio! 2002, 4:648-657.
91. Azoulay-Zohar H, IsraeÏson A, Abu-Hamad S, Shoshan-Barmatz V: In self
defence: hexokinase prornotes voltage-dependent anion channel closure and
prevents mitoehondria-mediated apoptotie celI death. Biochem J 2004, 3 77:347-
355.
92. Robey RB, Hay N: Mitoehondrial hexokinases: guardians of the mitochondria.
Ce!! Cyc!e 2005, 4:654-658.
93. Kim 1W, Dang CV: Multifaceted rotes of glycolytic enzymes. Trends Biochem
Sci 2005, 30:142-150.
94. Sirover MA: New insights into an old protein: the functional diversity of
mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochiin Biophi’s Acta
1999, 1432:159-184.
95. O’Keefe P, Gallet B: Update of nuclear medieine--PET imaging. Mo lied 2005,
102:127-130.
96
96. Warburg O: On respiratory impairment in cancer ceils. Science 1956, 124:269-
270.
97. Warburg O: On the origin of cancer celis. Science 1956, 123:309-3 14.
98. Semenza G: Signal transduction to hypoxia-inducible factor 1. Biochem
Pliarmaco! 2002, 64:993-998.
99. Sernenza GL: HIF-l and turnor progression: pathophysiofogy and therapeutics.
Trends Mol lied 2002, $:S62-67.
100. Kaelin WG, Jr.: von Hippel—Lindau-associated malignancies: Mechanisms and
therapeutic opportunities. Drug Discoveiy Today. Disease Mechanisms 2005,
2:225-231.
101. Baysat B: Krebs cycle enzymes as tumor suppressors. Drttg Discoveiy Today:
Disease Mechanisms 2005, 2.
102. Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers
FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, et al.: HIF-1A,
pirnonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in hurnan
head-and-neck tumors. Int J Radiat Onco! Bio! Phvs 2002, 54:1537-1549.
103. Kim JW, Gardner LB, Dang CV: Oncogenic alterations of metabolism and the
Warburg effect. Drtig Discoverv Todav: Disease Mechanisni 2005, 2:233-23$.
104. Kim JW, Zeller KI, Wang Y, Jegga AG, Aronow BJ, O’Doimell KA, Dang CV:
Evaluation of myc E-box phylogenetic footprints in glycolytic genes by
chrornatin immunoprecipitation assays. Mol Ce!! Bio! 2004, 24:5923-5936.
105. Arsharn AM, Plas DR, Thornpson CB, Simon MC: Akt and hypoxia-inducible
factor- 1 independently enhance tumor growth and angiogenesis. Cancer Res
2004, 64:3500-3507.
106. Garber K: Energy boost: the Warburg effect returns in a new theory of cancer. J
Natt C’ancer Inst 2004, 96:1805-1806.
107. Faraj M, Lu HL, Cianflone K: Diabetes, lipids, and adipocyte secretagogues.
Biochem C’e!! Bio! 2004, 82: 170-190.
108. Phan CT, Tso P: Intestinal lipid absorption and transport. front Biosci 2001,
6:D299-3 19.
97
109. Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN: Regulation ofdietary
fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle.
Diabetes 2002, 51:2684-2690.
110. Yeaman SJ: Hormone-sensitive lipasc--new roTes for an old enzyme. Biochem J
2004, 379:11-22.
111. Zechner R, Strauss JG, Haemmerle G, Lass A, Zimmermann R: Lipolysis:
pathway under construction. Curr Opin Lipidol 2005, 16:333-340.
112. Kitamura Y, Accili D: New insights into the integrated physiology of insulin
action. Rev Endocr Metab Disord 2004, 5:143-149.
113. Hamilton JA: Fast flip-flop of cholesterol and fatty acids in membranes:
implications for membrane transport proteins. Cttrr Opin LipidoÏ 2003, 14:263-
271.
114. Glatz JF, Luiken JJ, Bonen A: Involvement of membrane-associated proteins in
the acute regulation of cellular fatty acid uptake. J Mol Nettrosci 2001, 16:123-
132; discussion 151-127.
115. Voet D, Voet J, Pratt C: Fundamentaïs of3iochemistiy (2 nd Upgrade Editiol?).
New York: John Wiley and Sons, inc.; 2001.
116. Coteman RA, Lee DP: Enzymes of triacylglycerol synthesis and their
regulation. Pmg Ltid Res 2004, 43:134-176.
11 7. Bartlett K, Eaton S: Mitochondrial beta-oxidation. Etu J Biochein 2004,
271:462-469.
1 18. Frayn KN: The glucose-fatty acid cycle: a physiological perspective. Biochem
Soc Trans 2003, 31:1115-1119.
119. Dulloo AG, Gubler M, Montani JP, Seydoux J, Solinas G: Substrate cycling
betwecn de novo lipogenesis and lipid oxidation: a thermogenic mechanism
against skeletal muscle lipotoxicity and glucohpotoxicity. hit J Obes Relut Metctb
Disord 2004, 28 Suppl 4:S29-3 7.
120. Randle PJ, Garland P3, Hales CN, Newsholme EA: The glucose fatty-acid
cycle. Its rote in insulin sensitivity and the metabotic disturbances of diabetes
mellitus. Lancet 1963, 1:785-789.
98
121. McGarry JD, Mamaerts GP, foster DW: A possible role for malonyl-CoA in
the regulation ofhepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977,
60:265-270.
122. Rudemian NB, Saha AK, Kraegen EW: Minireview: malonyl CoA, AMP
activated protein kinase, and adiposity. Endocrinotogy 2003, 144:5166-5171.
123. Kahn BB, Alquier T, Carling D, Hardie DG: AMP-activated protein kinase:
ancient energy gauge provides dues to modem understanding of metabolism.
Ce!! Metab 2005, 1:15-25.
124. Hardie DG: New roles for the LKB1-->AMPK pathway. Curr Opin Ce!! Bio!
2005, 17:167-173.
125. Ruderman N, Prentki M: AMP kinase and malonyl-CoA: targets for therapy of
the metabolic syndrome. Nat RevDrugDiscov 2004, 3:340-35 1.
126. Deviin T: Textbook of Biochemistn’ with Clinical CorreÏations edn Fourth
edition. New York/ Chichester/ Weinheiml Brisbane/ Singapore/ Toronto: Joim
Wiley and Sons, Inc.; 1997.
127. Vaughan M: The production and release of glycerol by adipose tissue incubated
in vitro. JBioÏ Chem 1962, 237:3354-3358.
128. Reshef L, OÏswang Y, Cassuto H, Blum B, Croniger CM, Kaihan SC, Tilghman
5M, Hanson RW: Glyceroneogenesis and the triglyceride/fatty acid cycle. J Bio!
Chem 2003, 278:30413-30416.
129. Coleman RA, Lewin TM, Van Hom CG, Gonzalez-Baro MR: Do long-chain
acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative
pathways? JNutr 2002, 132:2123-2126.
130. Bertin R: Glycerokinase activity and lipolysis regulation in brown adipose
tissue of cold acclimated rats. Biochimie 1976, 58:43 1-434.
131. Pol A, Mai-tin S. Femandez MA, Ferguson C, Carozzi A, Luetterforst R. Enrich
C, Parton RG: Dynamic and regulated association of caveolin with Iipid bodies:
modulation of lipid body motility and function by a dominant negative mutant.
Mol Bio! Ce!! 2004, 15:99-110.
132. Martin S, Patïon RG: Caveolin, chotesterol, and lipid bodies. Semin Ce!! Dcv
Bio! 2005, 16:163-174.
99
133. Martin S, Parton RG: Lipid droplets: a unified view ofa dynamic organelle. Nat
Rev Mol CeÏÏ Bio! 2006, 7:373-378.
134. Murphy DJ: The biogenesis and functions of lipid bodies in animais, plants and
microorganisms. Frog Lipid Res 2001, 40:325-438.
135. Medes G, Thomas A, Weinhouse S: Metabolisrn of neoplastic tissue. IV. A
study of lipid synthesis in neoplastic tissue suces in vitro. C’ancer Res 1953,
13:27-29.
136. Kuhajda FP, Jemer K. Wood FD, Hennigar RA, Jacobs LB, Dick JD.
Pastemack GR: Fatty acid synthesis: a potential selective target for antineoplastic
therapy. Froc NatlAcadSci USA 1994, 91:6379-6383.
137. Swinnen W, Ulrix W, Heyns W, Verhoeven G: Coordinate regulation of
lipogenic gene expression by androgens: evidence for a cascade mechanism
involving sterol regulatory element binding proteins. Froc NatÏ Acad Sci U S A
1997, 94:12975-12980.
138. Swinnen JV, Heemers H, Deboel L, foufelle F, Heyns W, Verhoeven G:
Stimulation of tumor-associated fatty acid synthase expression by growth factor
activation of the sterol regulatory element-binding protein pathway. Oncogene
2000, 19:5173-5181.
139. Yahagi N, Shimano H, Hasegawa K, Ohashi K, Matsuzaka T, Najima Y, Sekiya
M, Tomita S, Okazaki H, Tamura Y, et al.: Co-ordinate activation of lipogenic
enzymes in hepatocellular carcinorna. Etir J Cancer 2005, 41:1316-1322.
140. Li iN, Mahmoud MA, Han WF, Ripple M, Pizer ES: Sterol regulatory element
binding protein- 1 participates in the regulation of fatty acid synthase expression
in colorectal neoplasia. Exp Ccli Res 2000, 261:159-165.
141. Horton JD, Goldstein IL, Brown MS: SREBPs: transcriptional mediators of
Iipid horneostasis. CoÏd Spring Harb Svinp Quant Bio! 2002, 67:491-498.
142. Anderson RG: Joe Goldstein and Mike Brown: from cholesterot homeostasis to
new paradigms in membrane biology. Trends Ce!! Bio! 2003, 13:534-539.
143. Chirala SS, Chang H, Matzuk M, Abu-Elheiga L, Mao J, Mahon K, Finegold
M, Wakil SI: Fatty acid synthesis is essential in embryonic development: fatty
100
acid synthase nuli mutants and most of the heterozygotes die in utero. Froc NatÏ
AcadSci USA 2003, 100:6358-6363.
144. Pizer ES, Kurman RJ, Pasternack GR, Kuhajda FP: Expression of fatty acid
synthase is closely linked to proliferation and stromal decidualization in cycling
endometrium. hit J GynecoÏ PathoÏ 1997, 16:45-51.
145. Van de Sande T, De Schrijver E, Heyns W, Verhoeven G, Swiirnen IV: Rote of
the phosphatidylinositol 3’-kinase/PTEN/Akt kinase pathway in the
overexpression of fatty acid synthase in LNCaP prostate cancer celis. Cancer Res
2002, 62:642-646.
146. Wang HQ, Altomare DA, Skele KL, Poulikakos PI, Kuhajda FP, Di Cristofano
A, Testa JR: Positive feedback regulation between AKT activation and fatty acid
synthase expression in ovarian carcinoma cells. Oncogene 2005, 24:3574-3582.
147. Porstmann T, Griffiths B, Chung YL, Delpuech O, Griffiths JR, Downward J,
Schuize A: PKB/Akt induces transcription of enzymes involved in cholesterot
and fatty acid biosynthesis via activation of SREBP. Oncogene 2005, 24:6465-
6481.
148. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chiimaiyan AM:
Transcriptome analysis of HER2 reveals a molecular connection to fatty acid
synthesis. Cancer Res 2003, 63:132-139.
149. Menendez JA, Vellon L, Mehmi I, Oza BP, Ropero S, Colomer R, Lupu R:
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene
overexpression in cancer celis. Froc NatÏ Acad Sci U S A 2004, 101:10715-
10720.
150. Menendez lA, Oza B?, Atlas E, Verma VA, Mehmi I, Lupu R: Inhibition of
tumor-associated fatty acid synthase activity antagonizes estradiol- and
tamoxifen-induced agonist transactivation of estrogen receptor tER) in human
endometrial adenocarcinoma ceils. Oncogene 2004, 23 :4945-4958.
151. Katz-Brull R, Lavin PT, Lenkinski RE: Clinical utility of proton magnetic
resonance spectroscopy in characterizing breast lesions. J NatÏ Cancer Inst 2002,
94:1197-1203.
101
152. Glunde K, Jie C. Bhujwalla ZM: Molecular causes of the aberrant choline
phospholipid metabolisrn in breast cancer. Cancer Res 2004, 64:4270-4276.
153. Wright MM, Howe AG, Zaremberg V: Celi membranes and apoptosis: role of
cardiolipin, phosphatidylcholine, and anticancer Ïipid analogues. Biocheni Ce!!
Biot 2004, 82:1 8-26.
154. Finney RE, Nudelman E, White T, Bursten S, Klein P, Leer LL, Wang N,
Waggoner D, Singer 1W, Lewis RA: Pharmacological inhibition of
phosphatidylcholine biosynthesis is associated with induction of
phosphatidylinositol accumulation and cytolysis of neoplastic ce!! unes. Cancer
Res 2000, 60:5204-52 13.
155. Terry PD, Rohan TE, Wolk A: Intakes of fish and marine fatty acids and the
risks of cancers of the breast and prostate and of other hormone-related cancers:
a review ofthe epidemiologic evidence. Ani J Clin Nutr 2003, 77:532-543.
156. Kota BP, Huang TH, Roufogalis BD: An overview on bio!ogical mechanisms
of PPARs. Pharmacol Res 2005, 51:85-94.
157. Nakamura MT, Cheon Y, Li Y, Nara TY: Mechanisms of regulation of gene
expression by fatty acids. Lipids 2004, 39:1077-1083.
158. Larsson SC, Kumiin M, Ingelrnan-Sundberg M, Wolk A: Dietary long-chain n-
3 fatty acids for the prevention of cancer: a review of potential mechanisrns. Ani
J Clin Nutr 2004, 79:935-945.
159. Sampath H, Ntambi JM: Polyunsaturated fatty acid regulation of genes of Iipid
metabolism. Annu Rev Ntttr 2005, 25:3 17-340.
160. Saadatian-Elahi M, Norat T, Goudable J, Riboli E: Biomarkers of dietary fatty
acid intake and the risk of breast cancer: a meta-analysis. Int J &incer 2004,
111:584-591.
161. Gottlicher M, Widmark E, Li Q, Gustafsson JA: Fatty acids activate a chirnera
of the clofibric acid-activated receptor and the glucocorticoid receptor. Froc Natl
AcadSci USA 1992, 89:4653-4657.
162. Hardy S, Langelier Y, Prentki M: Oleate activates phosphatidylinositol 3-kinase
and promotes proliferation and reduces apoptosis of MDA-M3-23 1 breast cancer
celis, whereas palmitate has opposite effects. Cancer Res 2000, 60:6353-6358.
102
163. Paumen MB, Ishida Y, Muramatsu M, Yarnamoto M, Honjo T: Inhibition of
camitine palmitoyltransferase I augments sphingoiipid synthesis and palmitate
induced apoptosis. JBioÏ Chem 1997, 272:3324-3329.
164. Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid-induced beta celi
apoptosis: a link bctween obesity and diabetes. Froc Nati Acad Sci U S A 1998,
95:2498-2502.
165. Hickson-Bick DL, Buja ML, McMiIlin JB: Palmitate-mediated alterations in
the fatty acid rnetabolisrn of rat neonatai cardiac myocytes. J Mol Ce!! CardioÏ
2000, 32:51 1-5 19.
166. Blazquez C, Galve-Roperh I, Guzrnan M: De novo-synthesized ceramide
signais apoptosis in astrocytes via extracellular signal-regulated kinase. Faseb J
2000, 14:23 15-2322.
167. Hardy S, E1-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y:
Saturated fatty acid-induced apoptosis in MDA-MB-23 1 breast cancer ceils. A
role for cardiolipin. JBioÏ Chem 2003, 278:31861-31870.
168. Brown AJ, Jupe S, Briscoe CP: A family offatty acid binding receptors. DNA
Ccli Bio! 2005, 24:54-61.
169. Kirasawa A, Tsurnaya K, Awaji T, Katsurna S, Adachi T, Yamada M,
Sugimoto Y, Miyazaki S, Tsujimoto G: Free fatty acids regulate gut incretin
glucagon-like peptide-1 secretion through GPR12O. Nat lied 2005, 11:90-94.
170. Kostenis E: A glance at G-protein-coupled receptors for lipid mediators: a
growing receptor farniÏy with rernarkably diverse Iigands. Fharmacol Ther 2004,
102:243-257.
171. Tunaru S, Kero J, Schaub A, Wu&a C, Blaukat A, Pfeffer K, Offermanns S:
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti
lipolytic effect. Nc.’t lied 2003, 9:352-355.
172. Hebert SC: Physiology: orphan detectors ofmetaboiism. Nature 2004, 429:143-
145.
173. Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M: Oleate promotes the
proliferation of breast cancer celis via the G protein-coupled receptor GPR4O. J
Bio! Chem 2005, 280:13285-1329 1.
103
174. de Vries JE, Vork MM, Roemen TH, de Jong YF, Cleutjens W, van der Vusse
GJ, van Bilsen M: Saturated but flot mono-unsaturated fatty acids induce
apoptotic ce!! death in neonatal rat ventricular myocytes. J Liid Res 1997,
38:1384-1394.
175. Rosenthal MD: Accumulation of neutral lipids by human skin fibroblasts:
differential effects of saturated and unsaturated fatty acids. Lipids 1981, 16:173-
182.
176. Buttke TM: Inhibition of lymphocyte proliferation by free fatty acids. I.
Differential effects on mouse B and T lymphocytes. Immtcnology 1984, 53:235-
242.
177. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Jr., Ory DS, Schaffer
JE: Triglyceride accumulation protects against fatty acid-induced lipotoxicity.
Froc NatÏAcadSci USA 2003, 100:3077-3082.
178. Welters HJ, Tadayyon M, Scarpello JH. Smith SA, Morgan NG: Mono
unsaturated fatty acids protect against beta-celi apoptosis induced by saturated
fatty acids, senim withdrawal or cytokine exposure. fEBS Lett 2004, 560:103-
108.
179. Averill-Bates DA, Przybytkowski E: The rote of glucose in cellular defences
against cytotoxicity of hydrogen peroxide in Chinese hamster ovaiy cclls. ArcÏi
Biochein Biophys 1994, 3 12:52-58.
180. Heimberg H, De Vos A, Vandercammen A, Van Schaftingen E, Pipeleers D,
Schuit F: Heterogeneity in glucose sensitivÏty among pancreatic beta-ceils is
correlated to differences in glucose phosphorylation rather than glucose
transport. Embo J 1993, 12:2873-2879.
181. Bligh EG, Dyer WJ: A rapid method of total [ipid extraction and purification.
Cciii JBiochem PÏnsiol 1959, 37:9 1 1-9 17.
182. Van Veldhoven PP, Swiirnen iV, Esquenet M, Verhoeven G: Lipase-based
quantitation of triacylglycerols in cellular lipid extracts: requirement for presence
of detergent and prior separation by thin-layer chromatography. Ltids 1997,
32:1297-1300.
104
183. Trimboli AJ, Waite 3M, Atsumi G, Fonteh AN, Namen AM, Clay CE, Kute
TE, High KP, Willingham MC, Chilton FH: Influence of coenzyme A
independent transacylase and cyclooxygenase inhibitors on the proliferation of
breast cancer celis. Cancer Res 1999, 59:6171-6177.
184. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson C3:
Growth factor regulation of autophagy and ccli survival in the absence of
apoptosis. Ce!! 2005, 120:237-248.
185. Katsurna S, Hatae N, Yano T, Ruike Y, Kimura M, Hirasawa A, Tsujimoto G:
Free fatty acids inhibit serum deprivation-induced apoptosis through GPR12O in
a murine enteroendocrine ce!! une STC-1. JBiol Chem 2005, 280:19507-195 15.
186. Burdall SE, Hanby AM, Lansdown MR, Speirs V: Breast cancer celi unes:
friend or foe? Breast Cancer Res 2003, 5:89-95.
1 87. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen 0W,
Turley EA, Bisse!! MJ: Phenotypic reversion or death of cancer cel!s by altering
signaling pathways in three-dimcnsiona! contexts. J Nati Cancer Inst 2002,
94:1494-1503.
188. Janrii W, Rack B, Schindlbeck C, Strobi B, Rjosk D, Braun S, Sommer H,
Pantel K, Gerber B, Friese K: The persistence of iso!ated tumor celis in bone
marrow from patients with breast carcinorna predicts an increased risk for
recurrence. C’ancer 2005, 103:884-891.
189. Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kva!heirn G, Nesland
JM, Naume B: Isolated tumor ce!!s in bone marrow three years after diagnosis in
disease-free breast cancer patients predict unfavorab!e clinical outcome. Clin
6’ancerRes 2004, 10:5342-5348.
190. Mu!!er V, Stahmann N, Riethdorf S, Rau T, Zabe! T, Goetz A, Janicke F, Pantel
K: Circulating tumor ceits in breast cancer: correlation to bone marrow
micrornetastases, heterogeneous response to systemic therapy and !ow
pro!iferative activity. C!in Cancer Res 2005, 11:3678-3685.
191. P!as DR, Thompson CB: Akt-dependent transformation: there is more to
growth thanjust surviving. Oncogene 2005, 24:7435-7442.
105
192. Petrek lA, Hudgins LC, Ho M, Bajorunas DR, Hirsch J: f atty acid composition
of adipose tissue, an indication of dietary fatty acids, and breast cancer
prognosis. J Cliii Oncot 1997, 15:1377-1384.
193. Perez Alenza D, Rutteman GR, Pena L, Beynen AC, Cuesta P: Relation
between habituai diet and canine mammary turnors in a case-control study. J Vet
intern lied 1998, 12:132-139.
APPENDIX I
Manuscript submitted to Molecular Cancer Research
107
Upreguation of Cellular Triacylglycerol/Free fatty Acid Cycling by Oleate Is
Assocïated with Long-Term Growth Factor Independent Survival of Human Breast
Cancer Ceils
Ewa Przybytkowski,”2 Érik Joly, .2 Christopher J. Nolan, 1.2 Serge Hardy,”2Ann-
Michele Francoeur,1’2 Yves Langeli er,1’2’3 and Marc i”2’4’5
‘Molecular Nutrition Unit, Centre de Recherche du Centre Hospitalier de l’Université
de Montréal; 2lnstitut du Cancer de Montréal, and Departments of 3Medicine and
1Nutrition and 5Montréal Diabetes Research Center, Université de Montréal, Montréal,
QC, Canada
The current address for C. J. Nolan is Medical School. Australian National University,
Garran, Acf, 2605, Australia and for Ann-Michele Francoeur is School of Dietetics
and Human Nutrition, McGill University, 2 1,111 Lakeshore Rd., Ste-Anne-de
Bellevue, QC, Canada H9X 3V9.
Request for reprints: Marc Prentki, CR-CHUM, Hôpital Notre-Darne, Y-4603,
1560 Sherbrooke Est, Montréal, QC, Canada, H2L 4M1. Phone: l-514-578-4609;
Fax: l-514-412 7858. E-mail:
Grant support: Canadian Cancer Etiology Research Network, the Montreal Breast
Cancer F oundation and the Fondation René Malo/Institut du cancer de Montréal;
Fondation Bourgie/Institut du cancer de Montréal and Fondation R.
Bourassa/l’Assernblée Nationale du Québec fellowships (E. Przybytkowski).
Running titie: TG/FFA cycling and brcast cancer celI survival
Key words: breast cancer, ccli survivai, fatty acid, triacylglycerol, lipolysis
10$
Abstract
We previously showed that exogenous oleate protects MDA-MB-231 human
breast cancer ceils against palmitate-induced apoptosis in part by increasing
esterification of this free fatty acid (FFA) into trïacylgtycerol (TG). The aim of
this study was to better understand the mechanism wliereby oleate protects
human breast cancer celis against apoptosis induced by serum withdrawal. 11w
metabolism of FFA, 1G and glucose, in parallel with long-term ceil survival in
the absence of serum, was investigated in I’IDA-MB-231 celis treated with
exogenous oleate. Ihe results were extended to a panel of human breast cancer
ceil lînes (MDA-MB-468, T-47D, MCF-7) and the non-transformed celi strain
1’ICF-1OA. Short-term (3-24 h) exposure of MDA-MB-231 ceils to exogenous
oleate resulted in dose dependent long-term (10 days) serum-free survival and
correlated with accumulation of 1G in Iipid droplets. Ihe cetiular 1G content
increased and the rate of Iipolysïs was upregulated by oleate in a dose
dependent manner and both effects persïsted after oleate removal. Rapid 1G
lipolysis and FFA reesterification, supported by high rates of glycolysis that
provides the glycerol backbone for 1G synthesis, are consistent with the
presence of very active TG/FfA cycling in human breast cancer ceils. Only the
cancer celi unes capable of accumutating 1G showed Iong-term serum-free
survival after treatment with oleate. The resuits suggest that upregulation of
1G/FFA cycling induced by short-term treatment with oleate may be involved
in maintenance of human breast cancer ceil survivat and may provide one of
the links between lipid metabolism and cancer.
109
Introduction
Epidemiological evidence indicates that obesity increases the risk of
developing several diseases, including breast cancer (rev. in 1, 2, 3). Excess
adiposity is considered harniful because it is associated with increased plasma
triacylglycerols (TG) and free fatty acids (FFA) (4) that contribute to ectopic
deposition of lipids in nonadipocytes. This abnormal fat deposition is irnplicated in
the development of insulin resistance and lipotoxic tissue damage (5, rev. in 6, 7, 8).
The long chain saturated FA palmitate (C16:0) and the rnonounsaturated FA oleate
(C 18:1) are the rnost common FA in our diet, blood, and other tissues. Lipotoxicity
in vitro is induced by palmitate but flot by oleate (5, 9, 10). In addition, oleate
protects against apoptosis in vitro and prevents insulin resistance in vivo (11).
We previously showed that oleate supplementation leads to TG accumulation
in MDA-MB-231 ceils and protects against lipotoxicity by chaimeling saturated FFA
to the intracellular lipid storage pool and by sustaining the synthesis of cardiolipin
for mitochondrial membrane integrity (9). In addition, ceils with increased capacity
for unsaturated FA synthesis (ceils overexpressing stearoyl-CoA desaturase), which
have increased endogenous levels of monounsaturated fatty acids, are resistant to
palmitate-induced Iipotoxicity, whereas cetls with impaired TG synthetic activity are
sensitive to lipotoxicity induced by both saturated and monounsaturated FFA (12).
Therefore, accumulation of TG prornoted by exogenous and/or endogenous oleate
may have an adaptive function and protect against Iipotoxicity.
Monounsaturated FFA may also be protective against apoptosis induced by
factors other than palmitate. For example, the monounsaturated FFA palmitoleate is
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protective against apoptosis induced by serum withdrawal and cytokines in rat f3-
cells (13) and oleate prevents apoptosis induced by serum withdrawal in MDA-MB
231 ceils (10). Protection by oleate against apoptosis induced by serum withdrawal
might involve signaling via the ceil-surface G protein coupled receptor GPR4O and
activation ofthe phosphatidylinositol 3-kinase/Akt survival pathway (14).
FFA and glucose are both fuel substrates and their metabolic pathways are
interdependent and often reciprocally reguÏatcd (rev. in 15). Warburg (16, 17)
showed over 70 years ago that cancer ceils have increased rates of glucose
rnetabolism. However, it was shown only recently that oncogenic mutations are
directly responsible for some ofthese changes (18, 19) and that glucose metabolism
and survival pathways are intertwined (rev. in 20, 21). Tumor ceils have both
elevated glycolytic and synthetic processes in order to meet the need for continuous
growth (rev. in 22, 23). Little is known, however, how these changes in glucose
metabolisrn affect the metabolism of FFA or TG. The question becomes especially
important in the context of obese individuals and obese cancer patients where both
fuels may be available in excess.
The aim of the present study was to better understand the biochemical basis
of the antiapoptotic action of oleate in human breast cancer celis. Specifically, we
addressed the question of how the metabotism of oleate and 1G accumulation could
be involved in protection of human breast cancer ceils against apoptosis induced by
serum withdrawal. The metabolism of oleate, 1G and glucose were examined after
short-term oleate treatment (24 h) and retated to Iong-term (8-10 days) cdl survival
in the absence of serum growth factors or FFA. We show that hurnan breast cancer
celis treated with oleate respond by upregulating their level of TG/FfA cycling and
that this response correlates with oleate induced long-term serum-free survival in
those ce!! unes which also have an etevated capacity for fat storage.
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Resuits
Short— Terni Olectte Treatment Promotes Long— Tei-m Serum—free CelÏ SurvivaÏ
Long-term survival of MDA-MB-23 I celis exposed briefly to oleate was
measured. After 24 h exposure to various concentrations of exogenous oleate, the
celis were maintained in culture without senim or oleate for an additionaï eight days
(with daily changes of media) and the live adherent cef f s were counted daily. f igure
lA shows that serum-starved celis without oleate treatment dieU whereas oleate
treated ceils survived for many days. Short-term (24 h) treatment with 400 iM oleate
afforded complete protection against apoptosis induced by serum withdrawal for at
least 10 days, while lower concentrations of oleate provided partial protection in a
dose dependent manner.
The percentage of live adherent MDA-MB-231 celis at Day 10 post 24 h
treatment with 400 iM oteate was 108.4 % relative to the ce!! number at Day 1 (Fig.
lA). This suggests that celis protected against apoptosis by treatment with oleate
were pro!iferating at a very low rate, if at att. Using FACS ana!ysis, we examined the
celi cycle distribution of serum-starved and o!eate-treated MDA-MB-23 1 cel!s from
Day I unti! Day 4 post serum withdrawa! and compared these with the 5% FBS
control at Day 2 (fig. lB). A gradua! decrease in the percentage of celis in GI phase
ofthe ce!! cycle was observed with a concomitant increase in the percentage ofcells
in S and G2/M phases. Together these resuits (Fig. lA and B) suggest that ceils
protected against apoptosis by oleate did not pro!iferate due to difficu!ty comp!eting
their celi cycle.
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Figure 1C shows that treatments as short as 3 h with 100 tM oleate protected
human breast cancer ceils against apoptosis induced by serum withdrawal. This short
pulse of oleate prevented activation of caspase-3 for up to 24 h. Remarkably, even a
one-hour pulse was partially protective against apoptosis.
The results indicate that a short pulse of a physiological concentration of
exogenous oleate protects human breast cancer cells against apoptosis induced by
serum withdrawal. The survival effect is oleate dose dependent and long lasting.
Surviving celis slow down their proliferation and tend to accumulate in the S and/or
G2/M phases ofthe celi cycle.
MDA -MB-231 Celis Have a High C’apacity To Store TG as Lipid Droplets
Figure 2A shows that a 24 h exposure of MDA-MB-23 t cetis to
physiological concentrations of 100 iiM and 400 jiM ofoleate bound to BSA causes
the formation of many intracellular tipid droplets. The lipid droplet materiat that was
stained by Ou Red O increased proportionally with increasing oleate concentration.
Control ceils (flot exposed to oleate) formed few if any Iipid droplets. The ability of
MDA-MB-23 1 cells to efficiently esterify oleate for storage as TG is illustrated in
Fig. 23. Total intracetiutar TG content of the cells was found to increase in a dose
dependent manner in response to 24 h treatrnent with increasing concentrations of
oleate.
MDA -MB-231 CelÏs Hctve High Rates ofTG/fFA CycÏing
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TG stored in lipid droplets can be hydrolyzed to produce FFA and glycerol.
This process (lipolysis) has been mostly studied in adipocytes, where it is carried out
by the highly regulated enzyme hormone-sensitive lipase in addition to other less
known lipolytic enzymes (rev. in 24). FFA that are released from TG by lipolysis
can be immediately reesterified within the ceil to form 1G again. Lipolysis and
reesterification are two opposing processes involved in what is referred to as
intracellular TG/FFA cycling (25, rev. in 26).
Lipolysis in MDA-MB-23 1 cclls was measured using two cornplementary
assays in which the amount of either glycerol or fFA released into the cell media
from the breakdown of TG was analyzed (Fig. 2C and Table 1). Figure 2C shows
that MDA-M3-231 celis have a high rate of lipolysis as measured by glycerol
released relative to their total TG content. Moreover, the rate of lipolysis increased
dramaticaÏly with exposure to increasing concentrations of exogenous oleate. Thus,
following 24 h of incubation with the highest concentration of exogenous oleate (400
tM), cellular 1G content was 52 nmol/106 ceils and glycerol released during 1 hi
was 35 nmol/106 ceils. This suggests that MDA-MB-231 cells reesterify FFA very
efficiently and have very active TG/FFA cycling.
The data presented in Table I shows the rate of lipolysis measured by the two
methods and reveals that the values are not stoichiometrically related as might be
expected. For the cells treated with 400 jiM oleate, we found only 3.13 nmol/h1106
cells of FFA released, instead of 3 x 35.8=107.4 nmol/h/106 cells calculated from the
results obtained using glycerol release (1 molecule of 1G is composed of I glycerol
and 3 FA). The rate of FFA oxidation in MDA-MB-231 ceils (0.05 nrnol/h/106
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ceils) cannot explain the discrepancy between the arnount of glycerol and FFA
released. The resuits therefore indicate that >95% of FFA are indeed recycled back
to TG in these celis rather than being oxidized. The net effect is that these ceils when
exposed to exogenous oleate, both synthesize and maintain TG in lipid droplets very
efficiently (Fig. 2B) in spite ofa very high rate oflipolysis (Fig. 2C).
Short-tenu Oteate Tnecttment, which Pmtects MDA -MB-23] CeÏÏs against Apoptosis,
Causes a Long-lasting change in ceÏÏuÏar Lipid Metabotism
Figure 3 shows that short-term (24 h) treatment of serurn-starved MDA-MB
231 ceils with 100 jiM oleate leads to long-tcrm stable (at least 7 days) intracellular
TG content (Fig. 3A) and elevated lipolysis rate (f ig. 3B). Thus, lipolysis remained
elevated between 20 and 17 nmol/h/106 cetis from Day 2 until Day 7, whereas within
the same time period, cellular TG content was moderately lowered from 20 to 12
nmol/106 celis. This suggests that during the 7 days post oleate treatrnent, the cetiular
TG pool continued to turnover at a high rate because ofvery active TG/FFA cycling.
MDA -MB-23] Ceils Protected against Apoptosis Lw Oleate and Cultured in Serum
free conditions, Maintain u High Rate of Glucose Oxidation
A number of growth factors-dependent ceils downiegulate their metabolism
of glucose when growth factors are withdrawn (27). It was therefore important to
assess the rnetabolisrn of giticose in MDA-MB-231 celis under senim-free
conditions. Continuous TG/FFA cycling requires a constant supply of glyceroÏ-3-
phosphate, which can be produced by gtycolysis. Figure 3C shows that MDA-MB
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23 1 cells have a high rate of glucose metabolism, a characteristic typical of rnany
cancer celis. In control conditions (presence of serum) MDA-MB-23 I celis exhibited
160% higher glucose oxidation compared to non-transformed breast epithelial celis
MCF-IOA. In addition, MDA-MB-231 cells maintained a high glucose oxidation
rate until Day 2 post serum withdrawal, contrary to MCF-IOA celis that
downregulated glucose rnetabolisrn by 65% 24 h after withdrawal of serum and
growth factors. The latter measurernents are probably overestimated since they were
perforrned on live adherent cells (flot on total ceils) because, at Day 2 post serum
withdrawal, the cells began to enter apoptosis. At Day 3 post serum withdrawal,
MDA-MB-23 1 cells protected by short-term treatrnent with oleate still maintained a
high glucose oxidation rate, while the majority of non-treated celis (> 90%) had
detached from the dishes and were dead as determined by Trypan Blue staining (see
f igure lA).
Thus, elevated glucose rnetabolism in MDA-MB-231 celis most likely
provides gÏycerol-3-phosphate needed for FFA esterification and remains the main
energy source in MDA-MB-231 ceils protected agaifist apoptosis by short-terrn
treatrnent with oleate. It is therefore unlikely that FFA released from droplets by
lipolysis are needed as an alternative energy source (via FFA oxidation in
mitochondria) to promote survival of these cells in the absence of serum. Consistent
with this, MDA-MB-23 1 cells were found to have a very low rate of FFA oxidation
(Fig. 4C).
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High C’apacitv to Store TG Is Correlated With Enhanced Serum-Free Cet! Surviva!
in Various Httman Breast Cancer C’ett Lines
The effect of oleate treatrnent on ce!! survival was tested in three other
human breast cancer ceil unes, together with the non-transformed hurnan breast
epithelial celi une (MCF-1OA) (Fig. 4). The design of the experiment was sirnilar
to that shown in Fig. lA and celis were counted on Day 6. The resuits are
expressed as percentage of control culture ce!! number at Day 1 (before addition
ofoleate). It should be noted that each ofthe different ceil unes had different
growth characteristics. The MCF-1OA non-transforrned celis were dependent on
both serum and growth factors for survival and were flot protected by oleate
treatment in the absence ofthese additives (Fig. 4A). T-47D and MDA-MB-468
celis responded sirniÏar[y to oleate treatment as did MDA-MB-23 1 cells,
although the three cel! !ines differed in their sensitivity to serum withdrawal,
with MDA-M3-23! being the rnost sensitive. Oleate treatrnent in the absence of
serum had no effect on the survival of the fourth ceil une tested, MCF-7. The
three ce!! unes that responded to oleate treatment accumu!ated high !eve!s of
cetiular TG, as shown in Fig. 4B, whereas the ce!l une that did flot respond to
oleate (MCF-7) had low total TG content, as did MCF-1OA celis. These resuits
further confirrn that high ce!!ular TG content is associated with enhanced serum
free celi survival after treatment with oleate in three of four hurnan breast cancer
ccli unes.
FFA esterification to fonu complex lipids, in particular TG, represents one of
two main rnetabo!ic pathways for FFA within the ce!!, the other being FFA
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oxidation. It was of interest to examine the relative rate of FFA oxidation in our
panel of ceti unes. We expected to see an inverse correlation between oxidation and
esterification. Figure 4C shows that MDA-MB-23 1 and T-47D ceil lines, which have
high 1G content, had a tow intrinsic FFA oxidation rate, while MDA-MB-468. MCf
7 and MCF-IOA celi unes showed high FFA oxidation rates. Surprisingly, however,
MDA-MB-462 celis had both a high FfA oxidation rate and a high TG content after
exposure to exogenous oleate. Ihus, the rate of FFA oxidation of the different
human breast cancer ceil unes tested was variable (high and low) and did not
correlate with the cellular 1G content or the ability for long-terni serurn-free survival
induced by treatment with oleate.
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Discussion
We found that three out of four hurnan breast cancer ce!! unes tested (MDA
MB-231, MDA-MB-468, and T47D) were protected for many days against apoptosis
and death induced by serum withdrawal by short-term (24 h) treatment with o!eate.
These ceils pro!iferated very siow!y if at ail, suggesting that treatment with o!eate
influences main!y celi survival with littie effect on ceil pro!iferation. The iong-tem
serurn-free survival in these human breast cancer celi unes was associated with
elevated TG content and was o!eate dose dependent. After short-term treatment with
o!eate, the ce!!ular TG pool increased significantly and the rate of lipolysis
(measured as glycero! re!eased into the culture medium) was upregulated.
Subsequent!y, both TG !evels and the rate of !ipo!ysis remained high for a long
period oftime (8-10 days). These resuits demonstrate that MDA-MB-231 celis have
very efficient TG/FFA cyc!ing, allowing maintenance of e!evated TG content in
spite of very active ongoing Iipo!ysis. Glucose metabolism remained high in serum
starved MDA-MB-23 1 cei!s protected against apoptosis by short-term treatment with
oleate, providing glycerol-3-phosphate needed for FFA esterification and being the
main energy source in these ceils. Thus, it is attractive to propose that elevated
TG/FfA cycling after exposure to exogenous oleate is involved in the maintenance
of Iong-term serum-free surviva! of human breast cancer cei!s.
Cellular TG/fFA cycling occurs in rnany tissues. It is a multi-step, complex
cycle involving many enzymes. At least one enzyme activates FFA to fonu FA-CoA
(2$), then at !east five others are involved in sequential esterification of fA-CoA to
glycerol backbone (29); subsequent!y at !east three different lipases are invo!ved in
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lipolysis (24). TG/FFA cycling is considered to be a “futile cycle” since its main
outcome is the consumption of energy (production of 1 molecule of 1G consumes 6
molecules of ATP). However, this process allows preservation of intracellular FA
pools when they are flot oxidized for energy production and has been linked to
thermogenesis in brown adipose tissue (30). The presefit study suggests a nove! role
for TG/FFA cycling, which is enhancement of human breast cancer cet! survival. A
model illustrating this relationship is shown in Figure 5 and is exp!ained below.
The mode! is based on the fact that many cancer celis, including the MDA
MB-231 celi une used in this study, show increased glycolytic rate. This aÏÏows
rapidly proliferating cancer celis to use glycolytic intermediates for synthesis of
nucleic acids and amino acids, and atso supplies their energy needs. In addition,
glycolysis-derived pynivate carbons are transported from the mitochondriat matrix to
the cytoplasm in the form of citrate, which becomes a precursor for de novo FFA
synthesis. Thus, cancer ceils are fu!ly prepared for continuous growth and
proliferation by being able to synthesize rnany of their substrates and complex
molecules de novo from glucose. The weakness of the efficient cancer ce!! synthetic
machine, however, is that the high glycolytic rate requires constant regeneration of
cytosotic NAD. In many ce!! types, lactate dehydrogenase (LDH) is a key enzyme
involved in this process. LDH oxidizes pyruvate to lactate with sirnultaneous
regeneration ofNAD from NADH, and lactate is secreted from the ce!!. Our model
in Figure 5 proposes that rapid TG/FFA cyc!ing provides a second (alternative) route
for NAD’ regeneration.
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fle esterificadon phase of TG/FFA cycle requins glyceroi-3-phosphate
(G3P). G3P is produce by G3P dehydrogenase (GPDH) from dihydroxyacetone
phosphate (DRAP) widi simultaneous regeneration of NAJY from NADH. We
propose bat channeling of G3P to FFA esterification to form TG followed by rapid
hydrolysis and release of glycerol from die ccli, allows die system to mn
continuously as long as FFA for nesterificadon are available. A very efficient
recycling of FFA in !vffiA-MB-231 ceils presewes die intraceliular pool of FA. In
addition de novo synthesis of FA can possibly also supply die pooL fie alternative
NAD regenention system described here and shown in Fig. 5 enhances tumor ccli
sunrival by setting a stable rate of cytopiasmic NADt regeneration, which would
otherwise be limiting and cause cancer ccli apoptosis and deadi.
It was ncendy postulated bat signaling for ccli survival might involve
confroliing ccli access to nubien in addition to inhiMfing apoptosis (21, 31, 32).
frOA-?vffl-231 breast cancer celis appear to have acquired autonomy in confroliing
diefr access to glucose, but dieir apoptotic machineiy can stiui respond to a lack of
semm powth &ctors. fie best-studied system responsible for ccli sunrival and
exaceliular nuffient upake is die phosphatidylinositol 3-kinase/Akt padiway (rev.
in 33). Our previous work (14) as wei as bat of odiers (34) demonsfrated bat dis
padiway could be stimulated via die G protein coupled FFA receptors, GPR4O and
GPR12O. It is possible diat die sunrival effcct dcscribed here, which involves up
regulation of TGIFFA cycling, is also in part GPR4O-mediated. flus, TG/FFA
cycling by preserving die pool of FA inside die ceils for long periods oftime would
assure continuing availability of small amounts of FFA reieased into die medium
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upon lipolysis, for binding to the GPR4O receptor and activation of the survival
signaling cascade.
The human breast cancer ceil unes used in this study derived from
metastases, so they represent aggressive, advanced breast tumors (35). Two ofthose,
which responded to o!eate are estrogen receptor (ER) negative (MDA-MB-231,
MDA-MB-46$) whule one is ER positive (T-47D). Furthermore, MCF-7 celis, which
did flot respond to oleate at ai!, are the !east invasive of the cancer ce!! !ines used in
this study. MDA-MB-23 1 celis, which were the rnost responsive to oleate, are
known to be the most invasive (36). Thcrefore, the ability of oleate to modify human
breast cancer celi survival in vitro appears to be independcnt of their ER stahis,
however it may be positively correlated with their invasiveness.
MDA-MB-23 1 cells protected against death by treatrnent with o!eate
were viable for !ong periods of tirne but blocked in ceit division. In this respect they
resemble disseminated tumor ceils, which have been detected in the bone manow of
patients with breast tumors. Most are flot actively pro!iferating and remain in a state
of”dornancy” for rnany years (rev. in 37). Persistence of disseminated turnor celis is
associated with a poor clinica! outcome (38). It is tempting to speculate that oleate
cou!d contribute to the survival of disseminated tumor celis via upregu!ating
TG/FFA cycling. Furthermore, upregulation of TG/FFA cycting, which confers
resistance tu apoptosis may also contribute to drug resistance common for
disserninated tumor ce!!s (39). More evidence, especially studies in vivo with
primary tumors and metastasis are needed to verify if increased rate of TG/F FA
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cycling couÏd indeed be a marker of tumor invasiveness or could contribute to
disseminated tumor ceils survival and/or drug resistance.
The in vitro resuits presented here provide support for epiderniological
studies, which show a positive correlation between elevated oleate content in breast
tissue and increased breast cancer risk (40, 41). Thcy are also consistent with the
recent evidence suggesting that obesity is associated with increased breast cancer
recurrence and rnortality, and that life style interventions, like dietary fat reduction,
significantly improve surviva! in postmenopausal women (42). Further work is
required to determine whether enhanced TG/FFA cycling promotes turnor ce!!
survival by NAD+ regeneration and/or FFA signaling, possib!y via GPR4O or
another FFA receptor, and whether our in vitro rcsu!ts are relevant to hurnan breast
cancer cell rnetabotisrn in vivo.
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Material and Methods
MateriaÏs
FFA sodium saits were purchased from Nu-Check, Prep (Elysian, N’ÎN). Fetal bovine
serum (FBS) was from Invitrogen (Carlsbad. CA) and was heat-inactivated at 56°C
for 30 min. FFA-free BSA (Fraction V, 96% FFA-free, was obtained from Sigma
(St-Louis, MO). [1-14C]palmitic acid (55 mCi/mmol) was purchased from Perkin
Elmer Life Sciences (Boston, MA). D-[U-14C] glucose (317 mCi/mmol) was
obtained from Amersham Biosciences (Baie d’Urfé, Québec, Canada). Unlabeled
and labeted albumin-bound fatty acids (oleate and palmitate) were prepared as
previously described (9).
CeÏÏ Lines ctnd Cuttitre Conditions
The tumorigenic human breast cancer ceil unes. MDA-MB-23 I, MDA-MB-468, T
47D and MCF-7, and the non-tumorigenic celi une derived from normal human
epithelial ceils MCF-1OA, were obtained from the American Type Culture
Collection (Manassas, VA). Celis were cultured at 37°C in a humidified atmosphere
with 5% C02 in a 50/50 mixture of Dulbecco’s modified Eagle’s Medium and Ham’s
F-12 (DMEM/F12; Wisent; St-Bruno, Québec) containing 2 mM glutamine and 5%
heat-inactivated FBS. For MCF-IOA cetts, DMEM/F12 was supptemented with
insulin 10 ig/rn1, hydrocortisone 0.5 tg/m1 (both from Sigma, St-Louis, MO) and
recombinant human epidermal growth factor 20 ng/ml (Invitrogen). Ah experiments
were performed in minimal essential media (MEM) as described below.
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ExperimentaÏ Procedure for OÏeate Treatment
Ceils were plated in triplicate in 25 cm2 flasks at a low density of I x i05
celis per flask in MEM (phenol red-free; Sigma-Aldrich, Oakville, ON, Canada)
supplernented with 5% heat inactivated FBS. For total TG content and lipolysis
measurements, ceils were similarly plated in 75 cm2 flasks at 3x105 celis per flask.
Afier two days of growth, ceils were washed with PBS and the medium was replaced
with fresh MEM with no additives for 1 8 h. After this period of serum starvation, the
medium was replaced with fresh MEM (serum/growth factor free) containing
albumin-bound oleate at concentrations ranging from O to 400 jiM complemented
with 0.5% BSA. For long-term survival experiments after exposure to oleate for 24
h, celis were cultured in MEM without serum, growth factor, BSA or FFA, and
media were changed daily.
Caspase 3 Assay
Caspase 3 activity as an index of apoptosis was determined in ccli lysates
prepared from individuai cultures using the protocol described in CaspACETM
Fluorernetric assay system (Promega, Madison, WI) with Ac-DEVD-AFC as the
caspase-3 substrate (BIOMOL; Plyrnouth Meeting, PA). Ceil protein concentration
was detennined using the BCA Protein Assay kit (Pierce; Rockford, IL) with BSA as
standard.
Fatly Acid and Glucose Oxidation
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Fatty acid oxidation was determined as the amount of 14QQ, liberated from
samples incubated with [1-11C] palmitic acid or [1-’4CJ oleic acid using a modified
procedure described by (43). Briefly, celis were grown according to experimental
procedure for oleate treatment in duplicate 25 cm2 flasks. Then, media were
discarded and replaced with 0.9 ml of fresh MEM containing 0.1% BSA and
incubated at 37°C for 30 min in a C02 incubator. Subsequentty. 100 t[ of the IOX
reaction mix (prepared freshly 2 h in advance and containing 10 mM camitine, 1
mM palmitate, 4% BSA and 0.5 1iCi per culture flask of Iabeled FA) was added to
each flask. The flasks were immediately sealed with rubber serum vial stoppers. The
stoppers were fitted with plastic tubes containing folded glass fiber ifiter paper
(Whatrnan GF/B) saturated with 0. 15 ml of 5% KOK. The sealed flasks were
incubated for 1 h at 37°C. Control blank ftasks contained ail reagents without cells.
The reaction was stopped by injecting 0.3 ml of 40% perchloric acid through the
serum stopper into each ftask with a syringe and the flasks were then shaken gently
for 24 h at RT. Filters were then removed and placed into scintillation vials
containing scintillation liquid. Radioactivity was counted 24 h later, using a liquid
scintillation counter (Tri-Carb 2100TR, Perkin Elmer). Resuits were expressed as
nmot ofFFA released/h/rng of celt protein.
Glucose oxidation was measured by determining the release of ‘4C02 from
[U-’4C] glucose. The experimental setup to capture 14C02 was as described above for
FFA oxidation. Cells were preincubated in 0.9 ml MEM medium (with or without
serum or with 0.1% BSA) for 30 min at 37°C in a C02 incubator (5% CO and 95%
air) after which lOOp.t aliquot of D-[U-14C] glucose diluted in MEM was added to
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each flask (0.5 jiCi/flask). The flasks were then sealed and incubated for 1 h at 37°C.
The reaction was stopped and the radioactivity captured by the filters was measured
as described above. The resuits were expressed as nmol of glucose oxidized/h/mg of
protein.
Triglyceride Assay
Cellular TG content was deterrnined using the GPO-Trinder kit (Sigma
Diagnostics, St-Louis, MO) and samples were prepared as described by (44). Two
million celis harvested on ice by scraping were washed twice with cold PBS and
lipids were extracted as described (45). The extracted lipids were dried under N2,
dissolved in 100 pi of 2% v/v Thesit detergent (Sigma, St-Louis, MO) in chloroform,
dried again under N2, and resuspended in 50 t1 of water. The samples were then
vortexed and sonicated in a water bath sonicator (Crest Tru-Sweep (50/60 Hz),
Trenton, NI) for 15 min at RT. Two hundred pi of GPO-Trinder kit reagent was
added directly to each sampte tube, mixed gently and incubated for 5 min at 37°C.
The reaction mixture was transferred to a 1 .5 ml microfuge tube and centrifuged at
12,000 x g at 4°C for 5 min. The supernatants were transferred to a 96 well-plate and
the OD measured at 540 nui using a microplate reader (Bio-Rad 3550). Triolein
(glyceryl trioleate; Sigma-Aldrich) was used as standard.
Lipid DmpÏets Staining
Lipid droplets were visuaïized using staining with Oit Red O. Stock solution
was prepared by dissolving 300 mg Oil Red O (Atlied Chernical, Brighton, UK) in
12$
100 ml of 99% 2-propanol. Working solution prepared freshly by diluting the stock
solution with water (3:2) was kept at RT for 10 min and filtered through a 0.22 trn
filter (Corning PES filter). Celis in duplicate Petri dishes (60 mm) were washed
twice with 5 ml PBS and incubated with 3 ml of Cil Red O working solution for 15
min at RT with gentie shaking. The ceils were then washed once with PBS and fixed
with 1 0% formalin (Anachemia, Lacune, QC, Canada) for 25 min. The celis were
washed again with PBS, stained for 5 min with Harris Hematoxilin (Sigrna-Aldrich)
diluted 50% with PBS, washcd with PBS, and 3 ml of 10% glycerol in PBS was
added to each dish to prevent drying. Photornicrographs were taken from a
representative field using an inverted microscope (Nikon Eclipse TE300) at 400X
magnification and a digital camera (Nikon CoolPix 990).
Lipolysis
Celis were grown in 2 x 75 cm2 flasks, trypsinized, pooled, resuspended in
serum-ftee MEM medium containing 0.1% B$A and counted. The celis were then
resuspended in fresh MEM medium containing 0.5% BSA at a density 2 x 106
cells/100 jil and incubated in 48 weIl-plates (100 .d/well) for 3 h at 37°C in a C02
incubator. Samples were then transfetied to Eppendorf tubes and centriftiged at
1,500 rpm for 5 min at 4°C. The supernatants were collected and frozen at -80°C.
The rate of lipolysis was measured using two different assays. Glycerol released
from the celis was rneasured in triplicate using the Triglyceride GPO-Trinder kit
(Sigma Diagnostics, St-Louis, MC). Total FFA reteased were deterrnined in
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duplicate using the Wako NEFA test kit (Wako Chemicals USA, Inc. Richrnond,
VA) and expressed as miiol glycerol or FFA released/h/106 celis.
FACS Anali’sis
DNA staining for FACS analysis was perforrned as described (46). Briefly,
celis were harvested by trypsinization, washed with PBS plus 0.1 % BSA at 4°C and
the cells were fixed with 70% ethanol for 10 min at -20°C. They were then collected
by centrifugation (300 x g, 5 mm) and resuspended in staining buffer prepared by
adding NP4O (0.6% v/v) and 36 ig/m1 RNase to a 1 x dilution ofa 20 x stock (1.17 g
of sodium chloride, 2.13 g of sodium citrate, and 0.10 g ofpropidium iodide in 100
ml of water, pH 7.6 adjusted with acetic acid). Stained cetls (10,000) were analyzed
with a flow cytorneter (FACS SCAN, Beckton Dickinson) and ceil cycle analysis
was performed using the Cell Quest Pro software.
StatisticaÏ A nalvsis.
Statistical signfficance was calculated with the Student’s t-test. A P-value of
<0.0 1 was considered significant.
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Table 1. The Rates of Lipolysis in Oleate-Treated MUA-MB-231 Celis
Evaluated by Measurements of the Amounts of Glycerol or FFA Released into
the Medium.
Oleate (pM) TG content Glycerol released FFA released
(nmol/106 ceils) (nmollh/106 celis) (nmol/h/106 ceils)
0 2.78±0.25 3.91±1.51 <0.5
33 4.76 ± 0.37 12.72 ± 1.3$ 0.56 ± 0.22
100 18.25±1.38 21.48± 1.45 0.84±0.39
400 52.28 ±3.62 35.8± 1.32 3.13 ±0.18
Note: Celis were senim-starved for 24 h and then treated with oleate for another 24
h. Immediately after oleate treatment, ceils were collected for lipid extraction and for
detenriination ofthe rate of lipolysis as described in Methods. The data represent the
means and SE for two independent experiments perforrned in duplicate (n=4).
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Figure Legends
Figure 1: Effect of short-term oleate treatment on long-terni serum-free survival and
ce!! cycle distribution of MDA-MB-23 1 cells. A. Two days after seeding (Day O),
celis were serum-starved for 24 h (Day 1) and treated with a range of oleate
concentrations (O-400 !IM) for 24 h (Day 2). CelIs were cultured for up to 8 days in
medium without serum and oleate and, viable cells (celis excluding tlypan blue),
were counted daily. Ceil survival is expressed as the mean number of live adherent
cells/flask. The data represent the mean and SD for a representative experiment
(n=3), which was repeated two times. B. FACS analysis for DNA content is shown
for control cells grown in 5% FBS (Day 2) or for oleate-treated cells collected at
various days. C. Celis serum-starved for 24 h were treated with 100 !IM oleate for a
range of times (O-24 h). Ceils were then washed with PBS and incubated with
medium containing no serum. Caspase-3 activity was assayed on total celis at the 24
h time point. The data represent the mean and SE for two independent experirnents
performed in duplicate (n=4).
Figure 2: Relationship between short-term oleate treatrnent and cellular lipid droplet
formation, total cell 1G content, and lipolysis rate in MDA-MB-231 ceils. Ceils
serum-starved for 24 h were treated with a range of oleate concentrations (O-400
tM) for 24 h A. Representative photornicrographs of Oil Red O-stained celis are
shown (400X). Contro! cells were grown in media containing 5% fBS. B and C. At
the end of oleate treatment, cells were imrnediately assayed for TG content (B) or
132
lipolysis rate (C). The data represent the mean and SE for two independent
experirnents perfornied in duplicate (n=4).
figure 3: TG content, lipolysis rate and glucose oxidation in MDA-MB-231 celis
treated with oleate and rnaintained in serurn-free conditions. A, B and C. CeIls
serum-starved for 24 h were treated with 100 iM oleate for 24 h. Then, they were
cultured for up to 7 additional days in medium without serum and oleate. Total
cellular TG content (A), lipolysis (B) or glucose oxidation (C) of adherent ceils was
determined at specffic days. Glucose oxidation is expressed as nrnol/h/mg of protein.
Glucose oxidation in MCF-10A cells is also shown for comparison (C). The data in
ail panels represent the mean and SE for two independent experirnents perfonned in
duplicate (n=4).
Figure 4: Effect of short-terrn oleate treatment on long-term serum-free survival,
cellular TG content and ffA oxidation in a panel of human breast cell lines. A. Cells
serum-starved for 24 h were treated with 100 jiM oleate for 24 h. They were then
cultured for 6 days in medium without serum or oleate. At Day 6 the number of
viable cells was determined and the long-term semrn-free survival was calculated as
the mean percentage of controÏ at Day I (before addition of oleate). The data are the
means and SE for 2-4 independent experiments performed with triplicate flasks per
experiment (n=6 for T-47D, n=9 for MDA-MB-231, n=12 for MDA-MB-468, n$
for MCF 7 and n=4 for MCF-IOA). ‘, p <0.01 eeitts respective control. B. After 24
h of serum starvation, cells were treated with a 100 iM oleate for 24 h and assaycd
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for TG content C. Fatty acid oxidation was measured afier 24 h of serum starvation.
For (B) and (C), the data represent the mean and SE for two independent
experiments performed in duplicate (n=4).
Figure 5: Mode! illustrating the possible link between TG/FFA cycling and breast
cancer ccli growth!survival. Exogenous FFA after entering the ce!! are activated to
form FA-CoA (Step #1) and esterified to form TG (Step #2). Cellular TG content
increases proportionally to exogenous oleate dose. The TG pool is flot inert but is
constantly tuming over due to high rates of both lipolysis and reesterification
involved in TG/FFA cyciing (Step #3). The rate of TG/FFA cycling increases as a
function of the original exogenous FFA (oleate) concentration. TG/FFA cycling
needs G3P, production of which is couplcd to NAD regeneration (Step #4).
Therefore, the high rate of TG/FFA cyciing sets the stable rate of cellular NAD
regeneration, which in tum allows the maintenance of a high rate of glycolysis. This
aliows the production of sufficient amounts of pyruvate (Step #5) required for
anaplerosis (Step #6) and de novo FA synthesis (Step #7), which can supply the
intraceilular pool of FA and contribute to continuing TG/FFA cycling.
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